var title_f3_16_3328="Gilbert's syndrome";
var content_f3_16_3328=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Gilbert's syndrome (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?3/16/3328/contributors\">",
"       Authors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/16/3328/contributors\" id=\"au4080\">",
"       Namita Roy-Chowdhury, PhD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/16/3328/contributors\" id=\"au3025\">",
"       Jayanta Roy-Chowdhury, MD, MRCP",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?3/16/3328/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/16/3328/contributors\" id=\"se8782\">",
"       Keith D Lindor, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?3/16/3328/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/16/3328/contributors\" id=\"de2797\">",
"       Anne C Travis, MD, MSc, FACG",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?3/16/3328?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      GILBERT'S SYNDROME OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Gilbert's syndrome, also known as constitutional hepatic dysfunction or familial nonhemolytic jaundice, is an inherited disorder of the liver that results in an overabundance of a substance known as bilirubin. While some people with Gilbert's syndrome develop yellowing of the skin or eyes, most people have no symptoms at all. Gilbert's syndrome is not dangerous and does not cause long-term problems, so it is not necessary to treat Gilbert's syndrome.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      WHAT IS BILIRUBIN?",
"     </span>",
"    </p>",
"    <p>",
"     Bilirubin is normally present in the blood in small amounts. It is a by-product of the breakdown of hemoglobin in old red blood cells, and it is usually converted by the liver into a form that can be excreted from the body in stool. Abnormalities in this process can cause blood levels of bilirubin to rise above normal.",
"    </p>",
"    <p>",
"     People with Gilbert's syndrome have an inherited abnormality that causes reduced production of an enzyme involved in processing bilirubin. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/23/42359?source=see_link\">",
"      \"Gilbert's syndrome and unconjugated hyperbilirubinemia due to bilirubin overproduction\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Every affected person has two copies of the abnormal gene responsible for Gilbert's syndrome. Because over half of the people in the general population have at least one abnormal copy of the gene, inheriting two abnormal copies (one from the mother and one from the father) is not uncommon. Interestingly, people who have only one copy may have slightly higher levels of unconjugated bilirubin but do not have Gilbert's syndrome. For reasons that are not entirely understood, not all people who have two copies of the abnormal gene develop Gilbert's syndrome.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      GILBERT'S SYNDROME SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     Most patients with Gilbert's syndrome have no symptoms. The disorder is frequently diagnosed by coincidence when a lab test done for another reason (such as a life insurance examination) shows an abnormally high amount of unconjugated bilirubin.",
"    </p>",
"    <p>",
"     When the level of unconjugated bilirubin rises beyond a certain point, the bilirubin pigment begins to discolor the whites of the eyes (making them appear light yellow). With even higher levels, the skin may also become yellow (jaundice). This potentially alarming appearance makes many people with Gilbert's syndrome see their healthcare provider.",
"    </p>",
"    <p>",
"     Levels of bilirubin can fluctuate in people with Gilbert's syndrome. They may be highest after an infection (such as the flu), following periods of fasting, and after menstrual periods in some women. In addition, newborns with Gilbert's syndrome may have higher levels of bilirubin and more persistent jaundice than newborns without. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?15/45/16083?source=see_link\">",
"      \"Patient information: Jaundice in newborn infants (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Gilbert's syndrome may also become apparent when an affected person takes certain drugs that require the enzyme involved in bilirubin processing in the liver. A cancer drug called irinotecan is one example.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H4\">",
"     <span class=\"h1\">",
"      GILBERT'S SYNDROME DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     The diagnosis of Gilbert's syndrome is suspected in people who have persistently slightly elevated levels of unconjugated bilirubin without any other apparent cause. A clinician may order several blood tests and possibly an ultrasound of the liver to make sure that there is no other cause of the high bilirubin levels.",
"    </p>",
"    <p>",
"     Genetic testing can also confirm the diagnosis; however, genetic testing is not widely available and is generally not required.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H5\">",
"     <span class=\"h1\">",
"      GILBERT'S SYNDROME TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     No specific treatment is required for people with Gilbert's syndrome. However, there is an increased risk of side effects from certain drugs that are broken down by the liver (such as acetaminophen and the chemotherapy drug, irinotecan). Check with a healthcare provider before taking any new medications. Do not take more than the recommended amount of acetaminophen (Tylenol&reg;).",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H6\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1804392669\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H437206\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/28/21953?source=see_link\">",
"      Patient information: Gilbert&rsquo;s syndrome (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?33/17/34066?source=see_link\">",
"      Patient information: Jaundice in adults (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H437199\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?15/45/16083?source=see_link\">",
"      Patient information: Jaundice in newborn infants (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/23/42359?source=see_link\">",
"      Gilbert's syndrome and unconjugated hyperbilirubinemia due to bilirubin overproduction",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       British Liver Trust",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.britishlivertrust.org.uk/\">",
"      www.britishlivertrust.org.uk",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The Canadian Liver Foundation",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; (",
"     <a class=\"external\" href=\"file://www.liver.ca/Liver_Disease/Adult_Liver_Diseases/Gilberts_Syndrome.aspx\">",
"      www.liver.ca/Liver_Disease/Adult_Liver_Diseases/Gilberts_Syndrome.aspx",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?3/16/3328/abstract/1\">",
"      1",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 2, 2010.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?3/16/3328?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3328/abstract/1\">",
"      Borlak J, Thum T, Landt O, et al. Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects. Hepatology 2000; 32:792.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f3_16_3328=[""].join("\n");
var outline_f3_16_3328=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           GILBERT'S SYNDROME OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           WHAT IS BILIRUBIN?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           GILBERT'S SYNDROME SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H4\">",
"           GILBERT'S SYNDROME DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H5\">",
"           GILBERT'S SYNDROME TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H6\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f3_16_3329="Resectoscope assembly 1";
var content_f3_16_3329=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F50056&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F50056&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Hysteroscopy: Resectoscope assembly 1",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 261px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEFAfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDZwvJbn6UGVV4GB9agxI2cJj8eaBE5+8D616SPk2TNOM4UbueaeJNwx0J/OogqpwFIqRRnIPUfjQSRYJcgAA/nUpOF5PJ9aYFVXJzjjPNLKxK8nj2oGQAkn/E08dRg59O9N8tCASDg1YRM8LkLQUPjjzyx5NPEeM8fjmm4+ckMSDSlsfebgUEMkIA4YY4prbdowPrTQwIGGHpzSjO0ADJ7UAaegRCSUynoOB/Wu/05NsEY9s/nXK6RB5USJ34BrrYGALeijFcFSXNK59ThqPsaUYFoH5sVZiPAqnH6nqatRHgVCNmXQaeOlRpyOaf7UhIU0gNDnapPoKihYuTmqBk9MY4pTUUz4GKAKc7bWFZOoXIjjfJ6Gr2oSbYy3pXDeLtTEFvKAeWkCCgEjolcOgYHqKntz8prA02dmt03dxWtBLjFJMpqxdLYOKJHwvFVvM3OaWZ8IT7UCscx4z1BbHS7q4c/LFGzn8BmvlXw64m1YyygszsWJ68k5Ne2/HTWPsvhuW2VsPdsIh9Op/QGvKPAFp5lzvC5O7rWkNWkYV5csG2e0eEwn2ePbEOPWt5iS2QOcYqpo8TR2gJVQfYYq04ZeWbP0ruR8xUd2MKsASMj60hDYw0m0nPA9KTjI54pMDJJ3c+9UZC4zgebz6Zpfn4YMTnuKaqjr831FO6HAJOO1AhSZOnel+Zwcj0/GjcFUH8/Wm7lOd2RSGJtVeWGcn1px2jGTt601fL/ALjflTlVeghP1PWgBoaEYGeB+NO8yMD5VbP0zTgCWIWLAHXNH7xiBwD70AMaeQnCoV/CmPLnJJbPHUYqcROT87rt9ulNaI7sbl+uKAK7Op+7zjinDGAcdetTeUqnBYf4U4rGMgkDkHOKAIOMHLDHvRgAZz70sjDGdw46cc0zemOSeDQIe2AMsff/AOtSM/GF6HninBgVPlr9KVQTgtIM+gHSgBXDBOhHqc0uCFycn6ilIG0Ft+c9zSSDj+Mg9eaBjC7A5BP5U07n+YIfxqTagAyo/OkGzPy/oaBjRuByV2nOOtNk3v0U9O9OkJYAAMwoG0ZwpBoERCI5GXA7cU8wqMAkk9qlLL/Dwe/FBmGBkqD9aAuxvlIR16/pSGFcfTvSvdAL8xA+lRfaOOFJ/CkPUd5QHIHX3xSBEGeM801pnJHyMMe1OPnNyNqmmLUcNvQrmimGOQj5pODxxRSGZol38kGnEnPOKjJ3DKkY9zTjtxxgn9KDRkirlff+dOJ2oSOgpnBA7A/nSXLgKAOW9h1oFa4yAeZKWcnFTyhAOgyPXtUduO/Oe9F23AA4Oe9AyIcgtye1TxLwMjj0BqGMcg84/lVhBj2JoBkqqhXk896aQgxtGR0pQMgD0GKckajqMigRGRtHQe3tVnTovOuUJHCnP1qEqvXj/GtnQ4BncB1Oazqy5YnXgKPtayT2Wps24CMn1FbNk2/fj1rElRt6lc9a0NHdlgk3g53ECvPufTs1Q+ZBjoKvw1m26knngVpQ7cU0Qy5H90VJ3pi/dGKcOaBCXB/ct9KisuUzUswzE30qtpjfu8enFMZcfpVG4kwTVq5cJGSelZF/Nti354piMzXbgJavz7V5jqcj6t4mtLOP5lWRpWH06fyrpvF+rLBaglu+fy5rG+E9m2o3l/q8w+QnyoyfQdaiUtkawjo5djrY7NokDNSndsKhipI6jtV++cGQItVLgCOPPc0Im5Na5wuTkgdT3qHULgIrLmrNoOOfSuQ1XUM6pcRFsLH94+lUtSXoeFfGnVjqPiv7HG2Y7NdpHbe2Cf0xWx8NdPKpGQvPWvO72Z9Z8T3Nz1+0XDyfhnj9MV734GsPs9kjFAMLnkV0UFdtnm5hU5YKJ0wYxxKFOABzUbHgnJGPepXdsnAJ9OlV5N2cHAHTrXWjwJMVVIzng/yp8e1erZ+tRfdPzN26A0JJF02sTj60ySUum7gjJFAPXLc/Soy8YwNpz9KUyBQQAxz0wMUALuTIHOeuMU7zBkHGD71ADKxCrGRn14NSBJVHIH4nrQAvmHsfem+dJt+UDinNDIePlXA/KnxWyg5LktjPNIREpmfDE9aBHOxIyAPc1cEajGT+NKWXAIyeOnSgCn5LdDKfcDtThb47uR0qyCAxJHX1pjSADJwOvQ0ARG2PzZ3Y7c0hhJxj9DT3uU3Y3AZHr3pBMhBJySPagCM2+Dlh39aeqooI/GmtLu3HG1c8cU0SAcde9AyUkEjOfQ7aVUxyq4Pv3qMO5GVUDHr3pdkrglnCY7DrQBKfvcn8c1HJt253c+uelRCIZ3NKx74pw2Bm4FACl1cEAdqady9QM4p4ZgDgDn1poV8fM4/CgLio+84BVfYUjggNhwMetG0B8hwR16UrozH7wAoAhwzZ+YkDr6U+O2GeQM9eOaeWK7gcEetGWxkAjBoBDzEgHQZ/nTNo29MHvTHz044/Smk8jvQNkpKr6Z7/AEprTdQMH05puB6getNAIHPH6UCHGQjBO04oprnngZX0xRQOxmEJzjnnH1pNqr/tY5pqLlsZGKeI+Se/pSRoPTbkHlfxqOZx5mR/9epVHYAZHGKjkX5gRx6ZoAlgG4ZyRUM3MxGSfr2qzEFCsRjpnNVkJLMxxgHtQC3JIxxkDODUy47Y+tMCk9yT3xUqr8uDgE9aAEOCRnJoyOcbsj1pzMcfKRj2pgAIwzdRigkkXLsqgEsT69q6qwQQQLkVg6Pb+ZPuOSBXUfKiBW6D1rjxEry5ex9FldHkpc73l+RTur8RAnGasaZqTTRjy4jgcEnjmnCCGXooJqS1haJdirgE81zM9LQ17Ys5BY4+lasAGOtULOHKDitKKEgcCqRDLUZG2n1GkZHNSYwKCRH5Uiqdids0qH1yKtv901RlJinSQdOhoBC62W+zLt7uoP51jeKJha6JPKT9xc1tagfMtm9ua4T4t6muneEmYn5pJUUD15z/AEobtqyoptpI8n8eaw91NFZRHLEYIHvXsPgywGieFLSAjEmzc31NeK/D3TJNd8VRzXI3KjeY57ewr3bUJhhY16DisIPnk5nVXioRVNerII2MspY9zUV+581VHY1btl2x7j1qjccybvStTmL1u2IjXi/xL1pdHtdcZW/0q4fyIh3yVA/QZNeuiXCc9BXy58Y7yWfx/fW7NmOIp5ajsWRST9aqLsTJXKPgDTzd6qr4yFwBX0NYAW1skaRnIxnFcV8KNAjt7FLmVRu68ivR8qpPseQa7qUeWJ87jq/tKjsUZXnbOUVRmo2gcsOc/Srsjgk7R1qPf17Hpx0rY85shVTn7uMHjNTIvzA5H0/wpF3AZZwB79qiaaJOHff7KM0xFj5WI6EetG5QM46dMCofNBOI4HC+/FG6fHCKPTmgZIXXoVbHXIpTITgBTk9KhaKZvvTAfhxQYQD8zMzd/mpBsPeUD7xIz6mo3uB/D8x9BzTlhTIY4PFKMIV+nUcUCIxI7AYjOe2aeiTkc4HTpTy/PAOKVWkAXCj8aAsMNu2Qd7YPYUq2gGT1Oe9CuSxyR7+5p4LDjJz6GgYqwIo6J+ApQq8HAHtmmOzY+ZsDsBTXZ8cE8880ADIpbse3NBKIRxk+lN2nkl+nYelIWRQrLyTQA9XBIwDj+dJ80hY4xxjNCtken4UrA44Y+5oAEjROZOT7mjEY6qPqe1Iqhc7QCQacz84AXn24oBBJgg/KMdKbhB3JPTmnZJPYDFJJ93rk+lICJeh4zTmypwv5daVm+VgeM8CkU4OfXk0wGhmIPekCswBHI9alc8DABz703DYxtGKQDVj9cc+/WhkXJOQDnmkwScE/MOtKQMgd/emO4hbacY+buMU3lmJ5HXr2p+AeSQe1IQMkc+3NADMZXBPAop+VzggdcHNFIVzKI6YJB9/SgI4ySSR604LkE574xTxGTg7gCORmg2CNQeW/nUcqgOO+O1TKCM5Oc/pUcpG8BeT0zQJEoH7lsjqDVaIHpjHAqcI/nCQTEw7NpiIHJz1zUOdrEHqewoBEg+UgevU1IowODzjHNRhc9Dx39qeFTCncc+goGxWKjjJxjrU9payX1wIYjk55JPQVULREBYwCfyrV0vRf7Vj3rdT2kyH5JIWwVP8AI/Q1nVnyRujpwdBV6qhLbqdXpukC3iHGT60ajbP5TbetV7W61nRIwuroNQs1/wCXu3TDqP8Abj/qv5VuW9zbahbrLbSxyxOMqynINecpXeu59Py8i02POLjW59E1BftKM0DHGR2rpbLxloZQG6uo4M95OKk17RoLyN45Yw6MMEEda861D4fWsknNzcLDn7gOSKmXMvhNYqEvi0PZNM8QaNeAfYtUspfZJ1J/LNbsUwIBUgg968M074aaJBIkhM05/uyPx+lei6B4e0+yjAtllh9PLmcfpnFNOfVEThBbN/cdsjgin5zWbBbzIB5VyzY7SDP6irHmyx/66M4/vJyKdzK3YnkGRgVVuYwyFT6VMkqSDKsDTJD1zzTQjOilLRPC/wB9Rj6ivCfjfrv2zVdO0qE7ltU82XH99uAPwAP517Vq86WitcuQqICzH2r5y0GKXxD4llurkFklmaTpyQTwPyxWNaTtyrqdeFiuZzfQ9I+F+mf2ZopupVxNPyBjnHausSMySZbkmptM01o7ePeMADhR2q/Hb7DnAq4x5VYyqT5pNkTJsiHFZ1wOvFbFwQIsY5rNnidhwKZmjLvH8uBj0wOa+bZ7C58YfEW/ubaJmthcbTJjjC4X+le7/EK8l0vwtqd1GDuigdgfTiuO+FkYl8PxyLtUNgZx1rppU1Lc4cbiHRhp1Ov02GDTLGO3jdvlUA8dTQ10wwEQke9S7I9oIBYjj2oKYXkYz+ldqR83J3K2+5lB28A04QynDO5B7gCrZxnDH346ComkRTjIIHemTci+zICu75u/zGpo0iRsDbk+1RmRCMsc4PGBSIyMSdgJz0FMRZ8xAOP1pDIu4N6VCGXGNuePShjyBtIPv60hkpkBOc4Pc0eYM9ec4GKjJ3YyCB7mkQsMkbAB2NADidw4DH1IpNz5ACcZ60Fm4y4Ge2M0jMOBvOfbgYoAepJ/i4PoKCcclst6VGrEDPPX/JpO+PTuaBj2JIwDjjgUw7jg5OOnrmjPzdjihnYEgDH0GKAsOVcg4TtnJpRucHJAOOgFMBdsAsPwpqhi2Mt780ASSKB05P8AKo9yRnKKM/WnAA43E+tOAVThRk9sigBUckZOAOvNPycjGB3qMscAjaD+lPXqcHnqKAQuwlcsfwHFMwuMcjt1oyzdDjHQ0pxg9NvWgBWAGcEHj64pAeCBj/61IGA5x24pST64xSAbk8gqpH05FJGcZw3PYUHdjJYncaUAjGD+OKYCttxnJyDikZvl6447mhe+/j8O9MOSQCCQTQAj4IBAz+NIJMjoOPSnnrzg/nTGRgTg8UgFXlD+fNLIDkgkH2pmB0GRilYdieT70xjn+UctwBRUZAA5GB0ooFYoZLFQpP1p4bAz6ccUbRtH93600AZ/pmkaEjS+XGzEfnVSN97lirc+lSz48th/WkgywXOADxjrQNImLZj+6ee9V1yXJXp6ntVmQY4GPcUyN0VfmznvQJCjd0IAFAJAx8uM8U0lnO9MYPG30pq428HcT3B6UhtWJFU8YPHPXpW/4bv7iOArZ2BmIYgsXC5P41h7xjIA6da3vBWoSXIe3toSpjchiR3z1rnxPwo9XKf4kvQ6fT9XvZZPLu9DvoB/z0GyRP0bP6VR1HSik8l94cdILsndNaN8sc31H8Le4/GustlZIwZG571Tu57G9LRI6zyJ/wA8DuZD9V6Vwtaas9xS10RzOn69Dfl4JVa3vI/llgl4ZD/Ue9JcjJ7Vk+LPD+t3En2mGzNx5IzFcoypcIP7rL0dfyNZOgeIhdDyLgqtwhw6Hgg/Q81MamtpGrpac0To1VyflJBFa+lPMkoUkkVlW8gkkUqSa07aQxXCFhxnFambOptpmAAatFH3DNZsJDKDVqF8UGTHypG3JGH/ALw4NV5JGiGZPmT+8ByPrVh+cmq1wTsJHaiwzivibKU8L6iEORJCwUj3rz/4YWkcNw1zeFIo14G8hRXXfEhmk8L6rbISrGPfHjscjIFZ/wAPvh1p9xp0d1rUTXMjDO13O0Vyz5nUXKjspcsaLcnbU7C48W6Da4WTU7QMOyyBj+QqOHxTYXRxZR3lz7xWzkfnit3T/D2j6eALPTbSLHcRDP51qqAowAAB2FbWqPdo537Lomc0ZbySMPHplzg9nKqf1NVpI9XkB2WUEXvJP/gDXWkjp61Vk+Un2q+XzIuux4r8W7XXx4dkgL2Jt7uVLWUIG3BZG25BP1/WrWjWUOl6bBZ2qhY4125HUnua7TxzdxWeiXEs6I0YxvLjIUbhz+HWuTXJ5A/Cu7DrQ8HNpPniiYyHPCjjp2prMxAzwPWkcZHce9AHHIP4Hmuk8hiE4xkEsDx3pyv32r/L8aTnpxx17UvzbugHbgUCE3MQMgZ9B2pPmyAoBA/SlO7PoKYXPZmJNAxxyo+Y4HtzTT64yfpSKxBLBCT05pTvK9QBikCAOyjhR7DgU44ySThie1MwoUlizY9e1OJ4+XigY0bd2SrOf60uCSONq9KU8kjPHvSFVHGR/n3oAUITznJx3o2qGPUk8dKFVOOfxNOG0YKcnt60DEI3MPSgAnoD1604EMBxk0uW3D5fTFADQrHqM9qNrEHnjsM1KQdvzHr1zScLgEjI/WkFhojY55wKQptblifpT/MCgHBwaZLJgbvL6jjNA3oIYyMgA8Hp60Hcp6nrQJHbO1GwOnPWl2tnBUcdt1MVgZjx0/xpNpZcnkeopxIUruU/WnRkEAggnHA60hEZJUcLn6dKA4bgDFS8ljnGR1GKawTYMEHnnHT6Uwv2GfMy4/EgnrR8x6de9A5A3EBfrSrhsje/A4waBXFTcpy5GPWjeCTjdk98UzcFOc5/3jzmkydwz+VIe4GQZO4MB2+XOaazy/woOeck0/zGDZC/j0zTGZjyV69hzQCQzMjHJYq30pVLDA+8tIWI5HBxxRkg5A5PNBSG8lvm49OOtFBBHAT2ooEV3PDN+HWoScHJPXsKa0khiVWIDE5OOv0pYkCkbuSOTk0WNWMuCEg4Od396p4AyICTkgdaileJpE2Hftx05wfqKnSRdmSp988UB0I5XY9V5HTjNRgu46L+AqUsGOQcDvgZpxjYA7c/nx/Kgm9hqwlxhm6cgE1NGiKxC4x6dKj8xg3OR6jdk1LnKglW3UBdseQAuMcV2Pg+BU0lZYCEaYl2bHJOcf0riXckfdJ6+nNUfC/ibUIdRuNPRd8CSfKe657Vz4lXienlP8Vp9j19tGs7vBv991/sSyEp/wB85xWzawwwQpDbxpFEo+VI1CqPoBXPaMZ5tryEgY6V0UPSuGKR78m9mybHBFeKfGbwddQzjxDoKOJUOZ1jHI/2senrXtYNRzIsiMrAFSMEHvROCmrMqjVdGXMjwXwf4ka/s97rtuovlkj9/Uexr0rRdTsr+JA5AfoQfWvKfG2hyeDfGUd5bKf7Nujg46AE8j8DzXYaSsO5ZQcHOTis6Um7xlujoxEI6Thsz063CbQFbirS4AHNUNPWN7ZChzx61c8rjqa2OLqTEDHBzVacYVh6in7WHRqQ/MCGFMDzX4hQyy2CJCCTK6Rn6EjNdz4dgNtpkCHsorD8SWxRolcZj8wFT+PSuptsLCg9BWaXvXLlL3FEnzRTCQOp4rA1/wAZaDoQI1LVLaGTtHu3OfooyatyUdWTGMpu0Vc6Ekd6gmw3Oa4nS/HEviK4MXhrSbm5QHDXFx+5iX3PU/hiusttOuXjB1K6DuescAKIPx6n8xWcaqn8Opc6Eqfx6fmY3iZbWWxlhuXiCOpUhyBmuIhPdT9Oc/jXoeuaLZXlhNbyW0RR1Kn5eeR69c+9ea29q1gkdkWdzABHvbq2OMn3ruwreqZ4Wbw0jJF1DgcsN2KRQdgPQHsaaoG31OelAY7flUfXNdZ4iH43dNppGwrduOM5pqk4JY9envSglyRjnpkelAWFOwHsTTWdcdcew4pwjJAyTz05pAqBuxOPTNAyItkYzkE047c7R1z1NSAcZHOfakztUDHueetADQWYng8deM9acFY4JBwBzSt8jbQp6evWk5bPOB7DNA7CsuRjPPJ7UFFDbhz9aTbzkZPHc0mfmyUyaAHhlGAT/wDWpTjIAAxj8aRCu4naA3508AY+Xbxwcf55pDsMztGRtPHNSK+cgjA4xxUYbGcgYz2GKVWyM/zFAhXfJBJwp49aapwQQ5BHfpmlIxtHP4UhwrEEnr1NMBQCTnBOR600ZBGQcijOCNoPzdvxpM9yB07mkALuLgcD06807JBzletNycAgqB+tIMBQOvue9MESL83XJx3ximOMn5MofUd6AduGz2xSOd/GPlpDGhflDO5dR/CeAfrTwxHIOCPamS52ruIA9uaVH3cAcZ6CgBx2jhgc03O4ZA9qTrnjJFODNu2/dNArCbhwCcZ6GgsCPUZ7UH5SxIPrTQDzgZB/SgLDeM5Iwc/WgdTgcdhTmHGRjA4ANRnJJI6jrzQFhSenXnpxSnjJ/XHakLEjJ5B7U05BUA4yOAKBikbh245/GimAHg4P19aKAKES7OEUAHnLHJpzRhuW+cnnk8UofKnIpARgkj8aCxwKqCAFAIx0pcq2TjHHYVFI+Ox/xpyn5exxQOw4ABAOeemBUhZgoMbYPQg1CqqeBg9qeRkY+923UCEQNvLHBb1FTKwGAT74qAsGPIJx2xU0YBGSCfc0C0ELMxGFyO9Zfhd4ofGV9EAMtGj4H1IrVdgAOQAO+eaz/AelPJ8Rrm6lIaNLTcAf4mLjH5c1lX+Bnflz/fr5/ke0aTE3kIWG0Ed60/Ohj4aRAfcisQ6aL0j7ZNM8Y/5ZrIUX8QMZ/GtSz0+yt0CwWkCD2QV5qufRu3csLcRH7siH6GnFxUb2ltIMPbxEe6Csq90O2ZT9mlurNuu63mK/pyP0qm2hJRe7M34jaRHrXhu5iKgyoN8Z9CK4TwGxvdIQMcywkxP68cVoeINY1zwvcquq3EOoaROwhS52COSJz0EmOMHpuGOetc/4G1FbLxTeW5Uqkx3lD/Cax5vfTt5HWqbVJq91uv1PUNJE1qAMkpXRwSllGapWpikQFcVejVR0rdHE2S8EUx8rUgqKQ+tMDM1iJLm1kjbg4yPY1m2eqs0IDjDDg1sXqb1OOuKx9N0SK9jeS4uJyokZfKRtgH4jk/nWcr9C4cv2ihrt9FNAy3V8bWDHJDhM/ia810/4aWWseM5NQt75ZtIkAlnx98Sf3AehzjOe2a9gm8L6KUZH022kDAgmVd5P4nJrl576x8Jaza6UkYtre5jLQHPDlT8w+oyp/GspUuf4zrpV3TTVJu532kWVrp1lHa2EEcEEYwqIKuGqGnXCywqykEGru/I4reO2hxyvfUhmViDgDH1rhPGGnmGUXiRlTkK2OQfeu8k3Z5NZ9/b+dC6MdwYYIPetIS5JXMMRRVem4M8yjyR94KD6dqlVQ2Tn5fpTdTtXsbzymOFySje3pio4+QR1HXNeimpK6Pk5wlTk4SWqJ8LgZ7dulLuAI24we9Rjj72R+FHXqPcYFMQu5twHcdz0pMhcc9f7tNVwzcjBz3HFKcsAF6jigBzkdSOR2xSH7nCHtTQXwNxXHsM0fe6k4pAx2SF3HaATjijeN2dxJ75GKF25A6juTSHLAAcjPcdaAFDctnJ9iKCTgt29RSFCCMZz+lDZGMnrxQA4OGBz1yBj/wDVQX+U8/iKRdobk46ZyKcei/N+QoGRr945zx2HX1qRehB6+9HByDyW79KYpzt4OcetAIfwCcAAdfamsRkDdjvSBQuc5OfWkG0HBI4oAViCpBZQcUgYc8ljS/u+fU+gqMOpwAMY5znrQFhdynoBux270uQCMHk+tAJdTkjcaEAEeMA0Ah+W44yuM5oBIUEdO3tTSSDk9xj8KaCTwT9OaBscxJXDDvzxUSkqxAyDj8KX+E5OTjoDSLg8kY6jg0CRJkLgc5I70bhkZ+8PTmogwUA4HrzzStj5iMDHYDHFAD93I5x9OaA+MZIx16VFnaVJxke2M07crJkZx60AwBLcHGO5FKWXbzu9BSsuFwP58UHaoHyknp9aAImP+yep7UuDjoeO9OBUg8MPrQcg4JGCMigBqE4GQMjjHeihmYjgfjmikUnYzyHAySPwpwAzgEEHgmnN931PTmmKuBkDI64FBdiGfgooz14xUgJ2k9h3/pTZQC3fI6H0pXI+zfMQO3XrTH0JVJxuJIGO46U7d3JAHtUC72+Y9MU/AwMduozSFYkTd8uG+mKUlgAS2ce9MDkKVUKffPNIwYgbunoOKBEeB65OfWm2epto2vWNzgrHMTA5Poen61KOexGO+K53x+GTQ5JVYJLHhk+o5FKavFo3w0uSrGXme9aXd+eqkHjFbEb+leafDPXk1nw7ZXit/rIwSPQ9x+dei2zZUV5aZ9TJFwHjmmS0qnIpHIIqiTlfF+mwajp8tvdxiSB8b1I6jNeR6daDSviLY26RXcdnNmJGuevAyAD3HFe76hF5kTAg4Irybx7BNJqmkurFZoJgEYDpwQDWc1fXsdNCe8ejPWLS0MSDBOKuKrisTwzrYvrZI7lfLukGHU+vqPauiUbuhrRanM009RqiQd6dgn7wqQLgdaazAUxFK7jKIWXoO1VdCkBmvYx0DK/5jH9KvXG50xjg1k6Ypi1m6TPDRq35H/69T1GjakxiuA+LXhePxN4ZeNXeK9tX+02syfejcDqPqM5Heu/baOvNV541kUgoSPans7hurHkPwe8bSXsUmj6yRFq9k3lyoT970Yex617DFMHUFTXzt8UvCOo6ZrsetaC4W/gy0Xbzo858tvcdq7T4Y/EGDxFpqliY7qP5JYm+8jdwRTnHkd1swpVPbpp/Et1+vzPWM5oZQR2NULa7WRRkZFW1KOOgqb3G1YxPEWjLf258sqJl5U+9eemOW3meK5BR1OGUmvV5YQ33Tiua8R6O91H5kYHnJ0PTPsa3oVeV8r2PNx+C9sueHxL8TkAwz7+5qTIyABjPYVAG8p2VvlYHBHvTt4PUZ/Cu4+et3JWJODyR6Cg4x6Z4wOtNyzDocjnA6CjDZU9B9aQx23OCQM9MZpR04HOPypCpZeDz19KQg4yQCcdqYWsGRnjj04o6DIOe3SgsoGW5HcA0vy9hx0APWgA46Hoe4HajscZBPT3/AApDg9e5xTTwQozzgEgcCgVhxTDAt+lPcDrjHYEUw/MABnPr3puBk5HHbHagdiTh1IBJ78GjjpxuJ6GozgNuHGMdadu46gYH6UAkKDzg4/EUgwTwBnPWkVOOcDj60pVQQcjkenWgLDT8pyQMZ6UufmOOT29+KazRjBP5EU0ypuyMEUASBuvOcdM5oLZB5/KovOBVcBugPA4FKJWJ2hT9T3oAexwQSvJ96dkhx8o29OKhWV+gQ8HPoac0rdHTB9zQCHdCMnJPTvgUzZ1xnB6Yo3yEADaAe+f0ppLt0bkdiDQGxIhHGOtBJweMHv0qLD84IGDg/LSEybh86jn0oHYlUkk8DI9TTMkE7d3J60wh8jlOfrzSncxHK/hmkIejk8YyRxgjOKa5453E9OtN+fHJGB60AvxubH0FMLEmR3yCfXtUbNzwQR/ShUHdmPv6U1tikFi2Tx16UD0HZz1IJophCFs5JPpmikGhSyzMC3ftQHxnJPHSoZmUEnnnpg1HbB9q7iGOOeMUGhZPCcE8Dr6Uj8qvPI55qQKMEBVz79qiALAgkgA46daAJFG5hjAz71Ls256A9Dj1pqRkDIwR/MU48tjGOM0CYKo2gDjuaHBG0kHPfJ6UBX3IwcKgOWXaDu/wokLO5H3VxQIeignAwB3rG8X2B1HRLmJScgcYraOBw2Rx1pCCylWyQeCGoKi7O6OE/Z81tra5vtCuGw0L+ZGD6E4Yfn/OvpSymBRfevkTVN/g/wCI9lqKArbyPiQj+4eD/Q/hX1T4ZukntPPLZGMLXmTjyysfWUqiq01NHRBwgBc/hS75H+6qovq1V42ydzdT0FTYDcvz7VIxHzg5lU1x/jqxEttBdIgLwyozEemea7BwuOFH5Vg+JoDJpN0QOQhNDHF2aI7eySRUmi+WQAHIro9MmMkQ3feHBrI0H59PiY9SorSgBjmyOhoXcGaRpmKeOQKQiqJI5fuVhwMT4hITvCQT+IrYuW2ocVys1y1tr0OTzIhX9QamTKirnUSzLFwg3v6mqskkz9ZCB7Co1cEZ708cnFAWKGp2KahbNDdASoeRuHKn1B7GvDvHXgTW/Dmr/wDCTeFIGu2U/wCl20IO6Zf723uw9vr619BcHk8Cmtgj5Y/xY4qlJpcvQzdNc6qLRo808D+OrPWLCF1fDE7WVuGRh1Vh2I9K9HsblZUBU5Fc14h8Iadq00l15IttQYf8fUC7WPpv/v8A48+hFVNIj1fRSsN6ouoF6Twg/qvUfrUbHS7TXmegKM02SMEYIqvYXSzorKcir+AapamL0OH8VaEshN3bJiVR8wH8Q/xrkoyvHGB7165PFwcjcprzXxTp0dhqhZXKQ3HzqMcBs811Yeo/gZ42ZYVfxo/P/MorIABjkjqacxLDgYxxUSeV03Pn3xTyYdxIDfixNdR49hVycBiAAetDY7nnr1pB5Z5CZx0yTikULgERJn/dzQGgpdFXlx7Zo8xSThgRSE9FCqMei0uWKDBIwecUAIGJGNjN74pqmQk/JjjOCRTyu08sfakYDGO49D9KAFQSEE4Xj3poSQgKXU/rmgnGB29KAw2jjmmK4MpJ+aQ5PGAopGRR1d8HnHFDlmJAAA9e30oIcgb8gDpzigdwAUL0cnrguelNZlyuUB981IMtnI470Ec4wox7UhO40SAdUT0PFNEyBRzjNSBATzyvXigxDPI56dKYtRm8cjcxHrntQVDbQf1pTACBgfqaeYyOThTgUANRF3MGOcjr60qqCBzkDI/+tSBefvDgk8U5U4bknjrg4NABjg7fmOOc0z5VGCoBB5HNPaM5GeV+lDsqk/LkDj5jikO1yNSoGfusfSgEAjHGfbpxTJruCLl57ZMdS0qj+tUpNb0uJiZdX05P+26Z/nQUqc3sjSb5sEHBHH1pCu1sDp61jN4n0IN/yGbFsntKG4/DNIfEmjsf3V88jDP+qglfI/BaTkluzRYaq9ov7mbKxBX+905ORTmxtHoOevNY6a9FKx8m01abPGYtMnP/ALLVhL6+kX/R/DniOT6acy5/76xUurBbtGkcFX/kf3FllZlHy5pTC+QVAHA7VGP7fkH7vwhrufWRYo/5vSmLxKP+ZYkiH/TfULeP/wBmNT7emvtItZdiH9n8iTyGJyxGB6Giqco8QJ9+w0OAdT5+txj/ANBU0UvrNPuaf2ViX9n8V/mUATI3TKj261Mv3SVU464zSqoXof8A69PPqoG08VucY1nZcERk544pSCHTPXryacGBwFyDxSb3eQ4Ule2aAJgy7sE5+gpC2D9e1Iq9dzA475xQV5HOT6jmkAcsSTjpyPSpIhgd/b2pijK4zn056GnGNgMhcAfU5/CgTHKcjK8Drgd6Uc5J+6D/AFoRWxzlSKQ53Y3Z56UBY4j4o6KuoaC80a/vYeR7ium+CPi37f4ehtZ5M3Nt+6kBPPHQ/iP61cuII7i1likGQwwe9eEG+uvA/jOd4MmLd8yf30z/ADFcuIhtI9vLKujps+z7O6DqDmr6yZ6V5R4I8ZWusWUUkMwbI9a9Bsr0OBzzXIeq0bWfWquoxedZToOjIR+lKkgkHJOKdKm6MqrEZFIRzvgLVVu9MjhkOJoso3vjjP6V1yJ8wNeY+HYjZavqVkGxLbzl1z3VuR/WvSLCVniBfGaIO61Kqxs7o0F4FIxHrRnIzUbsBnmrMyGZQPmY8V514lubibxdZxWShxChd1BwcHA/xrt9RugkZG4cCuC8I/8AE18Z6xds2IbYLApzxnqf51nN7I2pK15djp7e9BID5Vh1B4Iq/BOG755qC/8A7PC4uLy0QjoXmVSPxzVG1geTc2n3ttdovXypA2PTOCaYtGbyOGJPYdKfnPNYLXctq4FxGyA9+351ft71XAwwNFxcppKmetOMII5FNgkDd6soAapEMz5LUo/mQ8N396s21ysvyn5ZF6qauFBiqN5bZIeP5ZByDRsJstsQV9a4L4iKJZLOOM/vF3MeexwKl1v4haHock9vqd9FDdwgb4CfnGRkYHU57V5boHii58Y+LtWv2RltAix28bfwIO59zkmtqHxpnDj7+wkjpUtWGCzMxPqeakFltz/F756VOkTdQD61IbdtvQ/ia7rnzvs2yBbMKBs4IzwT0p62rjOSPxqDVtQ0XSrJ7jxDHeT2YIQJZybHZz0ydw44PesB/HfgBFPl+FNSnx/z3vW/+KNZyqWdrHpYbLXXhz3t/XqdKYsDLSIBnJ96jZoIyS11AgHqwH9a5GT4meEFP7jwDZH0ae6Jz/47UT/FvS7YZtPA3h6Mdi7A/wBBU+1fY6lk66z/AK+86177TYyDLqlqPXEi/wCNQnWtIz/yEYn7YUlv5Vyd38a9Rtgvl+GPDlopztLWhPTrjntWdJ8fPE6KTb/2Hbr2KWR4o9rLsWsnp9ZM9AGqaaVHl/aZPeO1kbP5LUq3m7HlabrE3cbbCX/CvLJ/j94zII/tu0jz08u0QfzrIn+OHjOViT4ou1x2jgjAqXVkWspoLdv+vke4xrqMvMPhnXXH/Xrt/mRU8GneIZmCr4V1JV/vStEv/s1fPE/xP8XXqc+JNdlycYicg/pUE/iHxjqSBPO8UXC7eMmU5PXstL2kyv7Ow0d/zPpQ6F4qKjb4dijHrPfRr/LNQyaN4ijB86Lw/bcYPnamP6LXzONO8V3gx/YfiKXPH7zzcH8wKUeCvFk/TwzeH/rqxH83FHNPuH1XBR3t9/8AwT6Lmt7qEf6Z4m8F2pHY3pfH6iqM1zYoB53xD8KxD/plE8v/ALNXCfC2x1Hwkl+uv+Fb2aS4aN4BbLbyhcBg2S+/aTleB6V6C3iq66W/g7VM4wPMuraLj/gMNTzVPMtUsEtdPvRTe70J+vxDRwo6WejPJj8cGkS58Ptkp4m8W3vb/RdCIH/ouro8VeJ8OsHhcIrjBEmtyAEe4RRUJ1XxLLgHw9oS4GP32pXUmP8Ax8UrVWVz4GPb7l/kJHFpMu7y4viZd+u21WEH8wKhe10ndj/hFvHk46f6TqqQ/p5gp7S+J3II07wfCfU2ksp/8ec1CbTxNMwP2/w5bc9bfRIePxZTS5Kr/wCHY/rWCjtb7v8AgEM8WkRKhHgG6k3HAN54nQY+vz0pt7LcRD8PPCg/6+dcEv8ALNWks/FSNgeLPKHT9xptsmPySpRZ+JW4k8ca4R/0y8uP+QFL2NR7h/aWFjt+pTjW8SVFtfAngWMMCd6xTXAXp12ofX9K0Nni+KMPYaF4VTPG230C4Yj8SgFVn0XUZlJuPFvieXnodQdQfyNV28JW8pJuNS1uf/rrqMp/rR9Wk+xLzah0TN61Xx3IgMlzHZMe0Ph5Vx/32wqvcDx0qkyeL7iE88LaWcA/8elrIbwRoTndPbyzMTkmWZm/rTk8EeHEfjR7ZvcjP9aawr7kvOKXSL/AW5fXduL34j3SHHOdTsoufwZqzbr7CwBvviNcP6hvEKnP4JEa2ovCmhx4MekWSj/rmKtw6Rp0QGzT7Qf7sS8fpT+rP+Yh51HpD8Thp4PCPJufF7zk+mo3cv8A6DEM1TNr4F893bUbi6QgYQWl7Lg/Uuua9NjtLdBlLeAf9sx/hT9mCdiqB7Cj6r/eJedy6Q/H/gHmgh8DMoEWk38+3OCuiyZP/fU39KK9NwQSSQM+hop/VI9yP7bq/wAqOdXgc4P40x3AAOe+MCkXHH3uvp0pLkNtGec8da7DxrWLFqrtzkE/XpSxsTIwXkZxk1c0uGRY0kWGyljYkN9onCbMA9B35wK0VCKP9Xo6jknD5qWzphhpSjzN/mZC5/un64oQEqCTgegHWubudWiur64uI7yyjVeRb+QXPZcAd/XHaqX2nHH9oXDf9uj9PwWs/aGv1H+9/X3nbBZOigDn0pRGeO5z26fWuLWdyy/6XdeuPsLnP/kKpN0oGVmvWPf/AIl0n/xmjn8g+pf3vy/zOzXPAx8uPrUIGMfK3XrXKr55A/fXmB2/s6T/AOMVZs0leT57idAecvpshH/jsQp8/kH1Jfzr8P8AM6YApydg44z/AErzX4ueGJL62/tKzTfLEPnUDtXeRWrj/mPWpHULJp14n6gf0q0IVZCk2qaVIG4Ixcr1/wB6A/zqZTUlZo2o4OdKanCaPmLQNevvD98J7JyBn54yeG/+v719HfD3x/a63aoVk2zLgPGx5U1zGu/DfwxPcz3U1+0R+8wtHkdT9B5NYkOj+AdFv1ms/E0qTR4+YLIT7g8KP0rjcWj2oyUuqPpXTL9ZlGGzW1C4IFeBWnj7QIEjg07XLyec4UCK2hQue/Mkp5/4CKvXHjee3Xdcf22QykoralBED6Z8uMkD8alxaHZN2TND4ia5a6D8S9P2Xtqj3MGyeEy/Pnqp29hjOCevQV2+h64JI1aKdHB96+ftWi1bxZrd1NpyzB7gjC+bJcOmAAMuVGenepbSw8S+BHV9a+2XEDkHekWAv1O7n6YpSUYq6ZpFSk+Ro+nY9SZwMsoqvfamsUZZn/CvF4vihp0NsBGt1PPj7oiI/nVBNR8YeMrjytHtBbwtx5smTtH8h+ZrJ1o7J3NI4We8lZeZ1vjbxXdLZzxaRCLm8xhULhRk8cknpXl6/atNs0a78O6VdXEhLyy3GoSsWduWJRCAOewr1Hwv8FLW3lF7r92Lu+b5mZd5wfqz4/StHxX8NbUW1suhx28bNKFmMynhMHkEHOc4rSDaV2HPBPlizyK21S7cLJB4X8KQD1e1uJj+OSa774eeMV02+MeoaZom+dfLT+y7P7PKWJHBLsFI49u3NdVofwl8PxxK1/GLmU9cj5fyJNdJB8P/AA1brth02IAjGAAox+AFaud9jNzjs9TPfxnZTrsOnABu0+oWi/mBKTWBd6vCk/mWl1ptrF/FHJfiXB9tiGvQ4fDOjx422EBI6bhkfrVmXT7MRlfstvtxjAjArOxHNFbI80Tx3aWZ2zatpW4dlju5CfyhqwnxLtV25vkII/5ZaRdN+rFa83+Odo/gvUrXVbBWbSdQdopoM/6uUDIK57EZ49R71j+FNatfEd5CbrU38ro5YksvsR2/lRJ8qulca5ZPXRHsR+Jtsz4S61F/aLSFX/0Oakb4gxtndB4jkXHURWkYP6k1qeHtD8PwwrJFDHMxGfMkbdmtTUbjT7a1ciO2VFBJJCgAeppKUuqRMnC+iPM9TuvDWvasLzU/B+paleFBH59xdoMKDwCUXA6nrXQ6Rc6NptuUsPBttbA9R9tJz7kheawLC8s9QM91prboJHOGXo3bI9AcVoc44J9s8V306V4pvc8PEZhJVHGKVkbq68FBEWgaQnP8cjv/AEFA16+UDy7HQYfpZsx/VqwVyeOmP7wqRWO36+tX7KJh/aFbpb7kZHirQbnxPqC3d5qFtbyIgjVbXTYeFyT1YEjrWCPhhZNK0s2saqZCQW8sQxDjOMYT3rr72/trCDzLq4WJcZJc8VljxroEZO7VIiPbNForQPrWJnqm/kZafCzQsu09zq8xflt96Rux64AqZfhd4TUANY3EiDPD3kpx+AarUnj/AMOoBm93D/ZQn+lVZfiXoUeNr3MgHpGf60rwQc2Kl1f4luP4deEojldDgYj+KR3cn82q1H4K8LxYKeHtLOP71urfzrnn+Kulpkpa3bfgBVWX4sWuCI9MmP8AvOAKXPAPZ4mW9/vO4h8PaNAP3Gi6bGe220jH/stXYrS3jC+VbW8Z/wBiJR/IV5dL8WJM/utMQD/al/8ArVUk+K2osf3Njar9STS9rAX1Wu9/zPYiCpyHKDphaezMV5djgeteHS/E3xBIPkS3Qe0ZNRHx/wCJnORJGD/swij20R/UanWx7luYkZPHSndF4Xv/AJNeCt4z8Uyni4kX/djH+FQv4j8TyDDX90Bn1Ape3XYr6jPuj38fKC3Q9xUbkdQQOuMmvnK913W8kTajdc/9NT/SsyTU75z813cH/toal4hLoWsvk/tH00ZIxkeav5jimtdWqqd88Q+rCvmN7ubvJKT/ALxqIzSt952J9zS+s+RSy3+8fTEuq6ZEW82+tV78yiqz+KdDjHz6paZB/wCegJr5sLN0xz9KQFi2AppfWX2LWWxW8j6Kk8a+HYxzqUJGei5JqhdfEfw5B9yaWXjokZ/ma8GVJmOBHKT7KanTTr6UjyrK4fPYRml9Yn0RX9n0l8TPXp/ivpaf6myuZPckCq//AAtmzYkf2bcY/wB8V5pD4X124/1em3RHumMVbXwN4jJH/EslHscCj2tV9B/VsKt3+J3zfFyzVvl0ucnsC4FVZPi78x8vSv8AvqSuMbwL4kHXTJB6/MKfF8P/ABJIc/YSo9WcCj2lZ9A9hhF1X3nTz/F28P8Aq9OhU+7n/Cqj/FjVWBCWdmOwPNZ8fwy8QNjdFAn1lHFWYvhZrW4bpLVR/vZovXYcuCXYH+KWunhEtU+iE/1qpN8SPEUh/wCPiNTj+GMVpL8KdTON17bLnnoatxfCeY483U4/fCGly1mHtMGui+45abx34ikOf7Qde3yqo/pRXaR/Ci3ztl1Nyf8AZQUU/Z1u4fWcKtl+B1yqdow54PAFIy4AJOOcnJ60wMSc7eemRTwfmHoP14rtPHKmoaetzHMY5XiWYKsybQwcDoeejdsjt16Cr6ryPu5P+NJkkYHCelSKCVOFJx6jigbbasSK0n8THg8Z6VKp29SfzqJFBGSMevGBUgGFyuOeaRJIGYHA3ZHUg0rMemMj2pAD97dj3604KAM5GDzjPUUAJglvnBPpzikZiAMgqDjJ9aCVXq5Azk9KhaVQGHmgEY6t+lAWJWPOCR16mmq7DkkjJpiGEvuM6cHk7s1KjIRtWRT6H0oGLuJxtUk+p5rznx/8PU1ffe6UixXoGWj7PXo2SQACpBp64U5J+pzScVJWZdKrOlLmi9T5IvrSeyuXguomilQ4KsMGtvRvFd1ZqsN8pu7YcDccOo9m7/Q17n408LaP4gtj9paGG8X7s4IBH19q+f8AxFosui3728ssMyg/LJEwYGuOpScPQ+gwuLjiFZ6M+kPh18QdFvLWK3tDHBIgAMeArfiO/wBa9Zt7uz1W0MM6RzROMFWGQa+A4pJIZVkhdo5FOVZTgj6GvU/AfxXu9Klih1Zi6DjzcZBH+0O31H5VkzqaPp608A+GUuBOulwl85wckflXV29vBbRrHbxJGg6KgwK4fwb440zXYYxbXSeawyELDJ+nr+FdmlwGqEktkTKUpbu5Zzmqupj/AEUsP4SDUwkBFZviGXGiX5DlD9nkIYdjtPNURezuSQ3JAG01dhn3/Wvnbwr8Ur2aBGEsN7GAN3Zh9fT8RXoWk/EXT5tonSSB/cZH5ip1iaJqWx6irnFDkEHNc9Z+J9PnUfvQp9+9U9a8WWlrbuwlXgZ61XMKzPN/2nYLjU/ClrY6bavdTpdrcOEGSiKrDP4lv518rwPPZ3IZGkhmQ9RlWBr2i71TUvH/AIpvpNO16SxtUPloqDhwO/49qrX3whmnjkn/ALZM12ef3icN9TW8aTcbo5pYuFObjN/mcfp/jfxFbQrHDqLhfdFP9KZq3inW9WtzBe38rwN96NcKrfXHWm6h4R13SpzFPp87gdHiUup/KpdN8NazfzrFBp11k/xNEVA/E1k6cr2saOtTtdNWPQ/hVrthY6M0Wo3kUODwHYCutuPHHhyIE/2hCx4+7lqxND+G+lwWSHVIjNcn7xDkAH0rXXwX4ejA2abE2PUk5/Wu2CmlY8GtOjKblr+BTl+JHh6M8TzSewiOKqyfFHSOfJtb2T0+QCujtvDejxcx6Za4HT5M1fi060iA8u0twOfuxD/CnaXczU6S+y/vPOPEXi631/T2t4NMvl7bvLzXGR6JcsRssL9wef8AU19CKiJkKgQdiABmpC/P1qZUubdmsMX7NWijwOPw1qUm3ZpGoNn1TFW4vB+sv00ab/tpKBXuOCScDnPr2pofcCwA9MelL2ESnjp9jxmPwJrjkY0y2UerTirMXw+1tufK06MdeXJr18kHgFQT2xQHG4ZzgHPXpT9jEl42oeWw/DnVHA33Wnxj/ZjLGrUXw3uxjzNViTv8luK9GMp5+bj6Uvmeh56/jT9lEh4up3OCX4ccjfrM5GcfLGFqdfhxZZy+p37j2bFdqZOEX65560m/AHPPqafs49ifrNTucivw50YN8818495v/rVMnw+8OqTmCaT3aY10zOxX39AetI0gCgenAp8kexP1io/tM5qT4eeHGIP2aRQfSU/lTk+H/htRxZs3uZCa6N5Rxz+tIJgAQcdPWjkj2D29T+ZmIngrw6uAumR8885NSr4T0FCdum2/1xk1qCUkDnBH44pBIG43D0x7U+VdifazfVlCPw9o6sAmmWv12CrEemafH9ywtkI6YiXmp93JB5P1pGch/vADk/8A6qdkTzt9R629unK28SjHQIBT1YbflxjpxgCoDLkZyR6HpUZbGRwT78UxNlzzefqPam+Zn09vaq6vuwfuj+dN8wsfQHsTjNArlkyKCSGABHJz1NAcsSAeR/KqrMWGAwJ/zzShsEDjHscZ+tArk5cn7x6nA5pPM5GACQRwe1QE+p4z3pC4JG0E84zmgfMTO/BIZQB39KA+c9c9DVYu3AIJOc59KduHPIGDnryfwoC5MX55OR1z1P8Anmiq5J6t8uPTpRQK5lop3fXnmnYbjJOT+lPT5eSaarKWOOM+nrQaog1Scw2xAljiI/ifoK5T7WJSWuPFAQZ5WNFGBXSahp8V+wW4ywPX0NS2WiWFqNq21vnGMlBUtNmsJKKONuLnS2IEviDU5BnkpwP0FEb6H1Gp6yfcF69AitbZD8kEfoDsH8qsqsfRkTJ/h2gd6nlK9t6/18jzsSaGV41HXAfq3+FI0uk9Y9R189gPm/wr0Q7AoG1OPUYppGTn5VA/u9RRyi9t/V/+AeebLSVf3UPiK4z6uQKdHpYkwYvDd/L7zXBH9a9GSMEc7jn17VKF5zznjvRyA6/Y85Ogzsp2eFyh9fteKhbwzquT9n01rcn0vzXp2Pl+8cnqM00IgxtYkg9+/tR7NC+sS/q55ifB/iaXAXUWgU/9PTNTT8O9XmJ+1eIH9xvY16mQA/C/n2zTegI5ORnr0peyiP65UW35HmUXwqjkP+lavcSkjoozn86vW/wm0FP9fJcyt/v4Brvyx65JGM4B/ShcEgqS3Qjmq9lBdBPGVn9o8c8ZfCd7aJrnw+7Soo5gc5P4GvJrmCW2meGeNo5FOCrDBFfXwYsFIIDAdcccdq5Hxt4HsfEduZEjEV8B8kiYGT6Gs6lBPWJ24XMpRfLV1Xc+dtN1K902USWNzJC2c/KeM/SvZ/h98ebyxdLPxZF9ptOAt3Cv7xP95f4h9OfrXkviLw9qGg3bQX8LKAeHA4aseuOUbaM9yLjNXjqfdmieNNG1i1W403UraeIjJKSDI+oPI/GvMfjX8VbRNIutB8NzC91C4QxTywHcluh4b5h1YjIwOnU+lfMGPauj8BXf2PxJbMw+R/lI9aIxu7Mia5IuS6GFDJNbSh4XkilXoykqRXVaL491nTThniuVxjEq8n8R1/GvafEPgXQ/Elkk2xLa7ZOJUwOffFePeKfh1rOhlpEQXdqP+WkXJA9xW86Mo+ZyUcdSraPRmwnxb1VItsVlar/vMSB+HFYHiHxzrWvQtBczRxW7cNHAmwN7E8k/nXMCB84IwR2NXdP0u5vrlILVGklY4CqM1jY7W4pXZ6H8EYJX1OaQD93kAmvdDgHpwe3f86474eeH/wDhHtHRJsfaHG5+neuoMoyQBn0+td9OPLFI+XxlZVKrlHYsK7KeOMHOaJJWyoyR3zVZpeuSck/Wm+bxg5APt3rQ5OZlp2JAGSB7iozJhsngfWod/cBvpSF/76jHOT2oFcmWT5TjAyc8d/bFOMoJ4J9Kr7gvzYBbAOM0/f3wcdsUDuSmTPQZKgdaTzeigDmmeaCehzS7xjOB6HPY0gHFycDZyeOeKYHYrkZAA60isSRgKePSl3yZxnB78UBqKXOMZBJXHWhGbgNxxwAKNzYGWyfQUhYrjJPNA7gS/uM+2c0oYgEtnIPQfrSb+nzHH1phyw5JwD25oC5Mc4zhsn14pg3MTg846ZpFx2wDjP0pOd3DH15PWgGSAN5fB5x6U3bkHLn06Uh4Ay/XtigkhcYLHjigBxRtuUC+xpgRuTkD260u47QPTOc03LMo6ADsO9ACYIzjGM5FIMf89M+u0UEBiMHOffinEsBxzjr7GgQgXMZPzD64zSYJXGTn69KXJVVOflYZH51G/J3dAccigdx3yh8Nk5J70EEZJDn0pGY9VYk9uwFNLZ44YdeDTAX+LOCDn17+9KSGXoN2aaME5wefz6UuH64/E0CYvzCPAII5pCXwcFsHkcDFNLll+ZTnrj049KbyxJBbkHgnpRYB7szDksSeo9abjIUKpGD6UjY3EqBnrQp5BIGe/aiwCqdvDDI4wacSOyjH1qJmbAIOe5x2oIPGM9e38qLDJGfkArhT096KikVsjeRk9eeM/wCTRRYL2M3bKwwzYB5xn+tTRIUAypzjjFWG2gfeXoM5PSoWuI1GC6sc9Ryf0pGlxFyWJ7k8jtVjBC/LgjuTUCzqMBVc568YqQzYIxE2fQtigLsl2/L94+nPGfepDjHQH05/z6VVM0m7GMexPvTvtEgGNi7c9eaBalggMQRggevangLweCfUH2qqZpjwu0Ht8vNMZrojO7bjkjjikLU0CdwAxn27UoDY+bAPXPpWcFmKnM5J9d2KcIZCTudipHc9KYWL7MBty4AI6Z60hmRFB8xQPrVEQ5bB59Kf5YAGMnjdyQcCgViy1ygGdxYd8VEbpR2GT39KPLUqASPlBP8A9ak2KigtgEHsOBQFhGu8Lwhy3qOlI11Lu+VBzz6ZqTYBz3GTu60rIMgAnb14NMVhglkZlHQdc4pweUZCsxYfpThhV4GWPPANSKQr+q0AUdQ0+31W3aG/hWaNuPmGcCvOvEHwjgmBl0a48pj/AMs5OV/A16ovIG08DHr1605GUBSCSKmUFLc3pYipS1g7Hzfe/D7xJZuVbTJZQP4osMDXR+BPh3qUl/Hd6pA1tChBVX6sa9xUjZk549RQ753Y6kDvWaoRTudU8yqzjy6DIYRDEiLjCjHApc8Ekn0ockZbp0HWmlsEgfe7jtWx59yheeHdFvH33Wm2sjcksYxn9KsWGk6dp6lbO0gt+MkxoFP51Y3d/LBGTnBpS24j5gVHftSsinNtWuKSGPB74zUbp+8JUNt/lTiwOVOQM8YoUnt246ZpmbZGqjOTnjpTxCNwOdwHHY0q7c4z7UL0x8xPTOaBDdoLYB5PU0u0DIbGfWlBUP0DHHBpGJAGztxQAYCnHc8njrT1OWxnOOAP896iAII+UEY5xT8EjGMcGgLg2Axz/SggAg8fhTdm3jaSew/pThjpyPbvQMVfkbJGT7CgHHtzQoyq449qbwDwRwemMUALv56KMj0xQcDBwMYznFB4bG0ZpSehI59aAuxDztA3DGPSmnlvmLAgetSIzHGzHH6U0Jg/UE/SkMReoBByfWkDZG4nAzk04EBiOQKTCq/J+Yn29KAD+IjJHXjn8DQTjhhnHPGelBO4k7Rnvmhlw3GD0BA/nTAZsBkbbkjqfajAHXOM9qlIyc8ZGOlNdNylicY/Wi4DRgccdKacsfbrzTuQjAZ57HpScEEkkjoaBCkZA46EfSmkHJJXHOetPHOflbPPfFICdp+6R0+tADACCNqjgZ5oVTwdvH1xxTsjcQpJP1JpFKggHORj8KQw29M7eTzkUjEK2RgZyMU5gGI4ODwcdRTcKxwDkg80wE2ryyHB9SOtHlHILAE54x1pVXBJ5PAONuTQwyCADgjI9eaQBt3clcjsR1pjANleSB7cU7kEEdz2Pb8accnOSPoaYEZB2n+9jilx36j+tKBgkKce3rj/APXQxIIK8jkUgGlSUOOvqRRQM5B7+mPvUUBozJMUakHbkkdxTkiVXz2H6fSpQOMAHPt6Gn4wwx1HccUkbNiBcH5M49elS7T0QDHQmlHHrjGfqKR0J53Z59aBCsCG28Dv/wDWoAwBjPXkmjCjCgqOOeOtKp2k7cE+n4UCuLjg54zSpgLycDHXHekbPy7RjB65oUHABA3ev+frTJuSAfIvAY/WnFgFZTwAAeTnjNMUZ5IxzgUo3Esfpk0C2FIUEcAlu+KMKcZz/LimEt1XGTk5/wDrVIxUDo3Y8dKAuPDDkYbYc/jmowMZJA4PBORmjiTO4YOPrmlPI+7xk9e1Agx8x2kcDt1oDDOFbBzk+/FAU4xuPP60PyMkg/L/AEpgKeATjgHnnFGctnseO3NGOARyPfmjHLZOQOR2zQIcucHA4/vZzmjcSRjg9e9GM4yNvv1pAflVTknjg0AOVsgErxilJ+8cMCD1z1FNUrnggc44OaQ8MxHHOc8UASc+nGO9Mkxk5Ukn3pSTt7ZIzwTQOSRnAx+VACrlew2nrz1pGyV6c4yDmnjlCSoPuBimrwThcnuM+1ABuPJIOaOTzgDAzilyQwyMZ6njpSDJJAx9KBDVbJY5+XOOT2p4LKSFAwOaOMg5wvQnHX608fKRgk574/KgCNScnIGPX3p4ySfu/hQACB97gkZpWHXOeg5HFA7Ddigc9OvPGaeB8x5AFHIAIA9OTij5s/MMn0BzSAYfRl69hz/WpFHAJJPpntTS2VyBtI6YHSlQn7zDAoBDV29DxwMEen0pWA3ZU4P3aQHBG7JPb2p3bleMetADWycDk+g7kUoGfvAevJyaQdyACPSnk5IwRj1zQA3A4HODzwoPFKU+bJxg+3Wmh+egJ9ORRuJAyxJzyAMUDHAjsF564oYFSxz9M9KaucDHTsetIcnnAB9u1AEgJDjI7YBNN3/MCB3zighjnvxwfSlYEYBOADwMUAISOQRx7c0M64JDYPsOtJlivI4x64xQ6k5wcc/hQAZyvJ5PYmmlsrlWX6YpVAIzlc9eaASRnjg5446GgADcckDpjHrSAHj/AGunNMz1x6c/SkLFsY69eD1oAfgqAAMn3oB556+p7UbvnIIz0xzmkHAOc+hwaAFOcjeAQOuRR/EB29cUxh03AgnoD3/+tQq9gVHuDxQMUffAOMHPp1pQxUEgrjp/9ak+bgrg4xgHimlFALZ/ligBwI3Z3dwDk0hIPBx+JpoP94544PTFDlst8oyfxoFcVWU9Tgex4ppjI7nJHpSZyFwMZweRikBG0Dcq84OPrzQAu3DEnPTr7UVGx3A9eOuDyaKAK3rjJ9yfelDHcAeD1yRTU2koMjj8DTo2wuTn2BpGjHEZw2RxnrUjfMQehpgJUjAOcmnSOxbG48c/jQAo4wDnPbnP5UpOCcjOOPpTFODwGAz0NKx+YcMMfrTFcMcDA4yO/wCVPLc5JAcDofSmlgVAyM+vBzTyBk9McAUCHZBYdMdc/hSh8klQp7EdqTcecnJ3Y2jjNC9cKCD3x+lAgyN2FBLECnYKk5IJ6df6U1cEkEnIGO/FCrhQpyD6/wCetAx6gDaV6c9RzQxJUZJI64P/ANemqMnJOOelKqAo2MEjPfvQIUrkE8kE+tKQQM+vpTVHy8qDj3xmhs/dBAGemMigWwqP8hJ4wScdKdwTggkduKjXJc5PJPHfipYwCvy8kjk5zQIQIN2ASMdQPpThuGNhG0noaQ7hg7sY5A9P8aVSQeeMnjNAxp4Uhe/TtjmlGN5yBx0pRyuQefQc5/GlHAIbO3kdaBAoz0JweMf/AFqUZI9CBn1waUZEYAK46ZNLjAOCucdB6e1ADWXbkgj6inArtBJxjAHNEfT+HB5FIGyB16YoBDj9737f/rpr5RcHd79aVsltpBx6Y/8Ar0u3d0OMdPpQBGFGVGSMjrg8VIGPcH8BRtC9yc9scU1m3HJGAeaBAAACTkA85pcDJG3g45ocjjJ96QBVYEnnpzQMcSM7cA9eOhFKMdhx6jpTSygYxwGzikMpIXauQep44oAUZ3HAx2Gacre+SBwfU0zexYgYx05PfvTdwDkZHrQBIjcEfiO+KH44JHP1INRcBumD1walJZhgk8YzzQA0sw4OCOx20oYn72eO+McYpTkHJwOeB6+9NYNjcpB7ZNAbBnHAOeex5pVYnAwT700oxK7yrNjpinfKBjOMHv1+lIYEnaDlgPTrSk7SAzDNM2goCBnvil4wN2xSO1MBSQ3PQ9OmaQNgYGMDHSjC7snGR7Y5odeOwx/nFADCSFyu3B6ZNKeeMc59TxTwRgdffPNN3ZJ4A7GgBufnwMEgd6bkHIbGe47UqNuzntkelO3cY29OeO/NAWGhjvxnk+gxTd56DI/WpHA5K49cBqa/scnOc+9ACOGx1ORwR6imFSSSxBOOPr61I2CcAndjGBx+tIHwp4wfTP8AKgBuMKGz3/z9aXYGLYHJ6HPtSlyRwR6800Y/udOcg9KAFYqQ2Oe2CaHOVJbG7sTUU3ytwBg9qlXHVvTAAH8qBgchvmXcDwCaYAARtwuOcmnnIQZyB3IpG4IIGRg8nv7UCsHBG9mJGAOc8Uw4OAuCRk5xThz90/hgUn3z1GOvXnH+FADsqFAOQB1zwaKUcZHylsdKKAM9vvuuBlcjPtTY2Pmlc84zn8P/AK9FFJGj3sSxAyLkNgFcgenPr+FIXKyFc9s5oopgOiALoh5L8k0+Rdi7xjkHjFFFBIzcQVI7nn371ICccHGc9KKKAGuMJvPPt+X+NOj+ZwOenWiigQ7O2dkOSSM5zUjjJxn35+tFFAAgyDyeSRRFh0bGRgkc80UUANdtqs3UjI5/KpB83zYAAOMYoooBCKQwGR1Pb3FLF88XoMkUUUIXYV8JHnGSDjrwfwpcbhEfU9+1FFISEjyzHoMZHSnD5i+ONrYz68UUUwHJhkzzgA8fSmAhgBjGTnPpRRQHUC5CAjA9vanDIYKpwB1oooBMeGxyPpyc1EsmZGUjlehH4UUUAxzZMec9fl55NNQnzdh5HTNFFAglLR7VBBBPpT0RWYcfeOMenFFFAN6hHtYhQuM59+hp4j+fkg/gKKKBIANznkgKcUgCmRsDBBB+tFFBY4A+Y2GIxjH5Uj5yOm7PXFFFAMQAc4GDjqKRiARgc9OeaKKBEjcoxHGD+dRoSRz9P1oopDYM2ZAmMEjr+NHQY56CiigYrLlQc8Ljg0g5XPHJziiimDFbjeOwxTdzNDv4Ge2KKKBMixh9mTxx1p7yEsR26YzRRQADOMnByo/z+lIcCTG0YIzwOnFFFAdBCPmK9hzzScI+0DPI+n5UUUhoCw4ULjn/ABpJOIN3fJTj8eaKKY0QSEbiccgA/nxUsZ3LgADqtFFBJIyfPjPUUzbuTg4wQOe9FFAMWPLAZ28HHTrigAl1JY5IPtRRQLqJIcMcjPFFFFAz/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Linda D Bradley, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_16_3329=[""].join("\n");
var outline_f3_16_3329=null;
var title_f3_16_3330="Malignant mesothelioma III MRI";
var content_f3_16_3330=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F59885&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F59885&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Malignant mesothelioma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 323px; height: 320px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    MRI scan, coronal, T1 weighted sequence, shows circumferential encasement of the left lung with loss of volume and ipsilateral shift of the mediastinum to the left. The aortic arch and the descending aorta are encased by tumor.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_16_3330=[""].join("\n");
var outline_f3_16_3330=null;
var title_f3_16_3331="Plaque rupture MI PI";
var content_f3_16_3331=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F60394&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F60394&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 558px\">",
"   <div class=\"ttl\">",
"    Heart attack",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 538px; height: 426px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Plaques inside the coronary arteries sometimes break open or \"rupture.\" This is what causes most heart attacks. When a plaque breaks open, it causes a blood clot to form inside the artery. As the clot grows, it can completely block off the flow of blood through the artery. That means that the tissue on the other end of the clogged artery does not get the blood and oxygen it needs, so it gets damaged or dies.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_16_3331=[""].join("\n");
var outline_f3_16_3331=null;
var title_f3_16_3332="Xanthrogranulomatous chol gross";
var content_f3_16_3332=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F67995&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F67995&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Xanthogranulomatous cholecystitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 216px; height: 330px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Surgical specimen of a gallbladder with xanthogranulomatous cholecystitis showing extensive necrosis, fibrosis, and gallstones.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy Faripour Forouhar, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_16_3332=[""].join("\n");
var outline_f3_16_3332=null;
var title_f3_16_3333="Tinea barbae 2";
var content_f3_16_3333=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87000&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87000&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Tinea barbae",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <p>",
"     Follicular pustules and crusted lesions in a patient with tinea barbae.",
"    </p>",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_16_3333=[""].join("\n");
var outline_f3_16_3333=null;
var title_f3_16_3334="Active surveillance following orchiectomy for stage I testicular germ cell tumors";
var content_f3_16_3334=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Active surveillance following orchiectomy for stage I testicular germ cell tumors",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/16/3334/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/16/3334/contributors\">",
"     Graeme S Steele, MBBCh, FCS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/16/3334/contributors\">",
"     Jerome P Richie, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/16/3334/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/16/3334/contributors\">",
"     William K Oh, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/16/3334/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/16/3334/contributors\">",
"     Don S Dizon, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/16/3334/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Testicular germ cell tumors (GCTs) have become one of the most curable solid neoplasms, due to remarkable treatment advances that began in the late 1970s, including a better understanding of the natural history of testicular tumors, improved staging and surgical techniques, and the use of effective platinum-based combination chemotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3334/abstract/1\">",
"     1",
"    </a>",
"    ]. Prior to that time, testicular cancer accounted for 11 percent of all cancer deaths in men between the ages of 25 to 34, and the five-year survival rate was 64 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3334/abstract/2\">",
"     2",
"    </a>",
"    ]. With modern treatment, the five-year survival rate is over 95 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3334/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Following orchiectomy, men with clinical stage I disease (",
"    <a class=\"graphic graphic_table graphicRef56341 \" href=\"UTD.htm?20/34/21037\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef82117 \" href=\"UTD.htm?35/13/36061\">",
"     table 2",
"    </a>",
"    ) can be managed with active surveillance or a short course of adjuvant chemotherapy (or radiation therapy for seminoma). For men with nonseminomatous germ cell tumors (NSGCTs), an additional option is RPLND. There have been no randomized trials comparing RPLND, adjuvant therapy, and active surveillance for stage I testicular cancer. Regardless of treatment strategy, the long-term cancer-specific survival approaches 100 percent regardless of primary treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3334/abstract/4\">",
"     4",
"    </a>",
"    ]. This topic will review the role of active surveillance following orchiectomy in appropriately selected patients. RPLND and adjuvant therapy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/7/13432?source=see_link\">",
"     \"Overview of the treatment of testicular germ cell tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/3/9272?source=see_link\">",
"     \"Retroperitoneal lymph node dissection in testicular germ cell tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/29/26070?source=see_link\">",
"     \"Management of stage I nonseminomatous germ cell tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/2/22567?source=see_link\">",
"     \"Treatment of stage I seminoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL PRINCIPLES",
"    </span>",
"    &nbsp;&mdash;&nbsp;For men with testicular cancer, involvement of the retroperitoneal nodes is important to both detect and treat for curative intent. If imaging of the retroperitoneum were sufficiently accurate to identify those men whose testicular cancer was confined to the testis (T1-3N0M0 disease, (",
"    <a class=\"graphic graphic_table graphicRef56341 \" href=\"UTD.htm?20/34/21037\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef82117 \" href=\"UTD.htm?35/13/36061\">",
"     table 2",
"    </a>",
"    )), orchiectomy alone would yield survival results that are equal to strategies that incorporate treatment of the retroperitoneal lymph nodes. Computed tomography interpretation is limited by the need to use size criteria (&gt;1 cm diameter in short axis) rather than physiologic measures. Therefore, false negative rates are frequent with CT or magnetic resonance imaging (MRI) of the abdomen and pelvis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3334/abstract/5\">",
"     5",
"    </a>",
"    ]. Occult micrometastases are responsible for many of these false negatives, as evidenced by a retroperitoneal relapse rate of approximately 20 to 25 percent in men with clinical stage I NSGCT who do not undergo retroperitoneal lymph node dissection (RPLND) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3334/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For men with early stage NSGCTs, the only reliable method to identify small nodal involvement is RPLND. However, approximately 70 percent of men who undergo RPLND are pathologically node negative. Therefore, the majority of men who undergo RPLND do not benefit from surgery. This has prompted use of alternative forms of treatment following orchiectomy, including active surveillance. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/47/41720?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and staging of testicular germ cell tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H900673895\">",
"    <span class=\"h1\">",
"     PATIENT SELECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Men with stage I testicular cancer and no risk factors for relapse are candidates for active surveillance. However, it must be considered a form of treatment that requires men who are motivated to rigidly adhere to a surveillance protocol. Appropriate candidates for surveillance include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Men with clinical stage I seminoma (pT1 or pT2 disease) (",
"      <a class=\"graphic graphic_table graphicRef56341 \" href=\"UTD.htm?20/34/21037\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef82117 \" href=\"UTD.htm?35/13/36061\">",
"       table 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Men with clinical stage I NSGCT (pT1-3N0M0) with normal serum tumor markers post-orchiectomy (",
"      <a class=\"graphic graphic_table graphicRef56341 \" href=\"UTD.htm?20/34/21037\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef82117 \" href=\"UTD.htm?35/13/36061\">",
"       table 2",
"      </a>",
"      ), provided none of the following risk factors are present [",
"      <a class=\"abstract\" href=\"UTD.htm?3/16/3334/abstract/8-11\">",
"       8-11",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Vascular or lymphatic invasion &mdash; In Europe, vascular invasion is the sole criterion used to define high-risk disease among men with clinical stage I NSGCT [",
"      <a class=\"abstract\" href=\"UTD.htm?3/16/3334/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Embryonal carcinoma component greater than 40 percent of total tumor volume.",
"     </li>",
"     <li>",
"      Absence of yolk sac elements.",
"     </li>",
"     <li>",
"      Elevated serum tumor markers prior to orchiectomy, which do not decrease by expected half life (one day for hCG; five to seven days for AFP).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The risk of relapse increases if any of these factors are present. In a series of 259 men with stage I NSGCT, four features were independently predictive of relapse: invasion of blood vessels or testicular lymphatics, absence of yolk sac elements, and presence of embryonal cell carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3334/abstract/12\">",
"     12",
"    </a>",
"    ]. The relapse rates for men with none, one, two, or three to four risk factors were 0, 10, 24, and 58 percent, respectively. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/29/26070?source=see_link\">",
"     \"Management of stage I nonseminomatous germ cell tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H900676917\">",
"    <span class=\"h1\">",
"     ACTIVE SURVEILLANCE PROTOCOLS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surveillance should be considered an active form of treatment with mandatory follow-up. Men undergoing surveillance must fully understand the risks of disease recurrence and should be willing to comply with the follow-up schedule. For men who will be followed without further treatment after inguinal orchiectomy, we agree with the surveillance recommendations established by the National Comprehensive Cancer Network [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3334/abstract/1\">",
"     1",
"    </a>",
"    ]: (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/45/9943?source=see_link\">",
"     \"Posttreatment follow-up for men with testicular germ cell tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H900676969\">",
"    <span class=\"h2\">",
"     Nonseminomatous germ cell tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;A history and physical, chest x-ray, and tumor markers (AFP, &beta;-hCG, and LDH) should be performed every one to two months in year 1, gradually decreasing to every six months in year 5, then annually. Computed tomography (CT) of the abdomen and pelvis should be performed every three to four months in year 1, gradually decreasing to annually starting in year 5.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H900676977\">",
"    <span class=\"h2\">",
"     Seminoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;A history and physical exam and tumor markers (AFP, &beta;-hCG, and LDH) should be performed every three to four months in the first two years, gradually decreasing to every six months in year 3, and annually starting in year 5. CT of the abdomen and pelvis should be performed every six months in the first two years, gradually decreasing to annually beginning in year 4. A chest x-ray is suggested only as clinically indicated.",
"   </p>",
"   <p>",
"    Surveillance is necessary for a minimum of five years and possibly 10 years following orchiectomy. Relapses more than 15 years after orchiectomy have been reported, although late relapses are rare. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21785?source=see_link\">",
"     \"Radiation-related risks of imaging studies\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H900675287\">",
"     'Radiation exposure'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/45/9943?source=see_link&amp;anchor=H3#H3\">",
"     \"Posttreatment follow-up for men with testicular germ cell tumors\", section on 'Duration of follow-up after treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H900675475\">",
"    <span class=\"h1\">",
"     OUTCOME OF ACTIVE SURVEILLANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term survival is identical for men with low-risk, low-stage nonseminomatous germ cell tumors that undergo surveillance, adjuvant chemotherapy, or primary retroperitoneal lymph node dissection. A 2003 systematic review of 23 studies including 1966 men undergoing active surveillance estimated the relapse rate at 29 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3334/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    More than 95 percent of relapses occur within the first two years following orchiectomy. One-half of relapses are retroperitoneal, and of these, one-third are not accompanied by significant elevations in serum tumor markers. An additional one-third of all relapses are in the lungs or mediastinum, while about 11 percent are manifested only by elevated serum tumor markers. With the use of cisplatin-based chemotherapy in the recurrent setting, over 95 percent of all patients who relapse are alive without disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/63/24568?source=see_link\">",
"     \"Initial risk-stratified treatment for advanced testicular germ cell tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H900675272\">",
"    <span class=\"h1\">",
"     ISSUES REGARDING ACTIVE SURVEILLANCE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H900675280\">",
"    <span class=\"h2\">",
"     Compliance",
"    </span>",
"    &nbsp;&mdash;&nbsp;A valid concern with respect to surveillance strategies for testicular cancer is patient compliance with the surveillance protocol. However, whether compliance impacts overall survival is not clear [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3334/abstract/13,14\">",
"     13,14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This was demonstrated in a study involving 197 patients with stage I nonseminomatous germ cell tumors followed at one of seven cancer centers, with a minimum of two years follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3334/abstract/13\">",
"     13",
"    </a>",
"    ]. The main outcomes were as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The mean compliance rate (defined as missing no more than two assessments per year) was 78 percent. Compliance with CT scanning was 64 percent.",
"     </li>",
"     <li>",
"      The relapse rate at five years was 29 percent but overall survival at five years was 100 percent.",
"     </li>",
"     <li>",
"      The only factor predictive of relapse was the presence of lymphovascular invasion in the primary tumor.",
"     </li>",
"     <li>",
"      Despite differences in the frequency of visits at each center, there were no significant differences in either the rates of relapse or survival.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H900675287\">",
"    <span class=\"h2\">",
"     Radiation exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The frequency of imaging (particularly by CT) should be considered when planning the surveillance plan, particularly in younger individuals, given concerns about second malignancies induced by radiation exposure. For men who are concerned with the radiation exposure associated with CT scans, the alternative use of magnetic resonance imaging (MRI) is appropriate to diminish this risk. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21785?source=see_link\">",
"     \"Radiation-related risks of imaging studies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1505287219\">",
"    <span class=\"h1\">",
"     DIAGNOSIS OF RELAPSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most cases of relapsed testicular germ cell tumors are discovered during routine follow-up care.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H45827474\">",
"    <span class=\"h2\">",
"     Serum tumor markers",
"    </span>",
"    &nbsp;&mdash;&nbsp;An increase in serum tumor markers outside of the normal range represents the first evidence of disease in over one-half of men with NSGCT who relapse, including some whose marker values were normal at the time of their initial presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3334/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. Elevated serum tumor markers are unusual among men with chemotherapy-naive pure seminomas [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3334/abstract/17-19\">",
"     17-19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/58/38822?source=see_link&amp;anchor=H17#H17\">",
"     \"Serum tumor markers in testicular germ cell tumors\", section on 'Monitoring response to therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We do not consider tumor marker fluctuations within the normal range of clinical significance.",
"   </p>",
"   <p>",
"    For men with normal serum tumor markers who present with evidence of disease progression on imaging, biopsy should be performed, particularly in the absence of retroperitoneal lymphadenopathy. The treatment approach for men who relapse following surveillance is covered separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/56/2954?source=see_link&amp;anchor=H14685207#H14685207\">",
"     \"Treatment of relapsed and refractory testicular germ cell tumors\", section on 'Chemotherapy-naive patients'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For men with stage I testicular cancer, management with active surveillance or adjuvant chemotherapy. For men with NSGCT, retroperitoneal lymph node dissection is also an option, while for men with seminoma, adjuvant RT is an alternative option. Regardless, orchiectomy alone results in cure in more than 98 percent of patients. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'General principles'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/3/9272?source=see_link\">",
"       \"Retroperitoneal lymph node dissection in testicular germ cell tumors\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/29/26070?source=see_link\">",
"       \"Management of stage I nonseminomatous germ cell tumors\"",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H900675475\">",
"       'Outcome of active surveillance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For men with low-risk clinical stage I non-seminomatous germ cell tumors (NSGCT) and seminoma, we suggest active surveillance following orchiectomy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). For men with low-risk disease who decline active surveillance or are not good candidates for active surveillance, adjuvant chemotherapy with one or two cycles of platinum-based chemotherapy, RPLND (for men with NSGCT), or adjuvant RT (for men with seminoma) are appropriate alternatives. (See",
"      <a class=\"local\" href=\"#H900673895\">",
"       'Patient selection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Active surveillance protocols vary based on whether patients have seminoma or NSGCT and include a combination of history and physical, serum tumor markers, and imaging. In general, a more intensive approach of surveillance is used for men with NSGCT. Surveillance is necessary for a minimum of five years and for some patients, up to 10 years following orchiectomy. (See",
"      <a class=\"local\" href=\"#H900676917\">",
"       'Active surveillance protocols'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An increase in serum tumor markers represents the first evidence of disease recurrence in over one-half of men with NSGCT, including some whose marker values were normal at the time of their initial presentation. However, elevated serum tumor markers are unusual among men with chemotherapy-naive pure seminomas. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/58/38822?source=see_link&amp;anchor=H17#H17\">",
"       \"Serum tumor markers in testicular germ cell tumors\", section on 'Monitoring response to therapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For men with normal serum tumor markers who present with evidence of disease progression on imaging, biopsy should be performed, particularly in the absence of retroperitoneal lymphadenopathy. (See",
"      <a class=\"local\" href=\"#H1505287219\">",
"       'Diagnosis of relapse'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3334/abstract/1\">",
"      Motzer RJ, Agarwal N, Beard C, et al. Testicular cancer. J Natl Compr Canc Netw 2012; 10:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3334/abstract/2\">",
"      Einhorn LH. Treatment of testicular cancer: a new and improved model. J Clin Oncol 1990; 8:1777.",
"     </a>",
"    </li>",
"    <li>",
"     Ries LA, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1975-2001, National Cancer Institute, Bethesda, MD, 2004 file://seer.cancer.gov/csr/1975_2007/index.html (Accessed on April 11, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3334/abstract/4\">",
"      Stephenson AJ, Aprikian AG, Gilligan TD, et al. Management of low-stage nonseminomatous germ cell tumors of testis: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009. Urology 2011; 78:S444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3334/abstract/5\">",
"      Richie JP, Garnick MB, Finberg H. Computerized tomography: how accurate for abdominal staging of testis tumors? J Urol 1982; 127:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3334/abstract/6\">",
"      Gels ME, Hoekstra HJ, Sleijfer DT, et al. Detection of recurrence in patients with clinical stage I nonseminomatous testicular germ cell tumors and consequences for further follow-up: a single-center 10-year experience. J Clin Oncol 1995; 13:1188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3334/abstract/7\">",
"      Nicolai N, Pizzocaro G. A surveillance study of clinical stage I nonseminomatous germ cell tumors of the testis: 10-year followup. J Urol 1995; 154:1045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3334/abstract/8\">",
"      Vergouwe Y, Steyerberg EW, Eijkemans MJ, et al. Predictors of occult metastasis in clinical stage I nonseminoma: a systematic review. J Clin Oncol 2003; 21:4092.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3334/abstract/9\">",
"      Alexandre J, Fizazi K, Mah&eacute; C, et al. Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapse. Eur J Cancer 2001; 37:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3334/abstract/10\">",
"      Albers P, Siener R, Kliesch S, et al. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial. J Clin Oncol 2003; 21:1505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3334/abstract/11\">",
"      Schmoll HJ, Souchon R, Krege S, et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004; 15:1377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3334/abstract/12\">",
"      Freedman LS, Parkinson MC, Jones WG, et al. Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet 1987; 2:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3334/abstract/13\">",
"      Ernst DS, Brasher P, Venner PM, et al. Compliance and outcome of patients with stage 1 non-seminomatous germ cell tumors (NSGCT) managed with surveillance programs in seven Canadian centres. Can J Urol 2005; 12:2575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3334/abstract/14\">",
"      Yu HY, Madison RA, Setodji CM, Saigal CS. Quality of surveillance for stage I testis cancer in the community. J Clin Oncol 2009; 27:4327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3334/abstract/15\">",
"      Loehrer PJ Sr, Gonin R, Nichols CR, et al. Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol 1998; 16:2500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3334/abstract/16\">",
"      Pico JL, Rosti G, Kramar A, et al. A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours. Ann Oncol 2005; 16:1152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3334/abstract/17\">",
"      Miller KD, Loehrer PJ, Gonin R, Einhorn LH. Salvage chemotherapy with vinblastine, ifosfamide, and cisplatin in recurrent seminoma. J Clin Oncol 1997; 15:1427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3334/abstract/18\">",
"      Vuky J, Tickoo SK, Sheinfeld J, et al. Salvage chemotherapy for patients with advanced pure seminoma. J Clin Oncol 2002; 20:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3334/abstract/19\">",
"      Foss&aring; A, Foss&aring; SD. Serum lactate dehydrogenase and human choriogonadotrophin in seminoma. Br J Urol 1989; 63:408.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2950 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-61.234.146.186-B09A38F648-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_16_3334=[""].join("\n");
var outline_f3_16_3334=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL PRINCIPLES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H900673895\">",
"      PATIENT SELECTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H900676917\">",
"      ACTIVE SURVEILLANCE PROTOCOLS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H900676969\">",
"      Nonseminomatous germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H900676977\">",
"      Seminoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H900675475\">",
"      OUTCOME OF ACTIVE SURVEILLANCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H900675272\">",
"      ISSUES REGARDING ACTIVE SURVEILLANCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H900675280\">",
"      Compliance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H900675287\">",
"      Radiation exposure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1505287219\">",
"      DIAGNOSIS OF RELAPSE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H45827474\">",
"      Serum tumor markers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/2950\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2950|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/34/21037\" title=\"table 1\">",
"      Stage group testicular CA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/13/36061\" title=\"table 2\">",
"      TNM staging testicular CA",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/47/41720?source=related_link\">",
"      Clinical manifestations, diagnosis, and staging of testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/63/24568?source=related_link\">",
"      Initial risk-stratified treatment for advanced testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/29/26070?source=related_link\">",
"      Management of stage I nonseminomatous germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/7/13432?source=related_link\">",
"      Overview of the treatment of testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/45/9943?source=related_link\">",
"      Posttreatment follow-up for men with testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21785?source=related_link\">",
"      Radiation-related risks of imaging studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/3/9272?source=related_link\">",
"      Retroperitoneal lymph node dissection in testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/58/38822?source=related_link\">",
"      Serum tumor markers in testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/56/2954?source=related_link\">",
"      Treatment of relapsed and refractory testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/2/22567?source=related_link\">",
"      Treatment of stage I seminoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_16_3335="Sinonasal undiff CA Light";
var content_f3_16_3335=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F72367&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F72367&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sinonasal undifferentiated carcinoma (SNUC)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 395px; height: 258px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power photomicrograph demonstrating sheets of large pleomorphic tumor cells with a high mitotic rate and extensive necrosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of G Kenneth Haines, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_16_3335=[""].join("\n");
var outline_f3_16_3335=null;
var title_f3_16_3336="Treatment of candidemia in children";
var content_f3_16_3336=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of candidemia in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/16/3336/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/16/3336/contributors\">",
"     Judith R Campbell, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/16/3336/contributors\">",
"     Carol A Kauffman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/16/3336/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/16/3336/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/16/3336/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/16/3336/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/16/3336/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 9, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of candidemia in children will be discussed here. The clinical features and diagnosis of candidemia in neonates and children and the treatment of candidemia in neonates and adults are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/62/31720?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Candida infection in neonates\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/6/25703?source=see_link\">",
"     \"Clinical features and diagnosis of candidemia in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/51/40760?source=see_link\">",
"     \"Treatment of Candida infection in neonates\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/13/29914?source=see_link\">",
"     \"Treatment of candidemia and invasive candidiasis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term candidemia indicates the presence of",
"    <em>",
"     Candida",
"    </em>",
"    species in the blood.",
"    <em>",
"     Candida",
"    </em>",
"    in a blood culture should never be viewed as a contaminant and should always prompt a search for the source of the fungemia. For many patients, candidemia is a manifestation of disseminated candidiasis, while for others it reflects colonization of an indwelling intravenous catheter [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Infectious Diseases Society of America has issued practice guidelines for the treatment of candidiasis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/2\">",
"     2",
"    </a>",
"    ]. The treatment of candidiasis involves removal of infected catheters and administration of antifungal agents; it should never be assumed that removal of a catheter alone is adequate therapy for candidemia [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/2\">",
"     2",
"    </a>",
"    ]. Several studies have noted the high mortality rates associated with candidemia [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/3-6\">",
"     3-6",
"    </a>",
"    ] and have shown that mortality is highest in those patients who were not treated promptly with an antifungal drug [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/4,5,7-9\">",
"     4,5,7-9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CATHETER REMOVAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;All intravenous catheters should be removed in candidemic patients who have intravascular catheters in place [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/2,10\">",
"     2,10",
"    </a>",
"    ]. Clearance of fungemia occurs more quickly when catheters are removed [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/11,12\">",
"     11,12",
"    </a>",
"    ], and higher mortality has been documented if catheters remain [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/4,12-14\">",
"     4,12-14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a cohort study of candidemia conducted in infants in a neonatal intensive care unit over a five-year period, failure to remove a central venous catheter as soon as candidemia was detected was associated with a significantly increased mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/14\">",
"     14",
"    </a>",
"    ]. Some authors argue that for neutropenic patients, the source of the candidemia is most likely the gastrointestinal tract rather than the intravascular catheter, and thus the catheter does not always need to be removed [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/15\">",
"     15",
"    </a>",
"    ]. Successful treatment without catheter removal has been described using antifungal lock therapy in addition to systemic antifungal therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/16-19\">",
"     16-19",
"    </a>",
"    ]. Nevertheless, the weight of evidence currently favors catheter removal in all patients with candidemia [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/4,11,20\">",
"     4,11,20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ANTIFUNGAL AGENTS AND DOSING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The antifungal agents used most often for the treatment of candidemia in children have been",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/12/201?source=see_link\">",
"     amphotericin B",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/43/26297?source=see_link\">",
"     fluconazole",
"    </a>",
"    . However, with the increasing number of antifungal agents available, data are slowly accumulating on the safety and efficacy of azoles, lipid formulations of amphotericin B, and echinocandins in children [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/21\">",
"     21",
"    </a>",
"    ]. These agents are increasingly used in children with candidiasis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Antifungal agents and drug resistance are discussed in greater detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/13/29914?source=see_link&amp;anchor=H2#H2\">",
"     \"Treatment of candidemia and invasive candidiasis in adults\", section on 'Antifungal agents'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/13/29914?source=see_link&amp;anchor=H6#H6\">",
"     \"Treatment of candidemia and invasive candidiasis in adults\", section on 'Susceptibility patterns'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Amphotericin B",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most of the experience with treating fungal infections in children has been with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/12/201?source=see_link\">",
"     amphotericin B",
"    </a>",
"    deoxycholate (conventional amphotericin). In general, young children tolerate amphotericin B deoxycholate better than adults and have less nephrotoxicity.",
"   </p>",
"   <p>",
"    The recommended dose of conventional",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/12/201?source=see_link\">",
"     amphotericin B",
"    </a>",
"    for older infants and children is 1.0",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day. Doses as high as 1.5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day have been used for meningitis or disseminated infection with focal liver or renal disease, but if higher doses are needed it seems prudent to change to a lipid formulation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Lipid formulations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lipid",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/12/201?source=see_link\">",
"     amphotericin B",
"    </a>",
"    preparations are preferred for children who develop nephrotoxicity with amphotericin B deoxycholate and for those who are receiving other nephrotoxic agents (eg, posttransplantation).",
"   </p>",
"   <p>",
"    The pharmacokinetics of lipid formulations in children are similar to those in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/23\">",
"     23",
"    </a>",
"    ]. The usual dose is 3 to 5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Azole agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Azole agents include",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/43/26297?source=see_link\">",
"     fluconazole",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/60/12234?source=see_link\">",
"     voriconazole",
"    </a>",
"    . Fluconazole is the agent used most often for candidiasis, but a randomized controlled trial in adults has shown voriconazole to be as effective as",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/12/201?source=see_link\">",
"     amphotericin B",
"    </a>",
"    followed by fluconazole [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pharmacokinetics of azoles differ in children and adults. Children require higher doses of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/43/26297?source=see_link\">",
"     fluconazole",
"    </a>",
"    than adults because the half-life is much shorter in children [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. Children also require higher doses of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/60/12234?source=see_link\">",
"     voriconazole",
"    </a>",
"    than adults because of differing elimination patterns (linear elimination until approximately 12 years of age and nonlinear elimination thereafter) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The recommended dose of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/43/26297?source=see_link\">",
"       fluconazole",
"      </a>",
"      for children is 6 to 12",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day [",
"      <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The recommended dose of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/60/12234?source=see_link\">",
"       voriconazole",
"      </a>",
"      for children up to 12 years of age is 7",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      every 12 hours (compared with 4",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      every 12 hours in children older than 12 years and adults) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/27,28\">",
"       27,28",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      In observational studies, the pharmacokinetics of voriconazole have varied markedly from patient to patient [",
"      <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/29-31\">",
"       29-31",
"      </a>",
"      ]. In one study, voriconazole trough concentrations of 1",
"      <span class=\"nowrap\">",
"       mcg/mL",
"      </span>",
"      were associated with increased survival from invasive fungal infection (9 of 46 children had invasive candidiasis) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/29\">",
"       29",
"      </a>",
"      ]. Until prospective studies confirm these data, it is advisable to monitor serum concentration and maintain a trough concentration of at least 1",
"      <span class=\"nowrap\">",
"       mcg/mL",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Echinocandins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Echinocandins include",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/47/21237?source=see_link\">",
"     caspofungin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/51/20276?source=see_link\">",
"     anidulafungin",
"    </a>",
"    , and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/29/9686?source=see_link\">",
"     micafungin",
"    </a>",
"    . Echinocandins have assumed an increasingly important role in the treatment of candidiasis in adults. Several randomized controlled trials in adults have demonstrated that echinocandins are safe and effective when compared with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/12/201?source=see_link\">",
"     amphotericin B",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/43/26297?source=see_link\">",
"     fluconazole",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/33-36\">",
"     33-36",
"    </a>",
"    ]. Echinocandins also seem to be safe in children, although there are fewer data than in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/37-43\">",
"     37-43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Caspofungin",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/47/21237?source=see_link\">",
"     Caspofungin",
"    </a>",
"    is approved by the United States Food and Drug Administration for use in children older than three months for the treatment of candidemia and invasive candidiasis, and for empirical therapy for suspected fungal infection in children with fever and neutropenia. Dosing regimens have not been standardized for children, but it appears that caspofungin should be dosed by body surface area rather than weight. A single loading dose of 70",
"    <span class=\"nowrap\">",
"     mg/m&sup2;",
"    </span>",
"    per day (maximum dose 70 mg), followed by 50",
"    <span class=\"nowrap\">",
"     mg/m&sup2;",
"    </span>",
"    per day (maximum dose 70 mg) is recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/38-41\">",
"     38-41",
"    </a>",
"    ]. Patients receiving a concomitant enzyme inducer, such as",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/19/33082?source=see_link\">",
"     phenytoin",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/52/17225?source=see_link\">",
"     rifampin",
"    </a>",
"    , may require dose adjustment upward (maximum 70 mg).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Other echinocandins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dosing regimens have not been standardized in children. General dosing guidelines for other echinocandins are as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/39,44-48\">",
"     39,44-48",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/51/20276?source=see_link\">",
"       Anidulafungin",
"      </a>",
"      &ndash; 1.5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/29/9686?source=see_link\">",
"       Micafungin",
"      </a>",
"      &ndash; 2 to 4",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day, with doses as high as 10",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day suggested for neonates",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Actual dosing regimens should be discussed with an infectious diseases pharmacist or clinician before starting therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     TREATMENT RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The choice of antifungal agent is guided by clinical features (age, hemodynamic stability, baseline renal function, immunocompetence) and the knowledge of the infecting",
"    <em>",
"     Candida",
"    </em>",
"    species [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. If the etiologic agent has not been identified, the approach to empiric therapy is influenced by whether the patient is known to be colonized with resistant",
"    <em>",
"     Candida",
"    </em>",
"    species, if the patient has developed candidemia despite antifungal prophylaxis, and the proportion of candidemias due to resistant species within a particular medical center.",
"   </p>",
"   <p>",
"    The following discussion is generally in agreement with the 2009 Infectious Diseases Society of America (IDSA) practice guidelines for the treatment of candidiasis, although the practice guidelines were formulated with few data on the treatment of neonates, infants, and young children when compared with the data on treatment of adults [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The treatment of candidiasis in neonates is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/51/40760?source=see_link\">",
"     \"Treatment of Candida infection in neonates\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H275376940\">",
"    <span class=\"h2\">",
"     Clinical scenarios",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Immunocompetent patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several large randomized trials in adults have shown that",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/43/26297?source=see_link\">",
"     fluconazole",
"    </a>",
"    is as effective as",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/12/201?source=see_link\">",
"     amphotericin B",
"    </a>",
"    for the treatment of candidemia [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/51-54\">",
"     51-54",
"    </a>",
"    ]. Similar comparative trials in children have not been reported, but case reports and non-comparative trials of fluconazole in children suggest that it is safe and effective [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/55-59\">",
"     55-59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The echinocandin antifungal agent,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/47/21237?source=see_link\">",
"     caspofungin",
"    </a>",
"    , and the azole,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/60/12234?source=see_link\">",
"     voriconazole",
"    </a>",
"    , have been shown to be efficacious in nonneutropenic adults. Experience with these agents in children is limited [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/60-64\">",
"     60-64",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/13/29914?source=see_link&amp;anchor=H16#H16\">",
"     \"Treatment of candidemia and invasive candidiasis in adults\", section on 'Echinocandins'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Neutropenic patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are fewer data reported in neutropenic than nonneutropenic patients with candidemia, but those available support the use of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/12/201?source=see_link\">",
"     amphotericin B",
"    </a>",
"    , an echinocandin, or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/43/26297?source=see_link\">",
"     fluconazole",
"    </a>",
"    in certain subpopulations of neutropenic adults [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/15,54,65\">",
"     15,54,65",
"    </a>",
"    ]. Similar data are not available in children. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/4/36938?source=see_link\">",
"     \"Pharmacology of azoles\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/13/29914?source=see_link&amp;anchor=H230580859#H230580859\">",
"     \"Treatment of candidemia and invasive candidiasis in adults\", section on 'Antifungal therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are several important considerations related to the treatment of candidemia in neutropenic patients.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Treatment of neutropenic patients with",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/43/26297?source=see_link\">",
"       fluconazole",
"      </a>",
"      should be restricted to clinically stable patients who have no evidence of visceral infection and who have not received fluconazole for prophylaxis [",
"      <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/66\">",
"       66",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      If",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/12/201?source=see_link\">",
"       amphotericin B",
"      </a>",
"      is used, we suggest close monitoring of serum creatinine and electrolytes, including magnesium (",
"      <a class=\"graphic graphic_table graphicRef57378 \" href=\"UTD.htm?13/11/13499\">",
"       table 1",
"      </a>",
"      ). If there is underlying renal insufficiency or a rise in the serum creatinine, then lipid formulations of amphotericin B or an echinocandin should be used [",
"      <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Empiric therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The approach to empiric antifungal therapy differs according to the host.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h4\">",
"     Neutropenic patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antifungal therapy in neutropenic patients is more commonly initiated for persistent fever that has failed to respond to antibiotics than for documented candidemia. In many centers, it is routine practice to begin antifungal agents after five to seven days in febrile neutropenic children receiving antibiotics. Most clinicians use",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/12/201?source=see_link\">",
"     amphotericin B",
"    </a>",
"    , rather than",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/43/26297?source=see_link\">",
"     fluconazole",
"    </a>",
"    , for empiric therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/67-69\">",
"     67-69",
"    </a>",
"    ]. This is partly because of concerns that",
"    <em>",
"     Aspergillus",
"    </em>",
"    or fluconazole-resistant",
"    <em>",
"     Candida",
"    </em>",
"    species might be the cause of fever in these high-risk patients. Empiric use of an echinocandin or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/60/12234?source=see_link\">",
"     voriconazole",
"    </a>",
"    may be considered in special circumstances (eg, voriconazole may be added if there are pulmonary nodules or high suspicion of disseminated aspergillosis). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/33/15898?source=see_link&amp;anchor=H23804813#H23804813\">",
"     \"Fever in children with chemotherapy-induced neutropenia\", section on 'Antifungal therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h4\">",
"     ICU patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who are hospitalized in the ICU and who have persistent fever, hypothermia, or unexplained hypotension, despite broad-spectrum antibacterial agents, may have candidemia.",
"    <em>",
"     Candida",
"    </em>",
"    species are the fourth most common cause of bloodstream infections in US hospitals [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Empiric antifungal therapy should be limited to patients with persistent fevers despite antibacterial therapy who have",
"    <em>",
"     Candida",
"    </em>",
"    colonization in multiple sites and other risk factors for candidemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/6/25703?source=see_link&amp;anchor=H3#H3\">",
"     \"Clinical features and diagnosis of candidemia in children\", section on 'Risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Candida glabrata",
"    </span>",
"    &nbsp;&mdash;&nbsp;The choice of antifungal agent when",
"    <em>",
"     C. glabrata",
"    </em>",
"    is isolated from the blood is somewhat controversial. Many",
"    <em>",
"     C. glabrata",
"    </em>",
"    strains are resistant to",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/43/26297?source=see_link\">",
"     fluconazole",
"    </a>",
"    , and the most conservative approach is to treat fungemia due to this species with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/12/201?source=see_link\">",
"     amphotericin B",
"    </a>",
"    or an echinocandin [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/71\">",
"     71",
"    </a>",
"    ]. Amphotericin B has been the treatment of choice for",
"    <em>",
"     C. glabrata",
"    </em>",
"    candidemia in infants and children. In adults, amphotericin B now is rarely used for this indication, and echinocandins have assumed this role. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/13/29914?source=see_link&amp;anchor=H19#H19\">",
"     \"Treatment of candidemia and invasive candidiasis in adults\", section on 'C. glabrata and C. krusei'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Combination therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of several antifungal agents together is generally not indicated for the treatment of candidiasis and candidemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Duration of treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The appropriate duration of therapy for candidemia has not been widely studied. If there is no evidence of disseminated disease, a minimum of two weeks of therapy after blood cultures become negative has been used in some adult clinical trials [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/51\">",
"     51",
"    </a>",
"    ] and is the recommended duration in the 2009 IDSA practice guidelines [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3336/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We recommend daily blood cultures after initiating therapy to confirm the date of sterilization. If blood cultures remain positive, then a search for a metastatic focus or endocarditis needs to be undertaken. In instances of",
"    <em>",
"     Candida",
"    </em>",
"    endocarditis or metastatic focus, durations of therapy are longer and should be determined in consultation with an infectious diseases clinician.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H275376660\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Candidemia indicates the presence of",
"      <em>",
"       Candida",
"      </em>",
"      species in the blood.",
"      <em>",
"       Candida",
"      </em>",
"      in a blood culture should never be viewed as a contaminant and should always prompt a search for the source of the fungemia. The treatment of candidiasis involves removal of infected catheters and administration of antifungal agents. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The antifungal agents used most often for the treatment of candidemia in children include",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/12/201?source=see_link\">",
"       amphotericin B",
"      </a>",
"      , lipid formulations of amphotericin,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/43/26297?source=see_link\">",
"       fluconazole",
"      </a>",
"      and other azoles, and echinocandins. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Antifungal agents and dosing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The choice of antifungal agent is guided by clinical features (age, hemodynamic stability, baseline renal function, immunocompetence) and the knowledge of the infecting",
"      <em>",
"       Candida",
"      </em>",
"      species. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Treatment recommendations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The appropriate duration of therapy for candidemia has not been widely studied. If there is no evidence of disseminated disease, the Infectious Disease Society of America guidelines suggest a minimum of two weeks of therapy after blood cultures become negative. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Duration of treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/1\">",
"      Fridkin SK. The changing face of fungal infections in health care settings. Clin Infect Dis 2005; 41:1455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/2\">",
"      Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/3\">",
"      Fraser VJ, Jones M, Dunkel J, et al. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992; 15:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/4\">",
"      Nguyen MH, Peacock JE Jr, Tanner DC, et al. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med 1995; 155:2429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/5\">",
"      Nucci M, Colombo AL, Silveira F, et al. Risk factors for death in patients with candidemia. Infect Control Hosp Epidemiol 1998; 19:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/6\">",
"      Fridkin SK, Kaufman D, Edwards JR, et al. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004. Pediatrics 2006; 117:1680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/7\">",
"      Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 2002; 113:480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/8\">",
"      Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005; 49:3640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/9\">",
"      Garey KW, Rege M, Pai MP, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 2006; 43:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/10\">",
"      Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/11\">",
"      Rex JH, Bennett JE, Sugar AM, et al. Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Clin Infect Dis 1995; 21:994.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/12\">",
"      Asmundsd&oacute;ttir LR, Erlendsd&oacute;ttir H, Gottfredsson M. Improving survival of patients with candidaemia: analysis of prognostic factors from a long-term, nationwide study in Iceland. Scand J Infect Dis 2005; 37:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/13\">",
"      Stamos JK, Rowley AH. Candidemia in a pediatric population. Clin Infect Dis 1995; 20:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/14\">",
"      Karlowicz MG, Hashimoto LN, Kelly RE Jr, Buescher ES. Should central venous catheters be removed as soon as candidemia is detected in neonates? Pediatrics 2000; 106:E63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/15\">",
"      Anaissie EJ, Rex JH, Uzun O, Vartivarian S. Predictors of adverse outcome in cancer patients with candidemia. Am J Med 1998; 104:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/16\">",
"      Buckler BS, Sams RN, Goei VL, et al. Treatment of central venous catheter fungal infection using liposomal amphotericin-B lock therapy. Pediatr Infect Dis J 2008; 27:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/17\">",
"      Castagnola E, Marazzi MG, Tacchella A, Giacchino R. Broviac catheter-related candidemia. Pediatr Infect Dis J 2005; 24:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/18\">",
"      Viale P, Petrosillo N, Signorini L, et al. Should lock therapy always be avoided for central venous catheter-associated fungal bloodstream infections? Clin Infect Dis 2001; 33:1947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/19\">",
"      Johnson DC, Johnson FL, Goldman S. Preliminary results treating persistent central venous catheter infections with the antibiotic lock technique in pediatric patients. Pediatr Infect Dis J 1994; 13:930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/20\">",
"      Edwards JE Jr, Bodey GP, Bowden RA, et al. International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis 1997; 25:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/21\">",
"      Blyth CC, Hale K, Palasanthiran P, et al. Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections. Cochrane Database Syst Rev 2010; :CD006343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/22\">",
"      Prasad PA, Coffin SE, Leckerman KH, et al. Pediatric antifungal utilization: new drugs, new trends. Pediatr Infect Dis J 2008; 27:1083.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/23\">",
"      Walsh TJ, Whitcomb P, Piscitelli S, et al. Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis. Antimicrob Agents Chemother 1997; 41:1944.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/24\">",
"      Kullberg BJ, Sobel JD, Ruhnke M, et al. Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial. Lancet 2005; 366:1435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/25\">",
"      Lee JW, Seibel NL, Amantea M, et al. Safety and pharmacokinetics of fluconazole in children with neoplastic diseases. J Pediatr 1992; 120:987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/26\">",
"      Seay RE, Larson TA, Toscano JP, et al. Pharmacokinetics of fluconazole in immune-compromised children with leukemia or other hematologic diseases. Pharmacotherapy 1995; 15:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/27\">",
"      Walsh TJ, Karlsson MO, Driscoll T, et al. Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration. Antimicrob Agents Chemother 2004; 48:2166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/28\">",
"      Karlsson MO, Lutsar I, Milligan PA. Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies. Antimicrob Agents Chemother 2009; 53:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/29\">",
"      Neely M, Rushing T, Kovacs A, et al. Voriconazole pharmacokinetics and pharmacodynamics in children. Clin Infect Dis 2010; 50:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/30\">",
"      Doby EH, Benjamin DK Jr, Blaschke AJ, et al. Therapeutic monitoring of voriconazole in children less than three years of age: a case report and summary of voriconazole concentrations for ten children. Pediatr Infect Dis J 2012; 31:632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/31\">",
"      Pieper S, Kolve H, Gumbinger HG, et al. Monitoring of voriconazole plasma concentrations in immunocompromised paediatric patients. J Antimicrob Chemother 2012; 67:2717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/32\">",
"      Br&uuml;ggemann RJ, van der Linden JW, Verweij PE, et al. Impact of therapeutic drug monitoring of voriconazole in a pediatric population. Pediatr Infect Dis J 2011; 30:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/33\">",
"      Reboli AC, Rotstein C, Pappas PG, et al. Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med 2007; 356:2472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/34\">",
"      Kuse ER, Chetchotisakd P, da Cunha CA, et al. Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. Lancet 2007; 369:1519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/35\">",
"      Mora-Duarte J, Betts R, Rotstein C, et al. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002; 347:2020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/36\">",
"      Pappas PG, Rotstein CM, Betts RF, et al. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clin Infect Dis 2007; 45:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/37\">",
"      Zaoutis T, Lehrnbecher T, Groll AH, et al. Safety experience with caspofungin in pediatric patients. Pediatr Infect Dis J 2009; 28:1132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/38\">",
"      Steinbach WJ, Benjamin DK. New antifungal agents under development in children and neonates. Curr Opin Infect Dis 2005; 18:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/39\">",
"      Benjamin DK Jr, Driscoll T, Seibel NL, et al. Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections. Antimicrob Agents Chemother 2006; 50:632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/40\">",
"      Fisher BT, Zaoutis T. Caspofungin for the treatment of pediatric fungal infections. Pediatr Infect Dis J 2008; 27:1099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/41\">",
"      Zaoutis TE, Jafri HS, Huang LM, et al. A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients. Pediatrics 2009; 123:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/42\">",
"      Maertens JA, Madero L, Reilly AF, et al. A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia. Pediatr Infect Dis J 2010; 29:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/43\">",
"      Arrieta AC, Maddison P, Groll AH. Safety of micafungin in pediatric clinical trials. Pediatr Infect Dis J 2011; 30:e97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/44\">",
"      Seibel NL, Schwartz C, Arrieta A, et al. Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients. Antimicrob Agents Chemother 2005; 49:3317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/45\">",
"      Heresi GP, Gerstmann DR, Reed MD, et al. The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants. Pediatr Infect Dis J 2006; 25:1110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/46\">",
"      Queiroz-Telles F, Berezin E, Leverger G, et al. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial. Pediatr Infect Dis J 2008; 27:820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/47\">",
"      Cohen-Wolkowiez M, Moran C, Benjamin DK Jr, Smith PB. Pediatric antifungal agents. Curr Opin Infect Dis 2009; 22:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/48\">",
"      Undre NA, Stevenson P, Freire A, Arrieta A. Pharmacokinetics of micafungin in pediatric patients with invasive candidiasis and candidemia. Pediatr Infect Dis J 2012; 31:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/49\">",
"      Blyth CC, Palasanthiran P, O'Brien TA. Antifungal therapy in children with invasive fungal infections: a systematic review. Pediatrics 2007; 119:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/50\">",
"      Steinbach WJ. Antifungal agents in children. Pediatr Clin North Am 2005; 52:895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/51\">",
"      Rex JH, Bennett JE, Sugar AM, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med 1994; 331:1325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/52\">",
"      Phillips P, Shafran S, Garber G, et al. Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group. Eur J Clin Microbiol Infect Dis 1997; 16:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/53\">",
"      Abele-Horn M, Kopp A, Sternberg U, et al. A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients. Infection 1996; 24:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/54\">",
"      Anaissie EJ, Darouiche RO, Abi-Said D, et al. Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature. Clin Infect Dis 1996; 23:964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/55\">",
"      Kaufman D, Boyle R, Hazen KC, et al. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 2001; 345:1660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/56\">",
"      Presterl E, Graninger W. Efficacy and safety of fluconazole in the treatment of systemic fungal infections in pediatric patients. Multicentre Study Group. Eur J Clin Microbiol Infect Dis 1994; 13:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/57\">",
"      Schwarze R, Penk A, Pittrow L. Treatment of candidal infections with fluconazole in neonates and infants. Eur J Med Res 2000; 5:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/58\">",
"      Fasano C, O'Keeffe J, Gibbs D. Fluconazole treatment of neonates and infants with severe fungal infections not treatable with conventional agents. Eur J Clin Microbiol Infect Dis 1994; 13:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/59\">",
"      Fasano C, O'Keeffe J, Gibbs D. Fluconazole treatment of children with severe fungal infections not treatable with conventional agents. Eur J Clin Microbiol Infect Dis 1994; 13:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/60\">",
"      Franklin JA, McCormick J, Flynn PM. Retrospective study of the safety of caspofungin in immunocompromised pediatric patients. Pediatr Infect Dis J 2003; 22:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/61\">",
"      Odio CM, Araya R, Pinto LE, et al. Caspofungin therapy of neonates with invasive candidiasis. Pediatr Infect Dis J 2004; 23:1093.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/62\">",
"      Merlin E, Galambrun C, Ribaud P, et al. Efficacy and safety of caspofungin therapy in children with invasive fungal infections. Pediatr Infect Dis J 2006; 25:1186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/63\">",
"      Koo A, Sung L, Allen U, et al. Efficacy and safety of caspofungin for the empiric management of fever in neutropenic children. Pediatr Infect Dis J 2007; 26:854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/64\">",
"      Pasqualotto AC, Shah M, Wynn R, Denning DW. Voriconazole plasma monitoring. Arch Dis Child 2008; 93:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/65\">",
"      de Pauw BE, Raemaekers JM, Donnelly JP, et al. An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancy. Ann Hematol 1995; 70:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/66\">",
"      Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004; 39:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/67\">",
"      Walsh TJ, Finberg RW, Arndt C, et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. N Engl J Med 1999; 340:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/68\">",
"      Walsh TJ, Teppler H, Donowitz GR, et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 2004; 351:1391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/69\">",
"      Walsh TJ, Pappas P, Winston DJ, et al. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med 2002; 346:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/70\">",
"      Blumberg HM, Jarvis WR, Soucie JM, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 2001; 33:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3336/abstract/71\">",
"      Fidel PL Jr, Vazquez JA, Sobel JD. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 1999; 12:80.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6014 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.248-3548BCC041-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_16_3336=[""].join("\n");
var outline_f3_16_3336=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H275376660\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CATHETER REMOVAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ANTIFUNGAL AGENTS AND DOSING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Amphotericin B",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Lipid formulations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Azole agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Echinocandins",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Caspofungin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Other echinocandins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      TREATMENT RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H275376940\">",
"      Clinical scenarios",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Immunocompetent patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Neutropenic patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Empiric therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Neutropenic patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      ICU patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Candida glabrata",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Combination therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Duration of treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H275376660\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6014\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6014|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/11/13499\" title=\"table 1\">",
"      Estimation creatinine clearance",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/6/25703?source=related_link\">",
"      Clinical features and diagnosis of candidemia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/62/31720?source=related_link\">",
"      Clinical manifestations and diagnosis of Candida infection in neonates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/33/15898?source=related_link\">",
"      Fever in children with chemotherapy-induced neutropenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/4/36938?source=related_link\">",
"      Pharmacology of azoles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/51/40760?source=related_link\">",
"      Treatment of Candida infection in neonates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/13/29914?source=related_link\">",
"      Treatment of candidemia and invasive candidiasis in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_16_3337="Broth dilution test";
var content_f3_16_3337=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F58379&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F58379&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 500px\">",
"   <div class=\"ttl\">",
"    Broth microdilution test of Candida glabrata at 48 hours",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 480px; height: 350px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFeAeADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD2exXFlbgZwI1HH0FWMe9RWY22sI9EX+VTU2ShMH+9QWKjJfA9aRiT8q4z3J7VWvbi0sLWS6vpo4oIxlpZmwBTvYCC71SSK+s4YlDxTPskck5HykjA79P1q6WtyMPDGQeu6Ic/pXl+t/F7wtHe2qQT3dyYLgMzRxYXoRwT9a6zw74+0LXLoWltetBeEZFvcjY7fTnBpJ32G4s23sdIkJMmn6ezH+9br/hUUOh6AluIv7M08xjoGiWtUEkf0NKV/wBlSPcUtRGM/hnw1KSX0fTiW64TGf1rMbR/CiXckMWkSoiMInuYZHWONz/DkN+tdPK0calnWJVHVmwAPxrkJdb0vU9SltTf6fbWMEoDrkb7pwc8ei5796E7FJGhbfD/AMM20vmxWkwlAYB/tT5XPXHPGe9ct4j0ax0n4keFDpdvLPdm3uJRFPcFlYDg9fTOa9IVbeTkRxkEZBHQ1wniGCNPjJ4QESbd+nXm7B9xSbCJJoXhjS/EVtc6lfR3EdzNPIjpDNhFwcYHHtWgPh/pC2f2VJ9RW3Cldnmqwx6crWn4SsYI9HyIyGaaVmwx5O481qypBBDJKwk2opZipJIA74prRCbOAtPCeh3NzHbW2sasJdpKxywIMqvXGVHTirknw5tmK7NYu12ncM20ZreHkjX7ae2uGuPtsRDIJNwRFGQy+nJx71uLGhHBf/vqkklsDZ5zqPwsivoZ45dfuFWUDOy1RSMdMYPFSR/DiaO3jij16Fgi7QXseT9SGr0MxDHDyD8aQQ8D97J+lU3dgmeZXfw91eGNFtNc00gEZae3K59ByeCalj+HmsNCPP1XTEl5ztjlI/Q10fih5HlMbQ3b2ttsm3rGGWRww/LaOnqa6SJhMiyLLIFcbgHjw3PqOxqbdQuecP8ADzWhNFt1XTCmfmO2YY4pz/D7Wz9zU9K/EzCvSRG//Pbj/dFOMb/89hn/AHKrmFc8uuvhxrs8YQ6vpifMGyrS84OcdKnPgPW1bnUdF55+aaVf0xXpPlyD/lsn4pWPqGmSXOpvcMtlcxrb7RHNGc5ByQMHjNCYzkD4D1wk5vNIH0kl/wAKRfh/re/JvdIwBx88xyfyr0O0JuLSGWGRRG6AqNvQelTBJM/6xP8AvilfyA88/wCED1rj/TNFH/f6k/4QDW2POo6Ko/3Jmr0UxynrMn/fFCxyBuZhn/coC552ngHUGm2PrekFlGWjS3kyB6/eqQeAb9j+9vdLGOjJbP8AyJrX0yOaFbO9u/s22W5ZBcRr+9JZiAWz1HbFdQIZOf8ASX+mwU7vYDy9fC9j4V1+5uL2+lu5LvT2Ajtrcrjaw7ZPHPWo/Bvw2sZLB7ldUcq9wzgJboQQQDgEn3ruZ7cx+Ib6Z5jK66YVG5QNo3E9vXik8F6bFaaBGttPMI3kaTbxgE4zj2zU3Kexl/8ACA2MaEtqd2AOTiCMY/Sqlv4Z0CW4ggTW9RkllbagCIoY+mdld0YVDf66dj2w1Z8cQu9WkleScw2o8tPnODIfvH8BxQroVzMHgXSwcm61Rj/12UD9Fplx4C02UDZe6tF64uM/0rqBbRH/AJ6H6uaUW0Q/gJ+rGi1xXZzkHgjRI0xJ9vmb+9Jdtn9MU2+8KeHLe2eWeyuZFBACi6kLMT0A+bvXSJb28edsSjPPesvxDLYw2RjumtoEZ1DtI4UqpP3hk5zQNGVY+EfC00z+boPk3ERG6K4lcsueh+9jmrsvhDwy5GdKtVZTkFXYH+dS+Ho7AX2oDTmW6tvkJlaTzCXwcjd3GK3kSPtGn5Ul5jlpsc/H4e0iA/uLewHtNbo/68GpFtLKBgX0bTZFH8dvEu4f8BIz+Vb20dlX/vkUyWZII2kkdI0XqzEACn5k3MhrxDcR2+k2tr5hTzGMkWwKucdhnOau6ZqK3tlHcRI4D5GFXgEHB/UVyviDxt4fjuIxJqJZgpXzLabYw/2ST/Ca2/CepWN1o9uljeQ3Gxct5bZwxOSBTuO1jYaaTH+rmP8AwGgvIeTE4+pAqUHINA6DjJo1ER4kzzGB9WFYHn6g19PZtONzzqu5WH7pdm4hf/r1D4i8Z2GlXDWkEc2o6gOsFvjCf7zdBXCT/EQx3VxLdWNvA00qyRtHdAtGVGO4wfpmluUotnqmnNcK91bO6yGBwFd2JYqRkZPc1leLEVNM1CeVI/PWNdsi/eXkAc1B4I8S6VrVvJ9iuWe8LeZOsuFcse+PT0xUvjdv+JHqZHaFD/49SewJam5oizJpcYeaMnLHIU+p96i14GTSLwNNkLEzYC8HA6H2rH1bxTp3hfwyl7qbtjkRwxjLytnoorwnxX8X/EupR3KWNuum2bAqqCIu5Hox7UXBRb2PoawKrrRYSvuktFcnAGeQMfTjpW5gN/HIfxr5W8M/FnX7S+R9TaG7j2CM7htYKD0Br6E8H+KLHxHp63FlJ8y4EkR+8h96LjcWjpfLTuGP1Y0hRBnbGnHJNJJNHFC0sjhI0BZmPQAdSa+b/ip491HxB50WnzTWnh+Nym2IlZbrHViR/D7UyUnJnrfi3xn4es5bK2n1mzEiXkbyxo+4oq5z0/CoPDfim117V5ZrX7NdXIchM3KqIY8/wjqTjk18rSLdQzCBLOS3H39u3ez+mTSWGoSWcyv8yrG28MjbHQ+oYfyNK5ryH3PJHFNy6qx7MOCPxqB1eEEs3mQ+p+8v19vevKPhR8QJdTs1g1KZXkhZY2kPGQ33H+h6H0Nevq2cMOnpQtTOScTDiHyKPYCoba7iukc27btkhibIxtYdRUOo3i2+nXMsZ3SRrtC/7Z4UfrVfT7ZtL1CO1kyUuIA249TKnD/nkVo3YhbGjcyx2ts8sr7I0GSTXGX2kXHiS5kublhuQEWcLfMtuCOJGXuxPTPStbxXOr6loemMf+Py4LEf3ggzj8yPyrvNO0O0tbu7uIIFW4uCvmuOr7RtX8hUS1RrTstT4W1rR9f0C+1HRbxbiB7mUGa38vd9oIJ2spxznPb1qbxT4R13wlbWmo3cJ8tlViRyYSR91vevuG+tNyMyRRvMoJQuoJB9j2rifGOiRarodzaXiLJ5kZVsjqcVm2bqFzz/AOA3xAk16xi0nVbjzbtFIglb7xA6o3qQOQe4r1fWNRg0vTZry6JEUS5OOrHsB7mvivwfdXHhjx4I4ic210ARnGdrY/kTX1mt5B4p8QaJZwkNCiNeTxg5AYfdU/iatSujncLSOD8b6T4k8VaRdTzvJHIF32+nxyFEQejHuxHrXgWtaNqWl3Nump2E1jczIXjR+uzOM/nX3deaO40+5+zIjXQicwh+hkwdufbOK+dvh/4D1HxdrL/8JzcahciMTJNBPujktZNw27Gxgq3PA6YqU9Tdx0OI8FfFDUfCksNvK8lxbK22aCR9ylfVM8qw9Oh9q9vbU7PWviR4J1TT5RLbTabdlHB+mQfevGf2ivBFp4W1Cxu9Jj8mym/dGMc7SBwc+9Wv2c737Z4ks4LiXaLJZVTc38Mi9B75Bqk7mMocp7xZ+IbXSPBi6hckkNJII41+9I284AryzxLqXjjxKW+xvJbRHpbw/KEH+03TP511/gjwxPL4m1Wxurp7m30y4byFdtyxmTkY99vP1NenpoUUUASJAqjooFS5aFwgj491K88YeE7yCWaa+tCxwGB3Kx9K9j+E3xaXXJ4dK19kjvX+WG4HCyn0Poa3fif4Q0zWNPitNRu1tZy+623SBGd/Rc9TXzJrulHw34zt7a4kuIbSR1bzAfmUZxkH1BojK+gVIdT7kP3feuX8Y+KRonlWljbfbtYnGYbYHAUf33PZaj+G/iI694Jtb+7YGe33QXJHdo+rfiBn8a4LwZ4ij1r4mahpd7ZOZ74HZek9MDPlAdlxj8qqTSRnCF2cL428UeNpr+4E2r3z2igMy6fFshRhzgHHOD3qr4d+MHiLTGWSXUJtQt8jfHfIGz/wMcivpa+8OQC2kiaNViKFDgYwCMZr5t8Z/CO+0rSZZYJVmaFXLTB8/aFzlQF/hwOue9JS0NXTPobwJ4w0/wAY6V9qsCY5o8Ce3c/NET0+oPY11BHFfFHwZ8Wz+G/FdvI7t5anbImf9ZGThlP06j3FfXfi7VDp+ig2rfv7phDAf97v+ANUnoYuOtjmfH/xIsfDDC2tYzeX5z+7QZAryPU/i54iNzPL9ligWZQjKMqHHYZ9a9ZtfCNrDC1xcx+Y+MtI4yxri0utG17xLN4dn0h2tdu7zpU2gkdh3HNYSqJux1RoO2he8B/GuxvZLex122Wxc4jSVDmP2B9K9phkSWNZI2DKwyGByCPWvjzxV4Kv9Hs7vVYb2xvmt7ohlsiGWNQeAw7EdxXsP7PXjZtfsbnS7kbZLUB4gTn5T1H0B6e1bJ31OaceVnsk0iQxPLKyoiLuZmOAB614p4z+NsVpetaeGrUXTKxU3D/dz7Ct/wCMt3d31s+hWFwbW3W3a6v7gfwRjoPx/rXnOgWPgUXvh/UY9O1p7yK1Mwt4ELplX25Ydzu79PWplIunTvqYVl8W/EEGq25vIooYFmaQJLG+xT3IFe2eA/ifpviSc2k5S3vM7VIbMcpxn5W/oea84bwVaf8ACwr7T9c8QRXl3dxyyx6ey8hGGV5/gdfT2ryTV9Nv/C92s32m3MUsjCGW2m3jKnjBH8QpphKB9j3UwbXtXi6FdLRvzdx/SoZNdsvDvhBL6/fbGoOFB5c4HArifhl4ml8S2upXsigXMWlRRTFu5RnzimroH/CwLKOO9aeOyTBESHDxtgHHpkVV0iYwvocB4m+L3iDVbmRNLDWlsOiQgl8e9cpY/E/xNpd0ZYr7KlsmGTnPrx619GeHvhrpfhuxeCxhZ3c7pJpjud//AK1ebfEvwA0+uwwafodu0Fwoee7DFZM5x8g6ZUcnPUVCndmvs7I7r4WfEyDxXAIL6MW+oLx1G2T6V6apyK+DLh9S8H+LhEkjpcW0qldpwHAPB+hr7HsvFSN8PZvEKjd5NoZcZ/j28A/iRVpruYyjqcn8XviYPDs/9j6LIo1Nh+/n27vs4PZR3f8AlXk2reEvEN3o1nq9yslxqFzNu/0yQmTaR8vB7969u+CWnwaz4Hj1bUrK3k1SW8meeZ0DkvnqpPbFaXiq7W01+zsPKkRXieY3LKPKBBACsfX2rKUmmbwpp6Hyymoav4Y8m5s5p7VQdyzw8d+T7jrwa+i/hD8SIvFsb2F/JF/akKBxJGMLcJ/eA7MO4rn/AIkaGlz4fvbp7RGuGO4IGAVh2ORntzXgHgjWJvDnjfTp4WIMdyAw6EBjgg/nVQdyakT7ouriO0tJJ7htsUY3M1fPvijW9a+IWr6jYaFcxrBZkbbbdtRkJxuZvXPau4+LXi4WXglLjSprWS5kdGEcrZXr91vfg8V1fg/w7oumaFFqWk6RDpT6nEt3cryWDEZI57ZPApykkTThfU8Mu/hPM1kolux9vC/OVHyMT2ArgLk674B1hZLeZ4Ch4ZG+RvZhX1vcwQSSQgu6RyHgbeR3/CvI/iJYW2vwXAijMNxEz586LCyopwFz65rNTubShoehfC3x1beMNHic/u79FxNET/EOv+P41p+NNUuIIYdN0zP26843DrGnc18q/CLVtR0vxeYrFZZJEbzWQDdwvDZHptP8q+nLeGXXrjUbtVe3uPLWKBWBO1iP5e1a82hgoLmOH1DRDJbJpen3jAl2ZhGdzSkfxPtOcEZ61m678PrMxW/2y/AdoiX8lMBW4AOPTnFes2ejrYWiyhltXlCea3lgOrfwqR1UH07U/XIJRDa/2VDbBmukW6LKG/dD7xA9awTd7nTZWsj5Pt5tS8G+J08iSWOWGQqu4Y4z90j0Ir6GTxNbeJPA2r30YYSQ2yCdAOh68evFeX/EKGXWdRu7kaZ9iFpN5KSK+8TgtwSf73r6V1HwktLpdM8RQFoGsJbxoBFJwdyxgtg9/pWsXcxnGxLHpt34u1l50u40kt90VpbSAnGOWkB7EE49etLd+DW09ZVstSdpppDHcK8SzLbsFyRu459/evRfhr4Tt4LGz1VJp97+a0kLYI3lzkg9RwMYqt4uuru01ixjWyhlht5Gnk+TbvdhhVHuOpJrOcramtNJ+6j5/wDFnhHT7bRoJrDUxdzBiroww4I69KrfCnxDcaD4qh+cpHLIsMmTwynoTXo+vaSlwusalLdxWrvh3gWMbWyemOv5V5Pb6ZjV9kQLILmNFYDG7dIo4H49KcZcyFOFj6S+KN5cP4fsbCx3efqVykG3djK/xAn0rzi98KWza9aR2tvNfxmMwtGuWWHnHykcOw7+grroE0nU/FUUOlXNzcPpereTeecx4bGABnt2zXaah4ftrjxXaiC6a1ZJvtBEQxnA5THTLdSfQUVL3Jo8qjdnlM/hSaxkOrx2j/ZYHdHSXaMc4+UDt71wXxA8Pm0vS6265n4cL91OMj69+a+lNT0u6eDVtOkRDYMwaJiMYVuTGPX/AOvXlHxJEQ+y2CxLFdbQjR5JKJjjn270ovXU0aTR5v8ADCRZddksoGKi4tZ7fDdQQu5W/BhmvqfwNqLav4P0q+l/1k1urP8A73Q/qK+WPCULaH4mF5KFLpbXNwefupt2p+Zr6d+GNnJYfD/Qrab/AFq2qlvqef61rF6nNU7lfVLcX01rZSxs1s26WbHAIUcDP1x+VVbjTILC3S8thMJbeRZTukLDb0YDPsf0qO08ZeGrhQIfEGmtkYAMwFbNlcRXVnHPbSJPA4+WWM7lb6HvWrRief8AxavjoviPwPrLNi0gvnilPYBwBk17pb3EboksZDRyqHVgeoNeW/Enw4PFXgy909F/0lR50HHO9ew+tc18EvidbyWKeHPE1x9lvrRvKilmG0Nj+Ek9DWbVjWLTR7tcAEE1x/iueO1sppJGCoqkkn0rorq7YQ70XehGQyfMD+VeS/FG9vZ9JuUt1jhRlIae6by4ox6k9/oKzbR0QPmTTYDrfxEuriMEwveAk47Fv8Aa+o/hh4hudR8VmPV9Mj0yWEPFCmwoZI2UFWIPc7DXnHwa8JRHVYJ4UMtlFuczyrtadj1k29geij0ye9dr8WnvtBvdP8VaWm97Qqk6eqA5B/Dn8Cau1lcwcryPeAFMZ4xkd6xL2xUXaXLcvGDtJP3c1H4Q8T6f4p0OHU9NmV43UF0z80bdwRTteuG+xTrDKElZGCMezEcH86TVzSF0z57/AGm7mDUtHW0tp4JLi2k8yRFcFkx6jtXlPwVlisbvVtZvDKLGxjjdxGcMxLEAL71U8YQ31jbTWmraY1tqAlcG5U5MwJOcn+LOa9++B3gWPRPDEY1e2ie7u8XNxBIoYRgj92hB7gcn3NVCOhFWWp3HwantL9tavrNWWO8kgul3/ew0QHPvkGvSZbcBTivC/DmtJ4K+IElnqDrDp905tweioC26NvoCWX2yK9183enPPGcipaWwJvdHmHxL8FSa/dxXSzWyosQgcXERcxKH3eZCQflk7Z9K+WPjdHdw+K5Fu1uVIBKiVgR16pjopGOvOc19M+Jr/wAV2/xClhFqZNBdkdLnd+7jhCkMhHQsTz6/hXzJ8WLweI/iLdx6cJJDJIkAjPO+UfKAv+fWpjuazfunf/CXUf7J+GAe71eazfUJ5VtoByLhgQCDx6cV7f8AD74bWOk68niSa+mu7iWLdbxMgVYN45/3j2BrC074fabZ+BtP066tIrq9061YRSEn5ZyNzEY6/Nx+Fdp8M9fj1rwvYsrYmiTY6E8gjgj6g1TRjF3WhW+K3iVdAj0zTILCW/1DWJvs0EKSCMD1ZmPQVjSmK/8ADUqNA9vNbs1rPbuwYxSLwVyOCO+e9dR8RPCNj4z0uKC7uJbW4t38yG5i+9Ga868ZXWnfDjwM9vFLcXs8spw8jbpbmZv4j/npUNK50Rfu2Z8m6qBp/iy88ofLHcMAB9a+wtFjXV7nw0L/AFGG4lskRWtkIzGWTI3j14r5b8IeG7nxP47gt5WRp5boSzKvIWMHLMT6dq+qbjQdK8La3Dq9ukyPqNwqTsz5UOoymB2zgitLMwbXMenNZI8O3GAfSvM/EPgl28e2msabI0PlbRIOqkDrn+tem2V6k0MchkRVkxt3MBnPYe9cfY6hqXiL/hJ9K1rTJdJhjzHDdqcblJwCCep4z6Vi4o6ITkrnmPxS8NaHo/hPVZrWeW3XUriPLw4YHHAUAYz157nvXlfwEa6tfiHKbKVY2it5Hcyfd2r2b2rvfii2t+FtBl06GYXOkFTPJq00a/vJm7Io+62eBjjHNZn7PHg3+1bPXtQ1ISC3vY/sCurYZsndIQfYYH1NbRWhlVep7r4V0xNT1vWp9R8i7W6jjVtoBjdCvQeoqG21+203xwnhfT9Is7XT7WIKJg4RwSwG1ExyMn196qW+pab8OtKmEnnvp2nQrA38UhBOY/zyRn2q9ouveE/E1lJ43g012u9OVldpF/fRFR029M4PBpSQoOyKN54O0bWdT1m7hvpXeaUyyxJtZEuAuwSBsbsAcFQcfjXhHxa8Inw14dmjkNgr3V4bkwWilUtlCgDy1Jzgkc17toXiDwrp3hHxB4p0qCeOBZT9rjZi4jkJBKqOgGWycd8188fG3W28RX9tdAyWxkVlkgyGjMYxtkQ9cN6GlFamknodd+zbqAtNBvri9u7eC3nvlt1884EjFchR7k44r6B+G2nJbeH9zKBLLPK7+x3mvLfhb8OLGTwFpdlrttIbhJv7QCByhilbGwHHcKBx716f4W1aKOWS1ZtvnSPLCDxk5xIn1Vh09DVS7mEXd2R093B8p2jmvAvjTouq33iVUTT9UvI5bVE0qWzmMcdnc7vmeUDggjHXtX0GZA65zXP+ILpLeJ3LgFRk81ns7m0G7anxl8b1jj8VhYpVluDGhmkCEHeAM4PcemK9JsRpNp8NtK0rXNQvoW1KwW4mijYhdmWyT6dBXmOpaWfFfxTbTNHVxbTXRVQzFgg6u/PRQM19VXPhuwv/AAzdQw2kDt9kNvauyAsqKuFAPUZ/rWqZlOyZ0/w3t9Lj+H2hLoChdN+yoYsdTkck+5Oc1j/EXw5fa3bJDYyDymOJYycbvf8AmKk+DtpbaT4A03T7K7kuo4lYlpMBlJPK/gciuwnkUISSOKykk9zSDcWeP+LTp/hLQbO1KM8sUDusQkAOxR8zDccHr06mvlOVjqHjVfsyBlmu1ZcjBILCvqT44Wum6rpQluoN8tmGkinzt8rjkn2+teI/B7w82q+Jl1e4BeKGXbbkjAnl7Y9l6n8KqnqgqOx7noemWniK/g0/xF4fWLTrG/3wlshLlvmCufXBxxXq3ilbxPDGo/2PtW+WFvI+XOCB2HrjoKxbmDyNNUAMwgAb5fvcdSPfvXnXxB+LuueHPNs49KtY1uEVrDVWkMkM47sFAxn/AGc8GqavsZRdztPhkmqXXhe3n1uG7juRwGvGzLJ/eYg/dBPQdqyPG2lXU9vcpcXMb2RYusZTJ/Ptjtir/wAH/GV94v8ADdzcaoI5JreXyvtMSbEnGM8L2I6GsP4r669pYyWNqd+oXZMVvFEN0hJ7Kvr79B1rHlu7HQ5dzx34NaRdy/EPxVdacypLBayQ28kgyokkICk/kfyr6V8EQ6jb2z22s3KvqbxDzJo+hYZGR+GK8z+CGjw6fHLa2pExjkMt9cK25Hn6eWrd1QcZ7nNeo6pK1k8d8mcQcuQCdq/3sDqPX2rdrQ5ub3jbgMl2bsT2YRFYRqXwTNj+P2HpWX4l0iS6sQlpIlveA5iuSgbyvU49SMisDwNALLxNrupXGvvcW2qMJYbad/lX3VidpA6Db26811Ot6rp1tD5t1qVpDGgJO6YDPHp3rK11qaptPQ8j1zR/s73MF0x8jzmvGbP7uIdWx+Rbn1qv4F8J2+vadpM13JcW9xDcS6uixHHMjfIGHugH51hfErxhY6gsenaYkz6WzfvGbIl1BgciNB1EefvMe1epfCuwvLXQBeaoMXt4fMI6bV7cdh6D0FXDRE1JXOk8N38GnaBdNPIsUdmWeTccBE65Pt/9envplpr+hwR3ohljYefFNBwrZ5DL9c1heKJZNGkN4oC2koKvKU3xxk9VlUcmNvUcg1AnxH0jT7CP7bZ3KQogVX09Rcw7e20p0HsQKTWo4tb9TF8V6PDottOYi0qtgAlslvVQK8rgit7bxFpzXA8uQTf2pdK3WKND+7X/AHnfAA9q7Dx98TNObTcaXpVyjM37u51BDEinttU8sfauR8A+Fr3xBqhu9TE8cPnrdXU8ud7j+Esvb0VfxpwpvqOpUue6eHdMSHQoLxYI0vJmM8rBQGck55PfFdDaZv2ecyywymPywUPC+pA/vds1EtzAiJFGrCMAIBt4Udga5jxJqGseGG+1abaNf2J+9GozIh9Mdx70SjfVGcJ20Z0viWGMxJPcTXBjimR0RG2gHpz6g5zg15h43giawm1PU3hjZGILIPvgE4Qe9alr488R67al9K8LMuJPJaS8lWJVOM5weSB7CuV17wb4816/W51S70cQYYLBvOxMjr2yalQ1NXOyseY+D7a68bePI7S3AW3klHnY6CNe30AH519fpGsUSxxjCIoVfoBivLvh94btPh9p8+LzRXvZuZLia6VcD+6BngVe1Hx5a2zP9p8ZeHLVOwhzK2K12OeV2fNkmsXNuoFxo+jyoo4LQYrs/B/xB0rStHggub7WLB8sWt7WINbxEnpGM9K9IuvhN4SlAVory33dNt4w/IGsab4JaE4P2bU9SjGf7yOB+lN6hdFaL4n6PIv+j+Nb+1fsZ7AsB+lc3La+FvEeq3N5rXjnT5Lm4ZQ3kW32cuPcEY3e9btx8DU5a18Quvp51qGH6Gl8DfCQX1+0s80FxbQMVF2kGwOB/dU9TnvRd9Slbob2jeGLLTdGlutI8e39rp8YYtudZgFAz8oPp7V55FY614y1qNbWdNTtDJ+7uLqXlVB++Y+g45wc17tB4C0LT0Ux6atxIhyJZiWbP8vyrhvFvgPSJLtrnThPpOpkl0eByFY/T/Couacrsd7o2kx6DoTR2p82RFBaR/4j/h7UtyU1m3eyniXy5UYMepVh3I9K5P4beM57u9PhzxGYzqIQ+RcD7t2q/eH++O4rvXgit5BLFFGoUYOODj+taXutDntZ2PCNR8PeIfAmrS3nhCWbaTmSxRvmUeqA8Ont1HStS48YfEK98PJqLaJa/Y2jZ2uJisXlgcEsCcj8q7y9g1rxVLImnTR6do8bFftZTfJKR12A9vfpWTrfgq0n0N9MvdY1W5ty2/a7oPm65xj17Vk9zojex494UtbnxT4qinczahqQcNFG8BS2gA/jP97HbNfS9pFFpFpbwStJLI+S83Uu3cmvI7TXNU8ET/vWi1LRkwsrxxBJ4R6so4I9xXrum3lj4i0u2vbSYSQONyMh4OeorS66GM073ZyXxF8LQ+K9OkaHzIb21YhZCvIOO47j2rx3WvFvjXR7e10i71u909bUFrcxN8soHQh/4h6Ln8K+j7+8tNHtLq6vpHSNBvZzyWA6AY6ntXzb41+Jsmp3lxa6RpNtDbsxYh081m9yPuqfoKQ4tmt4k+LmuXvhm3gitTDqJULcXxjIQ/7QBAAJqn8D/DT6r4jOtyt514jFvNZfliz1f3b0rmPGfxFvtfudLbULSFLeyH/HpETsc4xuYHvXs/wX8d+Hryxj023tItLuJG4XOVmb/ePOfY/hT0SCbbR6rG8CKYI3UGFeVPYepry/WrPWPBfieXWPDsZuNNu2M09qp5VscsnqcdR3r0qfTFea4dnJjlByoznOKzfFOraTo/hxrnVHaS3VQFVfvue230ND1Woouz0Ocg+M2hXVpuuYbndjLG1G8j6p1FeafFDXdM8aaYkWmx3sLxyeYl1clUVB0Py8k8fSqS/Ea00TxK17BoMEEMiMsgkcCaTPRmwMZ98ZrFu/Gukah4xu73U1l1G2n2qv2cmLyUx/qwpHOO571Kit2aub6Ho3wE8M2lpBNeWaPJEeZr2VdvnY/hTPRe+e9eueIrC117SJ9PlmXbcrlHRhuVgcq6+4PNZ/gjVdF13w8E0FkS3SPyjCBhoSR0Ydc1qQWP2aWBndAVON3JPTpn396rXcwPmr4jS6zaraaX4iuLi2+wysbW9iyYwTjJZR9Mj0rV8a/FXV5dU00WGoQXWhWsUKtFJjN0wADtJznnsK9R+K+peGrLTSuv8Alu7jaIsBi49CDXjVn4+8KWXhi9sNK0BIbz959lubiFZhGT3OeeOcAZpWi9zZTlYyPGt9d+MvF7yPqMlvo8wRY4GyEiXHRU7t6V9IfDfTIdK8OWcMKC3tlTy7aJjg7epY+rMeTXivwuv/AAHLf21xdtc/bRje9zypf1ZvTPbivo27tlvEtWgKFADyDxgjgirXYyk76nMeOtPmltTqNtaxahshe1vrHOFu7djyo9HU8qexrkfhxrGmeD9GvLXR4LjUbKWVpHLnNzEcYEc0R5GBxkZB616tZQLax3AdkADbjz93jknNfPvxV8XeEP7TI06wN7eRNxeK5jRGBz8rD5mH6VEo3KhJoyLf4geL4bq/t4bJJrS6eRU0hbTECgn2HX1J61B4a0Qf8JNb3viJIL3WgwNno1thorc9mmI4AHUJ1JrT+IXxat9f0TT7WBJbaAyKb2MfIZ8DoGXkLnrXYfBnWvCLTJb2Fl/Z+pv/AKsTMGV/XYw4z9eaVkhuTe56zosYsrIJdTqbpv3kxLc7jXI+MFm0fUG1S2imu9GvHWadbXHm2lwOBcRdjkcMv8VdobYtcvPuUAj0yQcY6VT1fVdN0bRZLi/nRbRBtwRnef7oHc+1N6omO5y0PxM2ps8g6njjztMO5j/vQn50PqK4z4geLdU1bTZRaWd3pdoww15qIFsg9styfwBNcZrnj6G08WjUvD+gwafNaSgfapuZBnjDD0PpzUfjzxtcavrVhNrkdrqawIdluylIlPcoD1J9alUrO9zV1GdH8F/Ddub2ZNGZ7vzlBv8AWHUqHTOfJhB5Cnux5b6V77Hd2yLGsTEBTtUbSP8AIrivhJ4w0DWdOW00qBbG4QZktW+8T3Oe9drJp8cabsu6g5woGcZ/zz1qzF76nD65Dq/g3V7jVdEja60m5fzLiyBw0ch6snpn0pdK+It94jS4h0LSHmu4FBljul8vZngZzjP4Va8d+M2sbr+ytAgS91dl3SFuYrdT3b1PtXgyeMPF8HiO5WLz/tsTFWQQgRhBznoOPSocUzWDkbvxX17UbuWfRNVQtcx4kuLe2IW3jXGcSN3+mTXofwn8KXOlaLFrWqqGuWiH2SBV2rEh7gep/OvB7Dxzr2j6zcyTQwhZ5DJJDcRBlYnqcGvpD4aePrPxlZtZzxpDfqgJiB+WRfVfp3Haq0WhM7s6+0u/PnEbRiNsHBz3H9K4bxj4Y1GAXE/h6OxvLKaTz7jSNQj324k/56xnrG3f5fyru7t4dNt5LuTZHBChMrHqqjv7/SvBPG+t6942MgtvOs9HBxDaoxRpF/vyEcn12jgUExi2zsfCk1xrOmaj9v1S+0L7C5860sZo5Yyu3duVwM/XvXE6H4f1jxbcySaYYrLS7nKtLHcebdzJ6yzE5RSP4VwTXF3PhDX9N024e0Z4mGRJGspBXjuB7EfnXJaNqt/4X1KK4MtzBMj8mJtrp9fX6HIoTSNJJn2To+jR+F9LsdN0rCQouGwn32/oPate1eZ5f3ueAcgrgexH1rk/hF4sXxL4eVbicz3ijzDMT/r1J+8B2IPBXtUnxP8AEzeGdEka0k23lwNseedn+0PencytrY4z4mpovh26kW01/wDs5rg75NKjj89S3dgnRM/hWH4jvPA6+F7e60iztra/lkVGlUGWWIdWcKxxzXD22i3XiHV5DZ3DOpi3zXeSzysT+Yqh4o8H6hpQAliaVMFg6DIArNyszdQdrHr3wm0Dwnf37XcepnU79QGaC5BEze77uSvsvFeuHT8yTySHCs+7O7qP/wBVfFfh/WrnQtUt5pneS2jcMJojtli/2lPt3HQ19oeGtUXUtGt7p5Y33IGMin5XBGQ34jmndS3Mppx1GeI9a03w9ob3Wszxx2qrsKkbjKcfdUdya+b5PiTYaT4qGpeGtA/saMsVZw26SZT1DL90D25q/wDEW6vvFXiQy4l+zLK0FjaoMnaOrY9T1z6VL4f+FtzNYrNqkVzBcKTlMZUE8rg9wR37VLnrY0jSdrmR4n+J9vqnjEX76Ut3EI0jSO6cpIgHXYw4BJPpXvHw48QaF4j8PtFokJsfLYGe0cfvIn9W/vZ/vV84+NPAV3pLebLGXYqWyDkKo9/Wpvgxr1xpfjq2tbmd1achEeTqc/wk91P86pMUoH1tJDHEY3Luqp1II25968L+JvxZvpp5dO8Gu0MIYxPfqm5pT3EfYAf3jXpHxNubmTwymn2TSRy6lIIGZPvCM8sB9RxXjsvhQXd9Db26vak5WO12kLIq44Lf3h1IHaquhQg5HBaf4l8Raddi6TWLj7QrvIkkreZhiNrdeOnFZuoa7DrVyR4gm1CB3P8Ax+QzuY9/+3GT09cV7fZ6F9l07V43023nZpFjKcAQcYxlsHaT0Pqa84+IHgiXS90gXdDtG5cfKCf60ozT0LlTaNHw/wDBzXdatoruFNCNpJgq5uWfcPwFeg6Z8GbiCMB4vDEDYwX+zSzt/wCPNisL9mrXntri98PXLny40M0QY52rnn8q+jRHgDHI9aaZjK60ON1IWb6vp6X4gaIxy4E2AN3HQnvVe4h0+yMM2mCGO4MyoqQSZEgJ5BXJ4xzntird5HFLrGnRzxxyJslOyQAgkAc896gvbKzsngurS3hguRMqqYwAXDHDL+XP4VXUkb40vf7P0CcxHEs7LboemC5xn9a77R9Ni07Sre1hQKkSBcYrxj45XEtloOjXcefJh1OIy49O3617naXKXdnDPEQUmQSKR6EZqLptmi0SsVLhUGA2K5jxv4eGr6HdJbuYbkKTFIOquOVP511d1HvXnj0rK1a9Sz0+Z5G+VFyahpX1Nos+PvEmr3dle+H9aiXy5rmTzJFX/lndQttcj2YDke9fSovYvEFrpkVlKv8AxMgpLIwJRCu5vocAivn74g6aVuvBek7P9LutQluTHjlRI+a9M+BlpBpXiAWR1ez1KcXEyubYnEX7vCqQe/ytVR0ViKnxXPbhYRx2scEKLHDGoRFXoqjsKyb7RLe6idHRWPpXVuBtNZEyFJzJnilJDhK582/FTSL3RZpHs3ZxtLw7+c4+9G3qCOlVfgF4nFv4jn0be32C+TzrdCc+XJjJUfUZ/KvSvipClzEBgcEmvm3wFZatJq2qt4egmuNSsIhLAkTYYneRkHtgGlB62HUV0ez/ALQWuXcVjbaTp/nq0x3zSxoWEa9h9T/IVzn7PPgS6k1O/wBYu7aUWH2cwpNPHjzpGP8ACD2A717Z8PLaaa4uH1MmS8EVt5okAJ3eUCc/iTXoU0AMWABgdAOMVTJVlZHgvxD+F2natp88sNtFFd4z5sa4bP8AWvl0m68Ma3PaXW4GNsOAcZHZh79xX37fQ/JJuyR2yOlfHX7Q2mw2fia3mjAUyowbHfB4qYytoXKKZ9GfCLxRJ4o8G28t3J5l9bN5Ez/89MDKv+IxWdqGnSeKtZubqRc2Ns5htkx8ruPvP+HQV5J8Idc1XQdJ0H7Crtb6p5sc5EW5V8rdgk/wnGBX1B4O0yGLw7pZUD5oFc+5YZJ/Wqk3Yygknc8M8c/COJ/DmqXmn2ct5rKx+ZGAxy2DyB6nGcV4d4i8Majp+nRXTRrIgiWRpIQf3GeiPwMP6ivqn4kaZfa9480u20m6e6sbSIie3sbxYpbOfOUmkGeV9q0/iFpEd54eube5CyFoiHbaAGbHJqVJo2cU0fK3ws8Z3fh7WYb2GQl4iBPHni4hP3lPuOoNfY1/qduuivqEX723aJZIwP4wwG3HvyPxr4H00NZ+Io4VxxceTg+hbFfVvwz1ufVNRHha6UG30i+jgVihBdRvIBPfGB+VaJ6XMGtTznQdH1bxv8UpDq1hdMlvK32yOdCEgQdFBPU0X3wo8Qy+LtQt5LBE0w75UuUICMgHyIo7MeBXvvwt17WPEc/iP+2LKOCGzvGht3RNoIBIKE/xEAA5960NUZ45nmlkWOFM792AuPUk9Kxc7O50RgndHxFq+kar4avI1u4Xs5tnmBJOuM4xX0V+z/4vnvbZNHvJBJE0Ze2fOdhAy0f0xyPoR2qh8f7Cx1LwYuoweRcOrgQ3MbgqB3+Ydq80+BeqtpF14hu9wkFhp7XyBvuhkYfzBNbQdzGpGx9H/EkXeo2q6PppInuY2ZyvBKgcKfbOBXhPw/8Ahvreq+K0k1zSriDTrYt532hcK3YKvrzXvvhHVYdV0W68U3ceIxYxzbE5wNpYhfqa1vAPimHxdZXTiwnsZ7ZgrQyuHBB6EMPyPoaiUmnoOEVY+WvFfwz1mzvdXlurNbWwtzJMLoD92Iv4Svv2x6157Y6jPpcsMm5/JJGDnDDHf2I7GvvfWLGDU7C9sru33WzpsYH+LPp9K+TPj14Xi0aVL9JZZZ7mYmWSTAzxxgAAdqamnuVKHY+hfhL4mfxJ4WimuX3XcGI5X6bxjKv+I/UGnQaQfFGuzarfKGsbZjHZwY+UkdZCO5NeKfC7xVd6N4S024jVWGpXclhK2wthVCkEY6EZPPvX1T4esUg0e1jQDbsHQ5pS2M4pJ3Z8x+K/hvruqfFu4uk0YfY5J0kS6GPJEYxkn/awOnrVXxv8K9Ts476eK+S5tBueOFlO7kk8n1Ge1fVl5F5Sng4x+Vcz4rtki0GaTYZfLiLHPfj+VTzPY2UU0fFnhfWz4fv7e6jaSC/tpwCwY/MvfNfaEWvo3hP+2M7ALfzfocZr4y8WpMuoXOpmzEETM3l/KTG+eCwJAyPwr3nwbc6vdanoOkXyznQZtMt59vlZiMh4IZ8dcds1peyMWrs6jwn4euxpn9oXaP8Aa9QP2uRyoOxW+6D+H861ZNAHk4OCpOcgcgeh9a72a1V4yARGiD5QDgBcYrI1W1BWNLcNtHynHXHXNcsjrg09Dwv4meDIZLIzRY84tlcjHH92vMfhdqdzpXxCs4mcrunCxsDwrdh+IyD9a+mvE9oRYS7lTbsJAz0P1NfMKW6x/FbS7WJj5n9oREKo4GWBrWlK+5lVjbVH0z8WNYtrPQtNgu5PJi1G7ig3HoATnn2p1/oEVnavazNbzS7x5nmZBSMjIKAduxPSuQ0XwBfa1rf2LxDeFdPTVZb6AJL5pnjUcRsc/J9K9qnt4UvIFt7yNfvFrfAbzQOoyefTinNak02kjhpvD6nT5LaeUTvziNvmMeQCqsR16ZBrxb4teHibqa/itTHbv8qMQMyMvDZHavpq8faA6WpRGAaXOB14APr/AEryL4pWsZmngMaWssiu25hkMo6MoJxnt2pRbi9DR2aPPP2edeGka5q9tduy2kMP2zgZKAHD4Hocg49q9U165TxBq63tjm6skgRNjR5wsmfnOemMY9s14p8EUjn8Q+Jr26hmewttKmhlWEZd95C/L7ntX0X8IItN0vQriC0a5XT3hili+2nMu07lKt75/nWnQxVlK5T8H+EBpGlhG0u3BL+ZL5HzMfQ7+mCOwo17RhJpGoNKAJGRvKAwFYclVI7MB1roBpep6Z4qub2wnWbQzbrEtir8wN3IHTn86TVdLjTQznHmRkzlJVwXbn73se30rK9jfR6nyPr+jS2sCzIrTQOd7TgBVQsThT9ecCvW/h54wk0b4UeH2kRHim1CXSpJHJyi5yuMd8EjmvPvFWhNFdTLezTsySsyx7v3arnPTuBmvTfgvZap/wAIL4fg0gWTW8t1NfXqXKZYwu+Bs9GwM1UEY1Dc+H39g+Jo2vILAyz6azwrJLlR52eRkdmHQV6A9u2nJCRas09zKdturbfl2+hyMgdq4rRvFdp4Y1y/8N6b4fmMttidlt1UecWPMpz2wQa9PEnmpFcrLLKxCoEBAGe+f89qhrU1u7K2x5L8YrKFtPt5LuXFgbsLMCw28LwAR0GetfOdxLDZ6/YS2ctzJEb6L7LJLF5bN84yMdl7CvqL4rQw3ejLaQtBPbO5ZoRxnBPCkd89a8b0XS0vvEmlyagyrbaeBe3RI+VIozn8MthR6mqUvs2Jl3PTru38Rw/EJ4r21km0d70tp0vnAj/VHKY6qBmuktrJdRu7exnltbq2so5LuAFSu8udvzZ6kEtjHtUfhzRIILCfX7c3Ju9SnF1LFNIWQNk8KD93IJH5Vq6Zbte3hns4I0hV1GwqNqYbccZ6c9feqnvcVJ6WOUtNNv3t5BBbyy2xbzA7jc0mG+9KT1VdvA61k/EK0Q+HfKk2RS3RyQiHg9cDP869MlsoNOEsYuTHcXQLO+753kHI2jpgDtivJPFEMdvbTEs5WEb2uriQ7R1JJ9DntUR1ZpJ3R518JXa2+Km/b+6js5g/PUben519b6TMZNNtnbPzxK3PuK+SPg9Zz6l8QJZLSMtbKpSRvVm6L9cZY19dwIsSLGv3UAUfQcVutzkm+hztzY2t40Ru7eOYxn5N4ztz1xUVvpllayb7e2RHBODknH0z0q6vUU31qrGZi+OvD48UeDdS0oELNLHuhb+7IvKn86574F/ES3m01fDmvSm11WyYwkTnGGHBQk/pXfRttOc9K8x+Jfw2Gs3J1zw7ItnrKj5lx8k4HZx2Po1S1fU0hLoz3G7mCoc8ehrjfEV/bwwvJPvlCc7FGc14T4Q8QfEB9cTw9HfHTbgq+37X+8gyozjPOM9qwte1/wAQarf3Gn6lf3utGKUxPBYr5MDsD0LD5iPp1qXFmnMkdj4F0u78X/EW68X6pGI9PtSbbTkzkSSYwSvqFGckdzV3xvbQfDrxRpet6JbC2sZGXzwuSDIGOCc+uSPxFdt8P9Nv7TR4r3Wwkdz5QSK2hXaltH2RV7f5zV/xXpdtr+nSadfWxdJlI2t06cjP9fXFW0rWM+e7ud9oes2mvaRb6hp8qyW86hgQeh7g+4pmpOFjIzXypp+s+JvhFqMqxvLdaO74DsCUPs4/hcfrXaH47RXdikn9h3crsODECUP0NZyRpCy1N74mXi2ujXs5x8kbEsTjHFcP8EfBMmq+D9Y1C7nmsG14iOKRB8626nJYfU8D2FcZ4k8Z3PjrV7fT7hDFYPKN1nbnMkxzwCewr6M8Faff6VpJXWrqF5pSBFDEm1LaMDCxL9BTjG17iqT6IwPhjqA0W+fR7qZ2mtHNg7yn5n25aFz/ALyEj6rXsMVysife4/nXiPxL0O5+2DXdDUS3Sp5VzAGx56DkAHs4PKn1yO9YugfGaeBY7fUrJpo0+SSZTslX3dD3HfFDVtgi09z2/XrqOG3cswGAe9fF/wAcNSOueNBbwYaK3XaCO5Ney+M/iXpt1YyRaXepcXMikIiKxYn0xXnfw20ISeKo9W15UutUeQNaacpDbX7Sy+gXsO5qYRd7sucko2PRNN8Ja5oPw+0UafqX2OHS7c3Oo2m3JuS3zMnTspI+tbnw8+KLweJ7XwjrlrFDFtSGwvImP7wEZQOD/eGMEd69Cjtgunm3nO8yKRIT/EW6mvmD4oaVcaDqdmJxJbrZuVs9QiBJVCciJ/TaeVPocVo1zGMZH0J4M8IanoPifUriW+sJNGe4e5jEaZuXkYYKyN2A9PasL42+Mbfw/p8VrHE91qF6Slvbx9T6sfQCvFvg/wCI7rSvHUDPcta2l0H+2yy3Ja3mXGQ3PR81P8bb6017U7W507VI5rmFTEsVvubeCc8t2qeR3SN+dWbPPfh14dudf+I+m2kycvd+bLjnaqnc5PsAK+lL6DXtM1q9l1q8tk0+9Mj6WIAA8AUHdnHOdjZ/A1xv7PmjRWctx5e2fVbk7bq4HK28Q58pT6k8sfwr1/4kaLNrXhsrYOItQs5RdWzkZAZRgg+xGQfY1aS1MHLUxPgBoGs+HbXXpNXSW0sbh1kijlk3IWAO6RefukY570zxNr+m/ETRdQ0XwpdSJqqSLLCt3CY4bzymDMik9Qcc+3tXLfDz4oQada3HhrxZBPHCgaIA8tEp6qPVfTFWdDi8OaTrEGpxeL7K7tLVWNvC8YSZTjALnvgcdOe9YuPc6Iy6owPGFvqGieA9dfxDDZQXOoTmf7BZ8ww8AYUdOSMnFc5+zloWoXNh4p1HTY4WvXt1srUXAHltIx3EHPGABmn/ABT8XW2vyPYaO5mZuDcS/LGg7kZ/nXrfwH0yOx8KW0duhFtEGIkIwZpG+8/8gPYVcE9zKrLodF4HM5tbnSPEaW5v7iAwXcduAsfmKDkKB0yjAilm0+0+F/hHWNS0aG41K+ncEC4fhmJwo46KM1ifEIXPh/xEniCASnTbmNI7wwjc9vIn+rnUd8AkMO6n2rWtPH+j3+n/AGfVpbWPzVwSzZgnB/iRun4HBFNoIaou+EPF8PiW0uYxcW9xcW8Mc0stshWMF85jIPRlIwa+f/2mb8TzWNhEMsXLk9hXqd94i8NeEtIni0UWdvFIxkKRygmRvUnOa8X0+2PinxnFrviQH+zEkAtrPo12wPCKOu3PJNQk2zSUkkel/D3wp4j034caBBoclnBu33moR3Kgs8cnRBnodozW3+zwup2XiLxdp0st5NpEDoYJZyWUk5I2k/7OAfpXouhxzJYI9wq/aH/eOoHA9F/LivMzqmo/DzxXeQyI82j3Tme2bsFJy0Z9Cpzj2rRrsYRd9Gdx8V9e0mHTDoeoXV7Dc365V7JAzwqpzvbJAxx0781gX+keIJbrT30rVobnRWtVdL9mIlJKnI8sfKVYkHPbGBWf8RtX8GeIfDcuq6jfXtsViEbrZ4Msy5yI8EEZz34xzWQnxU0bUPA97Y6TaXmk3tvZfZ7WGUhtg24Vt/QY7k1m4ts6IyUVoeO/EXwzrdtd2MGoXcFzc3lwY/s1s5aKFmbjbnk5/SvofTvDmr2EsV3FrCNpEFolpHYEcLMoAWTPTlx19DXzz8OdNhtvEli1zcNf34YtFGjFkRzwZCT+nrX13FpyTeH2024yFlhMbMp5BI6g+oNacttzCUtdCDwD4ibxL4Zt76SPyL0M8F1CwwY5kOGWt+QAglupPTHSvI9J8YT6BcSaXrsWzVbdiJVGFF6o4E0R6byMbl9ea25viV4fkiYNqK2zfxpMjI49qwnGzN4NPUn8cThNNuPO2RlQdhHQ8dee1eD/AAx0c6x8TJNanUmOy/fByOCT8qD6k8j2FdH468e2WqeZBpji4U9Z5/3dug9T3P071s/BGxe7ZpwkkemQP5zzzja93MePMI/hUDhV7DnvWlKDWrIqzvojt9I8N2vgy/R9La5lF3I07xzPuJkAJcL7lSxx321V0n4iaDrnxBvvDAsJxuyYbzgLLIq8kAcjIPU9cV2HiLThrGlzW0Nybe5UiWC4jOWglXlHH4/mM14w+uReFvFkmraxpVtpmu7GgnlkRja3GerwuOYmbqVIxVSjfYinPue1PPYQ2vkztKk0MflN82WcdBgj731ryH4w6l9k0WaKWdZNRJIed1wqR+px0GPxJrHeHxXqfjRfF9hptzcaeYt9uouUEAi24xuz93vnGa5OXUtT8X68pt1jvJYZP3bLGfscD9m55mcHoOmealQaepo5q2h6D8A9ETTLdoghW8u2W6uFI5hiA/do3+0clyO2QK9F8X6jJompWF/DEHfJVE6Cb+9FnpuIAZfcYqv8PPDp8K6TJDMst1qEv767ndgWLtzg+p9a29VsLXxJpVzp+oQ5tZlDZB5U54YHsQRVvsYc2tw0/VLHVLC3vPD+y8iaQ+dA0mxo8/eLqedwPGKx/FGoOINUgnnUwTA7DLhBCMcgk9vSvGPHfhbWfDd40/8AasEaA/LcSymKSQdvmU/MfqM1Q8Z+Gre00S31G68XS6pNdOI0jlBCR8cs2CScfrUOm3ubKorGB481mzvbx7LTJHlWXalxMg5m/wBiIdcHu1fRPwb064tPC0N3eRCOWdQI41GFRBwAPavOvg98N9KuZU1GS/t9RhXiSZJFZ3/2Ao/1a+pPJr29YSYp1DyII32khtqKB0VR6AYojHqROXNocd8RrezVZo7+4+wC+hNtFen5EZTz5Mkg+4QeVY8djWF8MPFlx4b0j+wvHFtNpsVmrtb6gHM0NyjE8blzyByOa9H8S3Gl2HhydvEDQ/YPLAlEvIbjoB3NfOtj4x8PeGvE0l54QsLmO0VSs8dxL+7kB7LEeM+4oauxxbSO58UeNNH+ySxaITdwI29bi6Bgt4OOSzt97kZwOa43wzpl/wCLbkQWbOmkyzi6u76VPLa+ZTw23+GBP4V7nmqPiXxxZ+LPFy3z6HHqFjbRosVrIwVo8ZJYL0J59K9z+HGsaDrmjumjCSGZSrTxTj98pHQn1X0xxTSS0FKTep1qGxisUsg263CCLoehHU+lcPq2q6r4PvpDcxXE9m5/d3ltF5ocek0XXcP7y9e4rurmFVZJJJX45Z8DBI9a8W+KHxanhmm07wssbKhKy3cibwxHUIPb1qt9yFdPQ2NU+IF43h+/8Q2ulWF7Y2UgSWdpJI2hc4GPLZQe46V5lInij4narG/lRWulIc73XZHz/dQHLN9a5G48aeKJra4SfVJGW4GHR4gY2H0x1rofhf8AEy98JXSR6hZW89hIRvdFxIg9RSSSNG5M+h/hz4HtPCOmxxwRFJAvyhuWyfvOx/vH9BxXY981U0XVLXWNNgvbCQSW8yhlYHP4VbIOM96oxZiDgjikAIJyMVTvnle4trOCQwvNuZ5B1RF649zwKrrZSafmWznuZk3fvIJ337hnqp7EU1vqKxqHriud1m41HUZpLLR5WtokO2a7X72f7qf1NaOv339n2cZQjzriVYI8/wB5u/5Zro9K0qK2tkiC5IHJ9SeSaipNrRGtKKbuzxbUfh2mHdJrlZWO5pDIdzH1J715Rrtl4i8B6wdRs7nMJbO9V4+jD+tfYGoWQKtleleZ+M9Hgv7K5hki3IwKn0NYc7vY6nTUkQfCn4h2vi2zNtcFItSQYeEn/WD+8vt7dq7LV7UtbSvDJLGypkNG4Ujnkkn0618bWd1d+DvGqNAxV7WcFeeoz0+hFfXl9dDVdFtI7WRDJqARQFOcBhk/kMmulJ21ONqzseYeNPFGpauJYvDmmiWJP3Rv5o8yXOOwTgY9zXnd/wCKvE+i+HZ9D1K2it7SYP8AJHtSUbjkjI6D2Ar6qs/C0MVskUSbFC4z32+lY2vfD3Q9TgeO50+3kYgjeV+b/vrrWfM09TdQTR85/Cbxto2j6vAb/Q4BLHwJ05kj/wBoA8E/rX1TY3Ntqtlb3lhPHLBIu5JV+YMp/rXxn8XPBcvgjXImt3kNlK2YnJ5RvTNek/s4eNZTqR0e7f8Ac3edq9knAzkegcdvUVpe5jKDTPoC6W2htro3zxLBt3Sl/lUKB1NfOvxH8R+Fbm+Elrp73boyst658hn2kEDjlxx1Ir2zxlE+rNFpSDdGR5soxxjOAD9T/I1gJ8JtLmJuNQtftM7Dq/QewFRKdtC4QurnlPxB+IWieIraxgtrVNKtDJuuo4owksxxwN6jha9F+Cg8JKXOinGolcskuN23uV/vfXNc74/+Dlq9jLPo6fZ7hBkJnKn2rwnQ9Wv/AAzrSoZHt5YJfvDrE4P3h7eo7iqUu4pQsj7suLd2ScxkKzg4kJ7emKxfF2m6bdaNK2qvAkSx4kaVdyMPQjv+HIo+H/iRfE/hi21BwqXHMVwg6LIvX8D1H1rlPE1hc+L9TkhUvHpVoxRYweJH7k+wok7IiEXJni9g/gHTPFVy81hfTadIhTy3lOxXzw6Y+bH1qhqD+GrnxjcwSP8A2ZpwZRAttKZI9uPvO4yxJ9BXfa/8GkuEaWxleK56l3OR9MdhXinjDwtqfhXUAt9AIw3KyJ9x6aqI0lTZ9j/D3RdK0nw4iaFcRXEcy5+0pgBvYegrovIcXEDhXRV42lsjH+NfLfwE8eT6VrKafO5awuGCSRk/cY9HX+tfUmr3cVjpVzeTldkCGTcTjGBnOfSmzGx5d8Y/Dvhb7MLnV7lbSZs+UITic/7g/iHsfzrzTw7pvge48L3zSyX15rdusrrG84g81R93PUDHfBrnfEeqap458USm1L3E1zIEj2qSQvYewrQ1P4TeJrHSJVWO3uA3zNEh+bPsTUKepqoOw/4ceHvDmu6lbpqOtrDPIQTBKu1Cf7qdifcn8K+rLOyisbS2trOJkt4V2hEOCD2zXwPFcXOl6h9nnhK7WxJGy4YY7V9TfALx2+vWTaPfzPLc26b7eWQ/NJGDgq3qy8c9wapsho9UW2Nxa3EN6pkV24B6/hXz/wDEjTfC+ialJFbaw8Mu8NNZ2yiSJueQ6HhSfY16R8afFE3h/QlttNZ01LUD5K+Vy5B7KOze/YV45pXwl1nV4vtOqTi0Z+ViT5m59Se9RKVnqVTi3qXPHt74Jj0vT28I2VnZTXUpE144Mj26gfdVGPUnvXa/BbwxodxdHVv7XGr38YwBKxMie5B6D0A4r588U+GWt9dn0+zvxqFxakiRPLIxgcgHuR6VN4C8T3eg6hbfZXWG6jYmK43Y4HVHHcGqVRbDlBn27sf7TNuR2yOCGwuMcD86p69o9nqOjPa6iFaEJy8nO0+tQ+CPEMHinw5balEoV3G2WPP3HHUfT+lcN8QLnVdfnvdI0OXyLC1QiSVmxvkIzt3dlFUtNTNK7seP6pD4O0vxZHbSa5eSacrlbiNDlQOmEb736VV1Sy8Japr8Wm+GtTNtp7RAm4uZS0k75+6CwG0Dp71keCvAOt+LJ9Smt0tVW03KHVwwaUdEHsfWsnxF4Y1qzhebUtHuohANru8eFU+x7/Wk5amtj6i+E3gTSNAgF5C8VzeMMB15EefryT7/AJV3MllKEiAXYUbrv+8fWvkn4N/Ee78O6vb2d1M8lg7BSpOSv0/wr69Go2s+ji/3B7Qxebu9Vxmk9dzJ3TOO+Li+Fo9D87xZLFChOIiRmRz6KBzn3FeI+D/HXhHRtRvxJpl3q1lJt8o3qLIYiM/d3cgGsjXLjVPil8S/sFnNHHdusn2f7Sx8vYvRF9Djv3NegaR8FLay0h49Yf7Tfycs8fyrH/sr6/WplKzNYQujzqy8TeGtZ8ZzX3iC1lWN5yYvLUGK1TPGI+Aa+stCttPbQbUaI0b2hxKjnnzPcnua+MfiP4IvfCN0J42L2hb5ZMcqfQ16J+zX44uIdVOkXEzNaSAYjY5CEnAZfQZ6j3pp6XJlFn0tbxCCd/MdQSmcdAB3P6V4b8VfidaSSS22g2UF2EJjN7Mu5ZCOojT+ID+8eK7H4/eIP7J8Irb7pFS8lEcvlHEjJ3VT2z3PpXN/AfwM7eEpNT1e1y91cF7bzk+YRYwMA9BnpTvZXCEObU8w/wCFm69beHZ9LEbRWkkZiCEbdgPZcAACtL4dfEm+0meOVrG0vLeEAGIKqSovT92emfYgfWvZvEXhzQ9Ta40e4aze4aMlrdWUTKv94DqK+Y/in4Ln8F3kXkzyTWs2Qkn3WBHY0lJPcuULH2loGpab4h0y31bTnE0E6fK3Qg9CrDsw6GuT+JvjaPwTpbJbwCbVbkEwRxru46b2A546Y7muL/Zk1s3fh25ErgEyfvcnCmQAfMPdlwT71f13wnrHjPxbfajpd+lnDp9xGsjjJlk2jdsT0x6e9NSVjNQvKx5XqXhbXfEUcer65PcxXN0+5Y7hgJFjx9/aegzwFFYHibw14k8Owp5M4mtk5IiIfbn+8tfSOv6rZ6ZpF1quoiSaK1RgpkhEcrSMcCNR7dC1ef8AhfX7HxDZ30r6edOa2TAQNuWVCDwx65z3rBVVFnX7K6PLPh74wbTvEcTGQaVqO4J9pj/1UnP3ZU6FT09R1FfY1vJHqWmQSXaquxlkdQ2QGA5+or4V8Y6clhr0E8cBigugJBGTkgZx/WvpPw340Nl4D8MQXcLNLqsMlv55cAK0WRgjuSABWikmzCUWjH8WJN44uru91O9fTdDtJvJtlY/e59O7N/UVif8ACuDfSXK6ZHJAyKu0Xce0W5PTeecsw+mK9gm0i60vwDbCwt4H1EzI0byRh2jkduHUHjIz+GK15YkGqXsOpwM0UmxCytnOR8zNj1I/Cs3LW5tGCsfMHij4c3+kwz3KSRyzW5Bf7O3K985HTjnNT/BnxZeQeOYItRYGSfESS9GD44B9QwHPvzXrF1pcGrXV6szLZQTyOjWxkPmTrGuE3H+7yTjvXgcFnLp3ihpEbL2c8W1wQckTKF5H1ojO6JnCzPrPx9fynRIbG1kEU+okx72ONkeMuc/TivNbP4f/AGedHeMF7i7SC1n3gwqpU/Mw745445xXU22m6vc/FbVIb/fJpY3m0Nw2UEbKpdUA5HOetdRfaVFq9jd2Glx+XbiZYyowArj5jLk8/gOeKqbd7CpRSV2eO+P/AAvHoDSWETx3CQ2BMZdQrCR2wA2Op6la858S+F4rTQtOvdMmDsqBbhGb593fI+tfRw8LiHV1lMEk88A2hnbzPNKkneGb+Pnp2Fcl8RdFjXTr6+ure2gu5C3lvCmMIegb1bqaUZO9jSaVjC/Zo8UXMUd/pV6WWK3lRgh/hVzjI+jY/Ovo9vunPWvjX4WyPpV14nme4Ls8MUSHp85kBr7JXJjUnqVBP1xWsX0OSaOWnAj1exmY4V0eHJ/vHBH8qnup0tYWlmyqAgcckknAAFSSRJPGY5kDo3VTVK30u2t5/NU3Erqfl86UuE+gNaPYzRwnxv1FtJtPC14SVhi1eMyH/Zwev517TZXSSxpIhBR1DAjuCK8v+Lnh0+J/AGpWUQJuIgLiL13LXP8A7P8A8RotT0mHw9rUyw6vZjy4fMOPOQfw/wC8P1rGaN6bVj3K5bcDXFeJI1KOcACupnu1VCCcEcEGvP8AxtrENpZTSSyrGoBOSaxabOqDSR8w/EmET+PDFCuWd41wO5JAr3b4SWX9neI2t7i9s7p11DaFgk3GJfJcKHHY5zXmXw50F/FPj+XWJ0dbC2nLIX5Msv8ACB7Dqfwr07xFpNj4F8RWWq6ajW9rfOI7uZ23COXdmOQ+i7uD7NW/LY5ZSvI9/j24we4xWXeQkSbv4Rmq+ha1b6vYpcQMOpSVM8xSDqh9/wCYp2r3nlwsRtPHc1MjSCPnn9qnyf8AhGrXOPNNyNnr714t8LzeJqGpXWmpM91ZW63kSxLubergcDvwTxXoP7Rmqx3V1bQCYy32SFRT8qKevHrV79n7wTfT+GNb1G2uPsVxqUYs7O5ORgKcu474zxmqhsTVtc9t+Fsk+tWkl/qSsLyVLdpA67WGY9xBHbkmvSpbceTwBXjHwqv59E1i90LWLw3N7DILaSd2OZG5aJsnnDAsv1WvZEuAyYJ6daH5iV+hhanbkxurKpTB+tfFvx60yPT/ABpvhAX7RGSw6c5r7X166igt3Z3VQASSTXxB8atSOtePJRHjyoV2J9OpJqE9TWXw3Z6L8H/FVzoOmaLaeTHLFrsT5ZnwY2hyCwHfIAFfSfhLSI4NEs8gFniDsfUtyT+Zr58i0fWvDfw/8JyWWi21xBZ2r3N/dTRBpLZJGyQpz8p2nP419EeC9RivvDWnTQyB18pU3A9wP8MVckYQfY0bvTo2jICgV4/8YfDEGqeG76GRBvVC6Nj7pHQ17bK+V5Nea/FC7WDRrwqN7eW2FXqTjpUO19DaF2tT4d0Sd7PVrcqxVhIFJHrmvri311PGthJ4VureWForyOxu3En+uTyy52kcjIAr5Y8I6RNrnjOwsIlIaa8UN/sjdk/kM19OaNdz6d40u3u9BXSrePUEvI7jDBr2MZikc5PJAZW47VqtUYv4jpfBv9naT4xk8MaVoPl2trGN94jLhHbHykfeOfWoPjY99ZT6Nb22py6Jp03mtPqEURk+dVykZx0DGuyu18K6R4sg1S/e1t9auF8qKR3OXHqF6fjXT3rRtCWcKRjPIyKyS0NubU+MvjVo08Oi6F4huYBHqM0CrdAptLEjhiOxrM+BeryaXr19qTqTHp0H2xlBxuUHawz2yG/Su+/aDv4dWi1nTjqEVvcac8Ui2cic3URXJlV/ZuNtcv8AA3Q5J9H8X6k2mHU41sVtI7M5And2B2cc9Bk4rSNupnUPbtMgt/GXjG11mWEhILWI28bnPl7xuJ9M+9eqxaZGkY2oM/SvHvCfifTfDdquoa3B/YsD20SG0wWMMkeUaJR1JHB+hrvk+JugT6HZ6jpVx9vjurlbWNVIjKSHs+77uBzzUu25SbslE5iz8O+Gr3W9VuNMZ3ljuHuXiKfuxNjY7o2MkDoRnANfMfxc8PxaD4guZ4J4U82eTFqv34wMYdh/dbPGK+n/ABLBeafqh1rwnpyvplxbyS3L20gGJ1bL71P3lIBGFx83NfNHxo12y8Q+IreaO6tZ7fyd0MtqD1bB2ODyCvIPuKUXuXPVHffArxqNA8L26XcMkyX12bNNrABJAuQxz2wcfhXoni7RNQu/gxdvpUc015eP50/k/wCsMbOd2314A/CvMPh/o8lh8PdBln8NtrKyX8l6TuYG3jAC7xjqep544r6N+G16snhe2g37pbN3t2PfgkqfxUg1fQyjo9DzH9n3waumQPqi22o23mQvBKtyuxG+YFdi9TgAkk+uK9J8UaPBd2MsUqB43Ugq3NdozhxzXPeJJY4bNyxAAGSaze5pGVz4E8cab/wj3jG9tbc4WOQPHjsOor6TsvG1va+Dm0jU4JRbxadBeSyQnLmOTGVVeueTzXz78TDJqvxEvFjQ+bJKsap39BXvmqeHL/U4P7Pk0u3tNHe0i05NZjTMyvGAASc8ruBAFXuZOyZzcPwrXU9I0fWvA8l3rmnXTMDJIwguLVt3Q8jG3ua+lhYtb6XYwXkyyXSRKjuf+WjBeTXFWuraJ8LvDmn6BF/aOqzbDdzC2jDSOjH5pnXspPYV3llf6fruk2mpWTpcWsyb4nI7H29e1Q9rGqbv5HmPxU0KG/8AD95DKgbKHGe1fMnwXEsfxJtIIjziVT+CMf5gV9W/E69jtdEvZGI+WNjycdq+df2e9Gn1HxZqesR7Y2gidIHYfKJZOFP4DmnTlfQVW259CfDDVj42X7dqtujmONkMcsOBkOBkKfYda9L068sdTgd9Nure5SJzExhcMEYdVOK8ys59V8E6BPP4iuE1a/t7eUSOhx5iNzHkgcDcCpPbIrh/ghqU+veCPG2n2JXStZco4uVfZEEbhVB/hOMjPfOabRK1Wh6Xa+AltPGt5rss8EiyTtcofK/fAldpjL5/1ffGOteb/tJ2MUvhKRivzxuGX1r2XwzBfab4agh1mSB7wDLLASUQY4UE8n6+prwj9ojUHu7EaZbMWmlcDavJxnp9SeAKhbmjd9zkPhHptxP8NNYMF7aWEz6pbiGW9k2RkhTkZ9cEV9UeAoUh0Jt6KJ3uJTOR3cORn8sV5l8NvAOkyeFLLw7rUH2prM/arzY+AlywHyZHXauF+uayPiTqt74O1PUtZ0jUZrS4jC27JsMiLIcD5h0CsgBDY+8DzWrjdaGKavY9Z8f6IusWEWnyFXtbq5BZSPmGASTmuEk8GWujWH2TQEZ5Z5V86dmyMDnGe1at18ZfDFv4c0XVHea8+2N5TiGL5oXXAcsD05PAHUGuz1TdPaEwR7Y2XeSRsUAjOSe1c7SbOmMmonyn8UNEkl1yzijceTaRvJLMw4RV+Zj9O3416X4U0i7l8K+DNOl0KC/tY7Rria9l5ezkmJIKjsQCtcH8SPEGk32qyaVp8xubMOv9oXUPW6YH5bWH/ZJ6mvoT4d28x8KQXN8gWe7XeyL0RcYCj2A4/CtIwtuc9SZom7F54Zs5XaNNpQSK77D5qEApnscill1i2mtru7E4jZJfLkaJd5jPYFfXnn9K838YmxkvZtC1+0uLmCSZLmS2ik8t5dv3bmA9C2OHTrxkUXfxk8NaVrI02w0q6kswUDXwQIA2MElTydvcmlKLRpCSaLHxAuU1aygsLdlSQkie6kHlzqg5IK44Ga8ofTLfS9a0m1AAMk638yPyY7WA7lL+hd8YFdb8WPHukW6CTwpfQXuqvKryzyR/uVUDvn7x7YrifAek6p4z18307sbe4nV57qUbftBU5wB2iT9TgUoxs9QnNNHuXhfQf7EC+KWubm4vL2Tz7pJDlRvz9388YrtdKI1hLmS7BFrJ8iwqcBl678jnJNWJo7T7ILQlTBsEWPUY/wAmvLNV17WvAN5PHexzXGmn5oriOMyKy/7ajlWHcjg9a0kru5lTn0Z6n4iuLKKK3W6CmUsTbR7tpZ1GcKfpXz98ZPETMUjnkEcsuVS2UZKsO7EcEVd1n4kavrXhifWrHT7NtOspwj3W5j5LkccEDnmvIN2r+N9beDS43up2OJJ8cKD156AUoxu7mjkkrI2PhDpx13xmlkA0371JJSo+RQDknPfpgV9lN1PpXnfwd+HsHgjR2aXEmo3ABlkxjHtXomK1tY5pO5hrjcM00jk+uaB94UHqfrVbkiqcEV4b8U/hXKNSfXPDGI2c75IV42t6ivca5DxlresLa3Nt4TggmvIh+/uJ2AjgB+vU0pNWLhe+h5P4R8Y+PZfENp4WnRGu5Vby1v1xwBn747YFZXjLVdXvNRubC+WS8aGQxv8A2fDiIkdR5rcYHTIqK/tpdR8T20dhquo3t7HDm+uIjsV3zk7OmFA4rG1vVtb8O6gLuyMltbs+4xgbo2P0PGazTinqatSse5/BrQLqx0MajqUKQBgTb2qZxGvrzySfU11/iOzttY06SxvYDJHMCjI44ORyp+o/pXI/CX4l2vi2MaffbYdUCcKD8s4HUr7j0r0SW2j3q6qxKH17evvWm+qMNUfPl1c+KPhpem6hkluNJI8tLsqXDIOkdwvZ1HAf0rbPxPu9b0jzrbQ9SnDEp5lipljLDtnHFdNr3iOfU9QvrbwrZJL9m/d3WpXDYtw393b/ABketect431DStHv7LTb3T5bedpDIbCERNGxGGI7A+9ZyaN481rnCyJp2q+Ijd6+85Tdl7OFt9zLj/lmMcIOxJr6j8CrKNGt7q5torCJoxFa2cfCW8Q6KPf1PevnX4d+KdI0zUbez1rRo0CkZmB++fV/X86+p9Ou7bVdPhuLKZHiYZVl5BGMYq1ojKbbep538TNCuZL/APtvRFWW9RPLntw23z04JTPZwQGU+o96peE/jNb+V9h8QiZLqM7fPKYY4/56J1DeuK9Rlgh/fidk8tkG7d8o2juT7etfPnxN1fwpqd3Mltps+r3kPH263zE4x2JH3/rilZbMcW+h1Xjv4k6bNZSR6ZeW887ghQSev0ryXwVoljceJEv/ABAzXUkkgeO0/jupM5AI/hjHUk9elavjjxn4e1TTbW303w9FpKl0+1yiIJMwA+6jAcZPU13fwV03wnc3AvNOlL30Y3C2m++P9osfvfhxRGKWqKlNtWZ7DHYtd+HprO9Cs93EwkXtlh0x6dq8U8G+KL34Za9LomrrJLo8rH7OzdQuegP95ehFe6SxSM0jRsF3A/Nnrx6Vy3jvwzY6xo8j6ilu0YUNMJZBGAR/Gj/wv+hodmyIysbMnj3QWsVnj1S3aNiFwT86k+q9R9a8y+K/ie0NhNCmpW0TuuAIm82Q59FHf64rztNH8HJcT2d14k1JYQSVuRCCE/2Ceh+orBsdB0vUdbltdO1c21qJMQmZlD3C+pbotZ8qextztHWfATQYh4mkuvK/fEbIoydzRqfvO57MfSva/ixpl3d6PZahpiiS/wBMlMkcbdJFYYaM+zDI+uKi+Gvg618LaNJ9naOa7nXczxnIA9Ae59TXWNHJJMiyeY0DKVZHHBU9yfWtTC+tzw6XxNb619glS8W1mtR5MUt0pJhA/gkxyrL0zggjGfWt7x9421TRfDei2/h+6i1BAnl3V5A6O2AOwzxn1I4xVX4peAdM3PqZ1BdJmYcXQIIk9pI/4j/tCvP7LQvBH/CKz32r6zJfaxbiUta2cnli4P8ACACMgHvScU2kaqbsYGty3PibUmWeaC9ursqVtwMiALnDyydFUZJIFfRvwd02y0zQIrXSHMtpAS8l3jH2mdvvOP8AZHQe1eL+AfAdz4gS3El/afZpgGe1tmCqg9JGzucj0r6XsdPi0mws7OyDLDGNo2rwTjv9aei2M5Nvc8l+N2lRi8uHvSY9K1LZIl4Bn7DeoNqyN/sOMK34GuH8GXdr4b0fxHJ4005LqzdI4jbQMG898nEif3eDjPvX0deacmq2N3aaggkjclRvTI56jHcV8++OPAqeGLs/ZdfTTbN/+XKZTLgf9MyOdvselEkpIqEmmbPiH4y6VYeGLGHw/YTIpi2R25+UW4HGCe5/nXjGj6TN4n12S91aEWVk8gkubkrsAXP3UH949B616F490nQNE0Szn0LxFLqd/dSKqRlYxHApGWdyg3ewFbnwt+HsmszQahqGpxX8MLb8w8RRH0Vepf3PShJLUcpNntnge3WPQ4fKg8iAoI44f7sQGAp/Dr7k15bL4hu/h54xuba6R5LWRuVPAuIOqOh/56JnaR3Fey24MLeTDvWKNcKqjoMcYPrmsTxr4UtfE2kiC9iSWZFyC52/+PfwkdjT3djOLs7ljS/HOjanarLaahAcjO1mCsPqDXC/Evx7pumWM/8ApcUlwQRHGjbmJx6CvILjw1pNv4misJPF8UdoZCkjNHlrc+hYfK31rM8VeH9Fs9cg07S/EbXkTxCSTUTDuQHP3EUHnHcmo9mrm3tDO+Hmmzan42i1G8UvdSTb4YupZz0J/wBkdfrgV9iXeiJdeFJNILtHvg2B1/gfqG+obBrgfg78PrLSIU1ZmSaVl/csXDu/H32I4Hso6V6WqTHyxmTAPIY8n1z7U7GUnqfPPijUvt8tt/a99caH4u0VHiF1DFvEqDqrJ/HG3UemcVp/Cb4s6db6Vb6DeWklisayP9rlcbXcks2V/hz2Fdl8atF8MzaN9u8RXK2TYKxyR8TN/uY6n9K8V+HOq+BbCS8tdZtJdXjeQNDc3oCeWAPutg9zScU1Y0jNk3jbx9eeNZrqx0/TtmkqSHuZpdiAf3nboB7dTXa/Aaw85lSxRho1o3mNcuuw3cx6uB2UdFHpzXAeFP8AhGvE+u3K6vqotohcs9vYHItkXPGFA+bHua+p9D0uytNItoNMETWw+YP2fjGeP5U0ktiJzb3MT4kWN7c6dHqGjxRXF3Zh0mtJT+7urdxh4m9OxB7EZr5t8Ty+Zp0mlaLJDbab5nnS6TOogufM9ZW/5aY6AjjvX1yiR2vnNJIoVRli3AA9TXzv8XPEvhC7vJLe30WPWJxwXb5UX/dbr+HSm0noKLa2LPhn4hXGjeDLHSf7O1O5mtYiHmkBVEBJONx/hAOATXG6dqOqeKvEgutLhEl0jERT7d0NoTxvH/PST+72B5q3rfxXvdS8JW+l3unRy20boskWcCaNOiN3rvfhZ478M7ElktE0vYQibyNsOePlwMY9T1paRehbba1PSvA+kReGfD0dk3mtcA7ppG5LOevPc5PJ9awPiZ4UuNdiOq6M3lahHF5M8Uqb47mLqFde4/UV6MIYyGZfm384zkc88e1cN4+8bR+GI1sNPtnudYlUskA5EY/vMfT0p3sZrVng+kHxPpd/baNpunQ6atxd+ZG9xEs9qsx6OHIO3pjmtf4nJ46K22na9rK6ld3YJjs7SXy4wAcbnPAxXD+Odf8AFt1fRvrF1PEsr8RwJhQewJHf0rmtUvdYe9SS8uLtpYF24mJLKOvJNJaPY2sz274T/CMtcjUNbXzHiGWIBCL/ANM4s9Se7/gK97gEwtolibCKuAFTAAx0+g6V86fBr4q3trcw2OqXL3dkR86ucvCv99D3A7g19MTzQ/YzO8wEATzPMU8bcZz+VCVzKV0ct8R9I0TUNAkl8QSwW0NuNyXMhx5Z9iOc/Tmvm/TdQ8Hw+KduqSX2saOQQUu2+62eGBGGx9a3/iBrWo+OtXXaZY9OWcW9nHtO1mJwCe24+/Sucg8AzrbSylWiVJmhIZSSCD19yemBQ5aWNI03uN8Ral4MvfF80cenD+xodq2qROQitjl2Tq30zX0t4Ds9Jl8Px3GjXUN4ZQm64CgDC9ECD7qj+7XyFrvhyezklxlkVyoIHPHcjtXdfAPxPPpuuPmc5DiO4tc8TRf3/wDeX+VRzNu9hSgfU8kCq0a7wozkjbwxrxT4tfFaO1um0fw7HbzzoxEl3KNyxnuEH9a734u63d6b4Y+z6Ohl1DUH8iEL1AIySPfHFeC+F/AzC4F9rmcLPsmRs7sEgYA9ee/pTcuUVOnzGHqPjnVr3Rr7TblY5be6wJYVhVEkI6EjqTXTfBv4jwaM62l/pVskKnBaFNrp/tY7j1rZ1jwdaeWttcRG5MSs2+HCFVB7tn73Pp2rzHxXoJ0i6l8mW4UDlZJV2t7H6GhTvoaSp2PtbT7yC+tYrm1kWWGRdyupyCKtV4T+zX4mNzY3OhzTmXyEEsWf4Qeqj2r3UdKpO5g1ZnH6ws0t1p0EF5NaGWRtzxYJIC5xzSb7rTZE+13H2q0dwhmdQrxMTxnHBBPGe1SX2f7W0fA6Syf+gGk8SMo0a7UjLSARxjuzlhgD8ap7XFcfr14NO0e8us4MUZI/3ug/Wqt/4fnfw1Z6dbRQq8mJrm6kb/VNjcWYfxZPbpXMfHO+n074dvNDnf8AaYBIR/d3DNeiRzRahp2kXsc7QxOIrh5EbAcbeFPqM8YrOpdm1F2dzj9S0lxJFNaW1tNaTbt10digRcccDJbI/KsLxZ4OfUYZBNb272V4iEDkNA4BBCgcHP3vrXaoI7W3kb7LHbrNPxGJMqzFuSg6ADPSo9RmuJVntkilTy40USNwM9x+nUVh1Oo+N7uS98IeLT5Emy5sLjCsvHIPB/EdfrX2HY6ude8LWN5YECTUYkEf+yzdfy5r5L+Khiu/FUzRxiOR5djIG3YIOOvqa9q+BdhqOl6q9tqqiJYLiKKGLzQ2FKOckA8c4reOqOWcfePQW8DwWejXemWVwzBo3LhpAr3EjdWb2IyBjpXP6T8L7C3sJYNLRLWN5QCl5F5rBCOoP9/qOa73SJnuL291GDy7xjKsEJc7GAA+YcjHB6GnwSwyQGWeZ44pHAQswDRN12n1yehrJo6I6aHzL8a/A1t4duVutI3rACscqH7sbEcEH3/Sp/2evGs9lr0ej30jfZLtvL2k8Ry/wsPrgg16D8cI7e/0C5e4ikhmZ9irjB2qeWbHUHqK+fPCkcv/AAkd4bHzGa2tmuUEYy25HUgD1NaU3fQyrRPrfxtm/jg0oyNHDMczMo529MfiSK5KHwU9rYmDSZFszGxaW6VAXU84Jz1B7D0rpvhreXmt6Xb3+pu0OoT2sTDzY8MuXc4K9ugrp42kuoQ5AW8gnkRHJGwZ/vAccds81M229B00ktT59174dXlzp5M06XF5kyvcIMbmbkBl/h46V5VLLf8AhHXlEbywSxMDkfKyn+8P8K+vtbs0xeQAAwyEefuBJkY+/pXzf8bdNiW+julypbdvLDkjPBpxk3oyqkFa59DfDDxWvi3w1HduVF3EfKuAOhbHDAehHNZPje0OpWd9f3aSS6ZYgiC2U/Kzjq5HfngCvIvg34jvPDllobQrDLHrcr2bCQkEGInDL74OK9/8S2US+G9ENyXfT4poTcxxnG8OQOfUbiDinN2MaUU5Hmtp4Pa8hMeoxOpbH7tGUB8jITH97Ix+FeR+M/COoaRPJNJbnerEtsAwo7dOQR0NfWk2x3v4rW3Q2W1p1kx8+4fxDPpzXEeLNP0prGBJ4nW/nUF1UlzKuM72/TmsozaZ0uKaPMPgt8S7jTNTi0vVp9+nSMEO45MRPAYe2eor6T1q8Sw02a7mz+5GVAP3j2H0NfDElt9j8SxwoADNcGD5emCcD+lfVPgzxMniqz03SJYJVuLKYW907kYkeNCcj8h1rpUtLnG4+9Y5TxN4dvdfvUvNcaaWSYFiqthYExnp/Qc1wt/8MWWy+1QXdt5bRu48pScf3UJ/vH3xX0N5NyrS3Mlon2ZQryS8MxQkgjaD/dxg9RWe2gQI+pWUH2hluCrpCPvSfLkZPGMdvpXO5djrUFbU+UkGo+D9XWS2862miYblBKkGvqf4QfESDxfYi0nbbqcUW9geBIvQkfTv9a8u+LGhrNp81zfXCTahE21QMDEQPfHVq4f4Naq+ieK5b2QOsWnr9qdVGT5ROxx78HP4VrB33OepDsfUvj3X5dD01vsBJv5xhFPIT/aA9favnDVfCmt69qssurSS4fDM4YsAD3LdPrXsd9q9h4r14RW9x5Rm05Z7dJPlcK5OGx7kYPpW5Z6ZBZ2qGN1Hzq/2eHG1sA8Y6kZJb3xUym02i6dNWufMvivwPNpNrI0NzHcRpNtPlHDE++OmPSovh/4vv/CfiJJftJRh2kJ2y/8ATNvr2J6V9Da/4ZS6jki0wzJO6R3N1c+TneV+8jdgTxkCvnL4h6Mttdi4iAQTM+1D1Ug9DTjJsc6aR9keENftPFGhW+qWW5Vkyrxk/NG44Kn3ryz42+NZIZYPDunzy+VOwSbys+ZNk42Ajt/hWH8B/FNvo2gSR3cspF/KIYPlzm4UYOfTgjn2rtkhHlWM9vHuvJZjuuvKV/L3HA68r0wCPWqctLmUKd5WPGNX+Hl1Da6jdXTQQW1nKE3tzn5QduB1POK5rUfCU8Xhmy1qCRfs0qlhn5WUg9l9K+p/EWn266lHcXQIa4bbHGqbxF8uGYqeC5Gcj057Vyev6RawaTKLa0UeRZmSWK55jIZsDB9ABkAetZ8zudHIrHmHws+KN74Yu4bS6USaY20yxZJKj+J0P64r6mv9QtIdIfUWYvbiMSqVPLZ+7j618L+Ilt7a+hurNt0e5WQLzgZ6H27V9P8AhPWP7Tt7fwrNCySWKJKZC4O6Mjcox14BFacxzyhqeX+PtM1rxh4hjvb2c3EUp2JDGRtgX0PpgAkn2rI1HwfoOk3UFpqd1cQXkyho5LZTIj56DH5YPvX0R4W0q1OqXItWtXnVgJorch96AHG4n+8Sc+lOvLC1t7+WW506B7nfug3pzb7h93vx8vH0rFzZ0xhHY+TfEvhi68PypMI9sTHfFKp6jtn0PtXsv7OPja4ubiTRLyQvGc7AT9x8Z49mGfxFVfiLpkS6JqlxEVExhWSJZBwFLHe6gdT7dq84+EVxd2Xim6ubYqHt7SW7DEZA2DOCP89a0g7q5jVgk7H0D8arvUr5rDQNKVzFP+9u2jOGK54XP93ua43TPClnLYzyzQ4RLpYQJF5miwfnX8R1FdT4K1aw8X6idQ1bmcw27BkYxqVYvxjPTI5rtJLLydJk+zeYpgdwftAzgNnb5ZwegyOKU5WZVKKS1PH/ABP4EtZEllhtHW2RTu1ADCheMDb3I6E4rxK/s7jQbmSDD7erwtykg9vwr671SGO2iD3EEzQqg3sH4EfJDOB1zkg/Svnv4r2Xlah8iJG3llQVHyBe232ohJvRlVIo94+CeuSXvw8tzPK04tE/dSOeWiIygPuPu/hWXp2l/wBoNJd3OowR3mol5HM0ZZiufl2nsAO3vXnHgjT9UfwH4FubHc+6a6EyC4Ee6MOdp25+fvxXtempa6lpFqFQOEtEiRFb5iSBlgM+n406miRnRirs5+fwtFHeGwuLiTSpJMfLAolWVgMmYlgQo7Dpiuf8UeFbEaQLZbV499w377YZt5xwxbqOTz+NeoanHHD9p8uTzkuIRLJuwylAAu31GTjjtzXNa1ZSwSSTRmeCWZ9mxJQ4udw+VF3cAdcHjgVmr30N7JrU+TrkTaJqMV3DhJbObcQBjoeQR6EZ/OvqLxB4ttbPwLdaPbu51L7ALiGMISvlMBsG7p1YDFfNPjRZLlHCrJHNNMU2kAHJOApxXuWqjSz4ytbUPenUtK0qG1KED7LI8aq7A9ywAP5VqvNnPJJux1XhbwbPaWWm2UzN5n2aJphj5oiSSXLdMbsZ74zXW3NrbLEbKCB4J42IhdVLbCeWfnp0JGeKs213dWqxtK7XLTom1FIwSoyQOM7TxnP4VaNwVL3dxEI5C6xBUwODn5W9ASfzrE6E38jyTx7pVg1vcvpYDNcI/mh/lMpXrjPTk9fbFeH+EYBYfErw/JFuC3N9HEyN1wxwf517n42u47VdixeXHtKFm/eFXBzs9+T16V474Bji1P4sabcKr+XprS3s6sc7jGpI/wDHsCtIPuZ1PI9n0fxM+o+Nbqw1XfPLodzPFGFj2qAq4TB79Tk13WkJZXhi/s6TZJcgyBS5JaU/ezkduOR9K5Pw/Ya7Z2ttqviaSG7R5jeBVAyqPkSJx1wpDf8AATXR6pf6Xp3iTT1fVoodUul/0WMcK8eeAMcAH36miorvmQUmrWK8WlSyPIBErySgmS+bAE+1uQq/wnA715X8WY5pbCcv5NwVXajKmNjg5Ct6cHIFesvrtzdtFLcMLd4rgy+XLH8oXJAww/ixmvK/Gv8AxM7u/vblTb6XAx86Ufcds/wnuzcVEGubQ0ne2pzP7PQlsPiHJHMGRpLNvMDHPJ5FfWyHKA+1fIvwV+16n8WGmhXEKozShRwmeET8BX14BgY7AYrdHHU3OIvTaaoLYwaqsMsL70lt5VJ5GCOalstOWO4E9zeTX06ZEbS4Cx+4A4z718k+c0MZVZrtU7hJAf6V3fwv8ZT6Los9paanpoie5aTy9UkIlBx6g/d9Ka1Jase5+OdETxJ4Q1TSm+/PEQh9GH3T+dcb8DfGsdzoi+GdakFvqNi7W+2XsQcFG/pRbePtYk5ittAu17+VfgZ/OuD8T+H9R8S+KodV0zTYNJv5fluJVu1eOXHRiBzkfrRKNyoux73JbfYLW+j8sTq3zwwvyUwMdT+lcF431C7gtLqS31GQKyKy+aw+QgHjH86owj4iabp/lxwwa7GF2qisC4HsxwcV5Z4u8S6rPrM2n6nZLZ3y4jlhgUySKOu30zWPJ0N1U0K/ww8Lz+MPGf224UnTNPlD3EhHylwcpEp7knk+1en6pow+H/jGPU0uZJ49XJV5nGPLnDb4wfYkFc+9anwW0+9OkJNc2y2Ol2hY29qvLM5+9JIf4mP6V13jbS7PxHo0thdq+2VTjA+Yd8qfUYyPpW1lFaGDldmzaTWmuWNvqmnspS4iIDEn5W6GNgOBjkGuRn1TVLOa/tNUspTFEwSzm8v5H4wScdsdDXjtl4n8SfC/W5LPUMTWsx35fPk3Q7SKezEdR610mu/GGw1HTBF9ju2MyNG6oc7QRg4Pr6Vk4vobxnpZlf4lamW8JztPLK8z7g25w3JP3OOoGKyfgX4Tv7nTda1Wy2wXdzEbGylkPCseZCD/ALI4z6muGkuIb8RWkJuoNPtuCJW3y4J6Kv8AePvX1D8NYTF4dtJ5LRNPtViENrag/wCqT3PdieSaqEXFamdSd9jD+Gt9c6FczaFq96X1O1lNs80jbtwcl4mBPUZ3rn1xXo1zcLbQ+S6eWJnYiI8eYw5PI6Z9a8y+LPhy5u5jrOhAS38SFJIVODMnUr7MCAy+4rn9F+LC3OlpZeI0kSYAqtzt+9j++p7gjmlOOmg6crbnpniDWo7cK0yyRqAo+fB8v1Ykdc+1fNnxf1RLvUdlvKJoACSd2Tj613njLx1ptzbr5N9BJcLH5a4U8fQV514bhtpvENjqGrW8l1H5uYLQjBu5M5GR/CgPJpQg92XUmraHo2naJr3hz4f+En03TI547FH1DUHkiVmiV23EDPKnZk8c17FKi6/4LhFpcgNAY5Y5F55TDL9cjH51oaXbyNoTQ35DT3SMZ+wJYdMeg6fSvG9O8R3nw11kaPqMbPppYi0kJ+Vos58on+8hPy+3FXKLehlTmk7nrNzdWFvqFtdIXku5YfIvULEEkgEnnuD6V574q1riSeKJ4vsTtCGkO13Xp5fue/44rqbHxNoOqK1zZ3UEkr/vCkuFZW9cHuK8q+IWpBNK+xQXkMZ3EvNLIHkbnO7A6tzWNvesdHOkjzDQ7KbW/ibYQImYReq4wOFCncT+QJr2j4carbWPja6aPSX02GbUDeeazsRKr7oycHpjKnj1rC+D+jWsc0sIBbU70eVHGTl4Lc/fkf0ZhwB6V658W9HmvvDtrc6ZGGutMfekS8eZGV2sn4gce4FdFuhzOWpf083B8U6jE0DLIWDi7MmQI+eFX6j8zUGoyFEhureOUfbgVkmDgB2YFWVgTlSOox0GawPA/juw1TSvs928f2gDYXkGC/19G9R61j+J9Ug0u1Uvq5kiR3dleLsf689fauZxtodUZJ6nGfF64dNPtoEhmRYmLuTHwzDIILHkDGCvrk1ynwtsILvTvGWp363D2I04WzLDw5eRwAqk8Z4qr478Xtr4j06wad41CRxdSz+x9696+A+hWuneG0sNsc8wbz75iAymYjAT32D9TW0V0MKstTnvh1pVrcapa6rprXUYj0P+z4LedwJPMSQh9zDqBkdOxr1i2uvMsY7dZY7S5AB8grl4gepA/h4Gce9cN8QJn8L+LBLbpHFZ34WW3cDakVyBtaNvRZF/8eArH0vxxZTeJWtRbzRMsJkNzMmQjHGcf7QqZpsunJHpHiG8ljtBHFM6KE8spt2oxHQfh3PevnH4tyNJfxo7xv5aEsUORk9f/wBVdj418X6NDbXNsxbZdbizCQ7mb+nc/jXkB3+JNUihXEUKt+8mL/KEXqxPoB3pU4a7jnNWsdr4bsLOx+HXhm71aG/DHUp71DbMAVjG1dzZ6jPavZ7LTLYSQ+JptVNvFLDFYzrIwWPCOWXYOznI/U10PgOx0678MQRizjOnCIW8CSoCwi24zz0JyT+NecDUbfS4b3w7r8Pnx2kgW4jYHLRK37m6T1wuFbHTGa0lHTQypz1PQGu/7TmiaBhcG2kIjedwsvndR3+YgenUVneJBEdFsJ5BCrSGUTxTz7WY5ydp9cjgdqxNZ0y11f7Fq+k3wsZYovLR4G3DYfvEY7kcVxvj7xRb2dqkEA3gYVt67trc/Pk9z1NZWOhyVtDyzVbGPVdds9JsI2W4kuFjZVOcFm+6T3POa900KaEfE25uotGkt0m22iX29j56RgIeOgBAyMeleXfCOAnxS+rXfz3crPHp8eMl5W4abH91Rnn1NfTXirR7hPA8dvpeBe6cqT24/vMnVT7EZH41sk7HNKXvFTTwbGT/AIl6hF3OixxjPnSDjaD2AHc8Vc1m5jh0qKWeQSHeMeVJnfGPvDPtnH4Vy/hrxxp16IpYnW1vQDE0Mnysh7ofQ5/OqXibxBdQQPHBEywmV2CRKMgFcYU+/JNYcrWh0qaZzvxc1FV0mYvdLOWcyrCIgrbj0I9OPTrXJfAvQr29tvEOt6aPLu7iP+z7FpPumRuXPPGAK5/xI97qd/MdTm+w2Kx7FYyDzCB6DsMcEn9a9q+BUTXkMb28BttFsI9lohGDIW6yH69vYe9bRg4rUwqTTYklxH4Ps577xXCr3AtktLhoUBZ3UkoABwCyMef9mt7wv4rtL3wlb3lgZ3sJ53gjEwO+BicGJh3PueOlM+MGmStaPerZNqGm3MP2XUrRPvsg5SWP/bQ5x6jivM/CfizS/DvhdNKjE0trHM8ovIjvMhPd1PKMBxilODeqHTqK1mereL7q4tYbuPTGt5UlXbMjvlw/XHsoGK+d/iJevr01pZ2939supZBDHJBjDSEgAADtniug1zx/Zy213Hpw815AyFiMNtYc5rjPAVnd3GrRnQYQ19AMJcAZjss8byf4pMcKPWphB9Sp1L7HvujfD+x1WO0ijuZEk8NQpZWrR/cMyjc5/wC+8jNang8WzXL2shKbgbi2c9QgblR/tK+VI7AD1rqfBNhBoHhm0si5EqDMpbJYueTk9z6+9cB8Q9H1LTL59T0SOS50+4lNz5MTbZbefHzSRH1OOVPBrRxUkYxm4s37bW7e58R3FjLqFgZoIyywRgMwJHzb19O4/WuA8dwRXek3Fx4hurlVkZWKxTYGE+7gdvYCvNfCVzKvxCa90S1utQ1ZjLK1ntKOWYfMxU9fpnFO+IU3iV7y1tNT0m6gnmTfDagb3wTjdgZwOtZulZm/tVYyfDrWl54tt7+9TGlaZKty5zkzEH91GB3dmwMfWvq7w3o/2nwck9xbQHVLhmut7KM+aW3Yz6fw/SvGPhf8LrsyR3etYR4Myrapytvn+Nz3kI4A7V9G27NDFbQpEiRBVVcHoP8AGtFZbHPJ3OE0DxBYWlzbi6uRFZgNDbzS9FYHmCU/wuh4GeGABq9LJqp0qCWOaIzktJKTg+Z83y+2QvOfWsj4j+BpZ7m71XRLn7HNcLi6Urvhk95E6Ee45FeS+DtBsdS1m90vxB4kXTGhVWgfTbgmKXJOV+bpj2qZU0zWFWyNf4qeIIbUXkMU6efKzFBjc4z2A/rXGfCaxu77Vmt9JRmaeZVv7sDPGcrAh9/vMfanyeFdA1Xxpe2Ka/JHp1tN5aqeZrnHfeflGa+kPBvg210DSoVtLaOIAgJBGQRGnf5v4mPc00klZESm3udHqWnebpYtIJFiljUeS552uo4OO47H2NfPWt63a6R4itW17SldrCYlbSWUxmFgc/un6PHnkA8ivo37P/pS4C7Qd2M8ivGfjl4m8N21wthJp8Wram3yvEQDGvpu/wBr6YqiItp6GTq/xd0S5geCy0S5mupBhFkk+XJOcjHXmuH+IFz4q1HSItQ1LT3t7NGC28SJst4CR97b1Zvc1Y8MeOr3wlptxYxaDYQqZHliV413xbunWqOu+M9X8a/Y7G41siJJfMazMKxkkf3WHB+hpKKNJSZ23wR1PQfDdjs0vT9d1m+f55biGzIWSQ9Tk9h0H51643ivW5Bm18GahyMg3FwkdfM2r+Ib63to4dG8a6vKR8rW8NuYvL9sisdrbX9Vf55/El8T/tSGrW9mZNXOu1D4PeMpF2rDpcuTj93cAfzrBuvhB4zi3b9CSfnHyTKT/OvqfVmuUNkljJFFJNNsLSJvGME9PwqPy9YWUbn06RN3zEKynHfHvUryC7Pkib4aeJoD+98LX+R3QZ/lWbpPh3UJvFdlpFzDcaddzzCJY52KlSRwT6Cvta+uFsbK5u3dhHBE0h57AZrz/wCHnw1vNT8VWvjTxHexzJJ/pdrbJyxZhwXPsD0pSZUNTkpPBniHw7pc6aTrmorc9WEchCkj0zk15IfGeu6Hr1z9vhhl3ybp4bmPDMe53dcmvuHUdNhCkMoyeteH/G/4e2us6PNd2sQXUIFLI6jG4D+E1F2mb8ia0Oo+GXjXTvEdglnFGlpcxxA/ZlIxtP8AEnqK7CS3WOWKTe7BOAMDAr4f8D6tdaLqUV1byPHe258yH5u6n5kI9CM19jT+JIrjwbHrVscLcW6yRD3YdK031OZpp2OF+L3iLQtNs5bCW0h1SR/mazlXdEhP8QPVTn0rz7wx41GleFZNOt4NI0mzlefa4BmnidvQH9Oa9gg+HcV1o8Nnq0AmudVUS3tzjPkHqq/gMDHqSaV/hvoh0lLIaPYmQAgtEpwy5OAG7EAZz6nFQ6lpaG6pXR4J8ONQ8KWmqQpq9lL5jHLXIbez88knsPXHNfWFq1vqGn2suntC0C4aPb93bjoK+Pfir4Sk8Ea7HdWyGWwuNwjMnRTz8ue+ByDXp/7PXjWSV4dIvZd6TqfJc8fOP4T+FXpIxmmj3FrSJ3ulm2Avhjs+XGOjZ7V4R8R7fwvrN1diLT73VLyDPm3ukqYwD/tfws3rivatetpNZmh0qOQxRzDfcSLwViHUfj0rDXwML1biBbxbHSI2McEKKM8DOc9znvUylZl043Vzwjxf4p8J6roMFtpmiQ6LKJUS5mEYM7oBghCOASetd98GdG8KXc8V1YXYuZIOUglYmQH1Oe3sKfrHww0q6jaO0QNcIu17ts4lI53ehf1xXhN1JeeCfFIFtK8ZR9wkQ89ev/1qSndjnTsj7cubZ5JJ3QhTImFkz93jnisHxZ4asdb0VodThgnTYDJvbaOB94N2YetVvhb4vXxd4aS4kKC+gYRXKL03Y4YexHNeV/HnxDql3qTaFpcV0umoMyNBnDv3yR/CPSqbsjOKbdjC0/w14T0zxJMuo+JLy90TynDRwRt5kL/w5kXgjrWXP4e0rW/Fs9l4Rv0trFQnkS3M2+4uSR8zKD+QFd8NB1HUfCQ0wyW8UoszL/osRAkjVcHB7/XueleaeJ/h3qWi2ltes0N07KZFkgkAdVGMMAP85pRmtzaVN2Poj4VeBrbwtp9xNHl7yYcszbnz6sfX+Vdfskka3V2kaN1IkRl6+vPtXz/8Ivi3Nb3UeneI7gSQ5Ea3L/fT03+o96+jLqdBatcSSlY0XzN4PbH61W+xzu6ep458Qvhl9ovJNR0K7/svUCdxlbiCf/f/ALre/euTsfBd9qXhy4ute8X6bZz2fmme2tkWYsijIIweSfpV+98U3fjjx1PY3Bl/sO1Vt1ugKqSOmTxuJPaoNa+HcOn29/fKkFrPDICFil2gxN2BHRhnvU86vY3VOTRxfgnwTrN/cx33li0tbgYiKASXEinptxwhPr2r6e8HaEnhTQrKyj8uIscP3C+2e59T3NfLFhqmu+AdeSSxkuYrYnc9vK25HH+e4r6d+G/jrTvGmnH7OQt3CoaWBxyAe49RnvVpmUk0aGv6PB4m0m6s76CKUAldjdGU9s9j79jXzt4v+H/iLSJ2uNCnW/sQ23ZcSCO4h/2SD9/HrX0Z4119fDGgXepsiylRhIjxlj3+nrXgXiLRNX8U3UOoeI7yeXUJj8lkjmIW8ZHDkj04+UZPIpNqK1Y4Rb2MXx98ONR8P6THfX2t6dfS3kqQwWdsuZJHYZ6nhQB1NXvAHwx1C/uYV1Ty0BIb7JA29OP4pnHBH+zXLeI/COsaPozyXEpS0WVVaZiQVkPATJ5z9K0/hf8AEXV/CN59mvHeeyL4eNjkg+vuKlNN6FyjJH1bYQCwgNlBIFSCIbcrksfWuW+IngmDxFaRXT+bFqES5E9uMSxtjqo7jsV711+i6na6zpkN9ZsrxyrwR1B7j8K8/wDiT4yvbW9/4R/Q50ivTGXuL48iCMDJ/wCBAVV7amcU27Hk2m+CvENr4ijsLvWrDT7Gcti+ilwM4yN0RIIJrN8X+BL3/hI49L0zW4NZnSJZbm5uD5cUOT8oA6scc1a1XwvNKl9LGraheRss0d/PJzcKwyCF6IO1cz4wsNft9Qi1O/e4kCw4jkB2ZUHnbjsDSUk3c1cGke8fCb4cxaKTql00lxdhMCaVcGQjpsX+FB2HevT4WmeaDLO8bL84ZePfNfPfwV+Llwl7b6Tr0/m2UriJJn+9Cx4XJ7qentX0F4n1e20PRbnVL6QpFbLuwD989l/GnzXMWnc8w+Kfg/SY7a4uZbu30vz8st2cblI7FerD3rzDQLvwOumyReI/Eut6lfwuxjNm0kcUgx8o9j61pXsOt+O9Zs9f1SeBrAO+LUIZBGADtUKOD6/hzXON4Otbu7slk1KSVtQiaaKcIscYw3zKR7DnipdTU3jTdiz8OvC/h3X9Wjnn1WO7upH3JZ3D7IYuf4s8vivqLT9Fh02ztra1jDImS7cAsT3/AMPSvjDxToV74W1GMMkpteRHMVKFx/er6F+Afji71mO40PVrgXE9rEr2sp5Zo+hVj3I4wfSqTT1uZTTR6osEYsZkuijRHO/nhRjnmvnT4hXPhOPWpptKsZ7++iIMt1anykAz0kP3T/Ouu+PvjOWwhbQdIEgup4i8skfJx2AA71y/hLw483h2zbV9OndhbcWCoRHMxPMzt1IGffmpc0iqdNy1MDxp4+0DXtGs7KPw1b2iNOGultdqvIAOASB0Neo/BjUPCl60MGliK3miG6KyCbVVh1Y92b61wvjHwJpX2aGOyt5RK+5kkt0YrGgH3WHcg9/SvLdOfUdG1lbaOaS2njfMcife3DmhTvsVKnyn3E1oFgdWZmXd5g2jkGuT+I/jHSfCmgMbtUu55lJit2ONx/vN6DNXPA3ihta8B22sXqgXMcLfaQowC6Dkj2PX8a8wn0u68UeHdY1rULcT3uoL5kUUgGyOANtXHocZP5U5OxnCDk7HkLePteu/FVvqFlKsNzEW8sqgHlqRyB3PHrUPiDxtrlz4gXVrq9f7QIlj3RsVyvavX9F+F9jpssUEMEyQ3EW4TXTLK+Mbgg29AWIyTzjiuT+IGk2Vxrdxp8WnzW8dpbssk0iAq7Ku7AA6HnOfepU7m7pWR6d8HPiTp+t21rot+kdvqEoOxwoCXDdcH/bI7d69Ym228BdTHGkQLHdwAAOcntXwr4euDpPiSyWRikb3CRtjgo+QFcehBx+tfTfxb8Vqnw3vooLlG1JwltOkZ5VmIXB9MmrvfU53GzscT8RfFup+N7xdM0GC7bTi+xQh2q4B5lkPdR2XvXldt4cD67qFnZwX0s0BHzSAoPYj2Pavof4f+Fv7PstBlnVZTDFvlUSsHUbPnYjowycD3q14pkkg8KSajaR29yY4gqDaQV8x9gaR8cIq9Tjisva6nUqUUj5S1CzfT71m8wEt8wY5XeD6Zr6B/Z78fXd9L/Yeou01sq4hlb78B7K3qp7Gub8S6dFr3hZr/UURNRwyFYo9yEhiMr6KcDbXIfBaeS3+LunWMWf9JR4CM8E7dwz9CBVJoynGx9M/FXxBPoHh/GmQyzardExW6xLuZBj5nx3wP1rzjw/8NLO/0+LUPEJmgv5bdWkt3bDK7N8rlj36Z961dH8TjxtrtpcTRqstoZIGjtWY7H3Y6+vHNelIrX63ontY0ulRbeP594CcEk+hB/lSnJ3sVSioq7PINa+GtpBMtjeQm9ucrI93HuL+Xkja3Yf15rx3xx4Yl0e6+0COaJHYld33lPUEY9q+tRZ2lyri7ikldSjgj5ZJMZAL4OCo/wDr1498Z4IE043TweW+5lBkbJj4wCAOxxUQlY0mlY6b9njWINb8MvBd29o2o2jYeYQrukB7k4617EibMBcKPYYr5f8A2Xb2RPEerW5YNGYQwKngnNfUg+7xW8W2jkmrM43Wo5ZX00QS+TL9p4k27sfKe3erNpHdRmQXlxHOS2UKR7MD0PPNGo2s1wlu1rOsM0MokUum5T2IIqLGqrL8z2Ei7ucKynFNKxBz3xi1GTSfhtrVzCCzsgiwPRjg/pW98Fmlg+GegpM/mSCIkHOeCxwPw6VT+IOkDXfBeq6bnHnRYB9D2P4GvMPgr42FtoN14a1qV7WeEvbs5OGgkOQfwPUH1qZuxrBJo+j7srNGWDAj1BzXCeKbiOG3m88gR7TnPpXAzHWvB3h7XG8PajHKZvLeGFm3FCD+8Zdx6kdK8t+JPxQvL3Sm06N384/K8r43lTj72ON3Ws2m9TeLUTyvWdk/ifUfsJzEblijKccFv/r17r4GXVrfTptN1JJ4YbSWKCFJDkEEO2QPyry74R+E5PE/imMEN9ktcXN22OAgOQuf7zHAFes+NNLu/h9qya5PP9q/tBtz9dsbq+9Qf1Wra0Mb3kfQPizWtP0C2XUdVeaDT7aUP5ka7gSeACPTmqHiGLUb7QVbw5fxWyy7JI5wR8yHkgccZyD+GKp3c1n4q8K2eoWkcN7pc8QM0UjcFByVPuP6Vj+MPE2oWGjodBgh8hHVUDAACPHRB3OKxlqzojZJWPN/2jzH/ZGl6f59scOXdyv8QXO0ehYmvLPhy0llpF/qtvIYjpdyLlXIztClc8f8Cqf4s6tfeIdTia5Ae6QBVt7f5iqke3U12XwQ0LU7nwV4on0+H7V5o+x2KTRgbpWwZGIPXaABW0FZGNR3Z7Z8OdWn1nw3d6xcujXM8EUikR8bSpYYWtzTZY7yEeXGY7d2ARY4v3UQ6kk+pJ59K8w+HetapptzpGjX0ccjyyPpl6QNr280YZo2wONrIcfhXdXrz6SyTLqFwUj3KSYR8wI6cdsDr61E9i6Wxf1gp5dwl1PFIVJWJYsqD7H3r5i+N1rbR6paPa2xhTDAcADGev417PqmvyWWty22oJ5M0yLPEu3Ix2YsO/avCPinrR1fWhDHcJPMh2AKuFDHr+FTHcqe1jd+D/iO78KQabdpHFLHq7/YikrFcskgAK+pw1erXPhmKDXbPxH9olM9yu2ZJB+7jDfxdDnsMeprzu50670HwV4O+zaRHfTWbtqc0kkZbyVLAgDHQlQT+VeyQ3tudGtWS5ijiDeWWkkwJFb5kA+oIxV1FoZ0XaRvah9llt1t7a4jC+ZHuVeAmOSRjkAn8PauO8Rab5kU6y2EX2vLebKz7tobJX8AQOOua6PT/wCzdN1G886NIftpzFBC+50QLyT6cA1y+qeIbP8AsC5aNpSsXmAxTf6y4I+631rDfU6NkfMfiC3XTfEUscalYxMQcjqp7V71pvjm5l+G91oi2lzca3YwRw5IyJgXAUDHJO2vD7+G81fxRYWkMXmySzKCM7juLAAE17Ba/YbL4k6/HY2lylwoik89pMpK1uVLhVxxxuI+ldMdEckrOR3/AIHbVrhriXxB4fisPOfy0twAWOFBEh4zkc59K2b6zT+1tQRIIIYw2JS53LO7c7iT3AH6Ulj5sesQTWzGa1k6SSNn5iM5H4Ej0PFVdJ1e01ZnuxJNFau5ikSSLDRFWIIZT0z61g/I60eVfGHRZpbEXkRjnWSNm3rlRJyM4X+HA6CvPvg74hfw742s52lZbeLcJwOcxHhsj26/hXrXxBvjY6ZePdta+YxZovKbd546BlH8IAHavI/htpkera/r00m6C0tdJuHeYLkqSuFI98mrh2Matj3bx21v4/aC1truVdBWza6lmT5XJ524B9cd609A0aVPCemlYZJSLRhK4chyQBtXcf73Fc/8JbeG90M6dPcySNqGklRNKuHDRyESLj1AYGu5t717OU6bPGEtpSkTSPIGKsFADNjocAH2om31HS0WhkalY2up2OoW4aHUImkiMsUm5hC6/ePvjgH0r59+L9g+n6tFfRQtbGR8hFwBgdx7fWvpfWpIY22znbGkbeYsKDMhB/1rduo/xr5x+LN4bzWWWF0dHQFCDnb8v3APrzSj5F1NUeg/s8eMLXT9GuLbULiRLa4udtruBP7zuvtxtNXp9FvrnxFeahI8skerp5ENsIiVO2TIkZugHBx9a890TTYLfwn4QvLia5g8/VZZ/wBwgIEY2JubPbI/WvfPscl7pmk3bX01uunLNaPDCm7DZILsO5Axge+aubsrGVJLmuYHhfTdWufEetwalBHZW0r+VAi9AQQQwboUOOR61jeJtDbWJo7gi4uIYzLCIJnGFfnO098dl9MV6fqDlNJuLfzpJbiJfNgQBUMxABGD7HJ+tcd4juZLSBLme4tka3IuJFjPzLvXDKU7k+v1rNaam7d0fLy2LWPiJYDKIkZ8c9+en1r6Y1jU/wDhL/D8HhuZHS4hlSC8eQ4V9qksRjnkL+teB6fpsniLx1plqVLzT3qhWx/DvyT9MAn8K9PjtBceMNbu9KhntZI9VW6LzSkxyplk/wCAjJH51r0djma95XO88B6HZeHYr0aegtw8i3NukxYfI3ysAe+Bn6YqHR7mwvoDG1lDcNpNy6qdmPL+bls9Wx1OKn0dbu6h0+bUYbjS5LJmnktW+bAIPysD246j1rXvPs9pZSeQLSee9hHlzoBGm7sfcDgVjJ32OpO2jPNvi7aC90i7kvpo3ZVWWBBgMzd2PqMdOlcN8KNXm0O7n1URRx/YbF5d0nCsBIFIP/fWPwrX+J2pOLC2h1C5F1fZ8l/JbIyDwM+w/lR8O9Hvbnwxrr6ZDHfXU6R6fbh03K43eZK209QOP0rSmnYwq7npmnT2+u2uoa1LaxTyTmOJiOfLjMaudvc5J/IV2V6sbaTbRWViUtSueNytgsAVHfn0ryWXXtX8PXM2iW/h9r26vrSOZoIHERjeIBJEA9wFYD3r1n+1Ve28nUbeQOYY3Vd3zlmHCH0I4zj0qZrlZVN3irGRrVjbIyHTlf7ezhZLcNsdMk85PRcdfYV88eOSX8dwyoY2nt5UjdkOUJU+vf3Ne5+NdXiixBbTsC6BJFA5jOcM5b1PQfXNeA61qUM2p+famRmVXhitvK2iOYtsQBurddxNFO7bHU2O40nU9RtNK8OWkZvvsGq2Ms0ohB8oEM4Bb8h+le4aXZW2laVJbQi53Na4WZSNzAc7U/8Ar151pfgy6nSDVra+b+z9Hto7RbcMfmSNcS4A4JbLfjXUWUsWo6TfaPNdPHcNEI5blDz5eAY5FPZSMHjvmqndoyptXsbMFk9kkEhjOnxzSqFhkbdIwAyNxyec1xPjKGKC5uPtU8YupQXMmAzgdfmUdqu6PBqnh+zsdMv7uxuo45DPCrF3d+v32PdgSc+1cJ8Qbmytrm4vHAjMh+Zg5O4gAcKex46Vmo62OiUtNTyvWIHv/FVnb265lub6JIwO5Ljn+teteKrCDxF4z8UWllqaSWS3ltm2EZG1o3Achu/zYH415n4Dnij8frr9yGMOmjzIoyc+ZMfliQD1LHP0FfSVj4R07SfBYvprWT7aYXlvXjOWcP8A6wgf3h94f7tbpaNHLKWqNDT5p7SdbpoZ547lFtWwSFj/AFxtA7+tXNQmEUOn2BKyO25ZTCc+YF4CD2Oc+1cbHrNvcpaabe3ke6ErNEyPtivY/wCGRT3z3Xsa5H/hK9FfWdQsLbVLiCSFZd8eSfKyCpAPfrWLTvZnRGSauN8bancCbUdPgjj8oxiUMJ8iNRwoIxz9a4H4USJa/Ea618qCmkWM90p7PNt2IPxJqnr+seVBLbQ3V1cRwxLCt5cf3V+6gHoOwrQ+EdlPquqwWFrEzwz3UUl9OR97adyQj6n5m+grVR5TGc+Y9g8A2F3pEccup2cWn3Vw2Z3gi8vcZPmBPuG3Ln3FdprN+LUwyWjRWshugF844EuBzj69MmtPxxaTHSDc2sAu5bRTvtycfaIiMOgPY8BgexFeMaj4903aBfM09rtMQuMATp/sSoejDpkcHFKUL6oKdRLRnbax4tAmSDT7OZNRAMcyzsdoQnJGe5569q8X+JGotbWElgjEOZPMYo5Yp6ZzWp4j8e6VdxzLpN0wvtm2N3QZTPc5rzq6mvde1WGy0pTf6lK4AjhXcC395j6foKIRs7lTmmrI7X9m5J4/HjW8KkxrbmS4YDozEbRX10cDOSAPUnFeX/BP4fr4Q0vzLh1n1CVvMuJgOGkx0B/ur09zXXeLkjkmsYpEV95KqHJCgk43YH0rRbHPNpslFIRlm+tA6UdXb60yAXByrjKsMEHuK8Y+K3w1ubrVF13wu6w6rt2yRnhblR09t2OOetey9DXF/ETxPd6bbDT9EtftWpTsI1JXcsbHofr79qHbqVFO+h8x6xPq+p6vBpV7puowaoR5MVuGZQzewNYV1oN5FriaZd2Rtb5iMxzEllGPvEV6Hf2WrXOtvI99qWq3cEwR7yE7Io2xkqjHrjpxWT4wbXdK8StrW5reeT92ZlwwIAxg+9RGUUzVxkeq/Anw/c2L3aGNYdOhYPJjlp5AOGY+g7L2r0P4g6TZ+JPDzWd2rmOUEcLzj1HuOCPpXOfBTxxp+u6PHpkkUNpfoDuSP7kuf4gf7x7ivSZ4VWSFxuxHxgdMeuK0euphsz5Z0nxD4j+FGrS6dO4NlIMosnzQXKHo6/UdR1rQ8V/FyPWdNSCHToYGcMruJyNoxjKDHBr0Lx5LaarPeaHo2mQa0sR3XIuwBa2LH+LzOqn/AGa8+h0jTtH0+/sLuy0iaa3Z/wB4kLSOm8ZVlboR6VnKKXU3Tb1R5Dp8sttqImtbySGcjb50eS2DwcdyTX198HrX7D4RsQY/s1sqlLeNz8xycs7HuxPWvA/h1b+E31mK31CSa1u1GXmlG7zB32k8Ka+sbK3tJbSx+x7Bawp+7VORtxxiqt2M5PWzPG/i/oV9Z6nP4g0Le7AK9zFCfmIU5EgA/iU/oa4Lw742ubvxxBrWoarM4clbiFm/dvHswECdOvOa+mLiyjf7UzyxxPkPvHAQgfeOexHWvnnx/ofg/VtTmbTLO/bU0bdK2kDNu3PJIPAz7UrXWpUX2LXi/wAczXccgtYoRgbd8hHyj09a8x0F7OTW4ZL4ma18/wAyQKPnnYn/AFcY9CeCfStzxaPBX2UQaPpd/pd6kyi4kupTIVjxyUXoea9C+EXgHQrpodSt7gXUKMMzO2XJ/ugfw04xsEpX3PZ9Dt3ufDkou41SS+RjIgHCgrgKPYDAr518Rn/hHb+10bxFbXFzp1u+612OV82IEkLn++hJH0NfTcto5N1JEwQsm2L0UYrlvF3hGz1/QvI1a3+0LtDOY2AeNgP9YjevqO9Dt1Ii7HAaf8TbXU9bkU2iRWUSB1mmIVy/QDFcX468QBpJorNYrYvlvnb5QT1K+9VR4K0i18Voup+LmutIZHWWS1hPnx8fKGwMdetZ/iLwhptxr8Gn+F9YjmTyVdrnVJArOT/DGvtx1qORbm3O7WNH4NwW1t4sTVb2Tzbtl8uwgI5kl7y47Ko/Wvf/AIh6LPceFYpdKjjTVrGVLqJ9oBZhwysfRgSD9a5P4P8Aw1h0O9/tS93zXKrtR5vvOcdh2UfrXqEkNyYrcOzsWP7xCM7gex9OKv0MW9TxDQfHy2tqljfxzQhZP9FYctGM4Mbe6nI+mKkPj2ztJ79HCQsqGNJpG3mUddxHrmr/AMWPhraX5l1C3vY9Ku1G4XUpxBMB2k9GHr3rybwt4bt/EfmW174strO8hlKeWI/PWZQOZFbjj2NJ000aqo+hQ8aeJ21G68uMtKiKVSUjkZPQAdua9h/Z60m0j0eazuI1nvbo+ZqAYZCIP9XCff8AiP1FeNeHvCtxrmvTwW+q28cVvM0eWINw+D1SP1NfVHw68Ir4U0K3t7ZDFPPJukDHcwGM/Me7Hqfyp8q3REpN7nnvxbkuvBHiix1PRo1t7BSs0JRflilxtZT/ALLjg+4rU8M+IPDOtXVxq9q6WutXLK8sNxLhd4GMrngjviu/1/Rl8Q2N7Z30McyjIRZF+VgeqH6+vavm3xj8Op9AuDNp15E+ns2PsV5J5VxEfQZ4Ye9LkUhwnY73xTqkwQsuou9qYijhyq7uckbuyk14brl2by8CCWFi3BkQbY0/3fXHrWvr/hTV9I0mO9utT0m4t5ZFiVbOcSspIyMjsB3rb+HfwxudbvoZL64hu5iQwjhbdHCP70rfyXvQoKJUqnMe/eANE0zVfBNjHdWcctvHbC3ty68quPvD3JOa89i8cNoOp3uma9G4SQeRfqv3ty8R3KeoZQA3uK9t0+wbT7BrS2d1gt1CRYUZJwOfxNcN8Ufh9Z+JLZLqbfHdxrk3UA+eFu7Ed0PcVW+hnGVmV5ddsW0lbrTr+yuwigInmYKBfu5zzkdT9a8Z8feJriK/iheeB4pEy9wo3OwyTtGOmO1UrXwZPBrn9n6n4q0W0tHVtt0G3gnsCvbNUdY8GRxeKo9LsvENjNFGEY30owhJGcKnfHrURp63ZrKq2rGt8Irsz+NredUJl2NFax4+ZQ3DSN744H1r6H+KNrdWvheC90y3WaWzbE8CqP38LDDr9e49xXP/AAq+HdvokD6kod7mQExzSEGSZv75x90egr0x7V5LgRTZktjGVcMevH+NVYyb1ufNvgjxdaW0GpRaprmpXcHmmW3LDdIi7cFHB5OPStC88YadbTMl3fxTpP8Auk8qNjti2jDMuPkPsKd8ZPAXh/T7iS+udUTRbmT5lmjwwn/34+ob3HWuB02w8G/2L52pXuvXGpLG7pIi7LeVv4SM846ZqXTTNVVdh/iXWNNjgkhtmL78kzzddp67R/CP9o846V7D+ztbzz2Ml28TQWcS7bdGGC2erkdi3p2AFeU/DXwp4d1nU4G/tKO/1BiCLe4HlW8J9SOr47DvX1VpOg2+m2kNvbklUQ7nPBdz1Y+nt6VVrLYzlK55L8ctMvLDWLbxDpyTFFxK8lv/AKyGReN49Rjhh6fSqFl8W9H1D7Nca7b+dPDGUE9qQCSepKnv9K9pubK2bRpkv5o44UJdpc4ERHfn/Jr5Q8ev4Xu9blk0LSJ7q6ilBku7bMdvPg907Z74pSSa1HCTWx0uufEbw81zcS2tpNctgLtlYKCRnlscmuH03+3/ABjri6nbRJshkCC4VQIrX/dHdvQetVfFOqQtDawS+FdO02JpA8jW7kGVT/CW7Cvd/gnf+GdTmSxtYotPuLT95Bpa8oWxzJu/5aH+VEVyqyHOTe56V4Ks7bR/CVhZbuVj+cNyST1z6n1rxf4h2GoeE1e5sftUlrAzNBNCNxihY52MP4kB7dq+g3to0to1G7EfzAr1z615p8Y/HGmeGNNS0hjW61QjMfPywA929c/3aZmnqeORfEfUNd3C3guLqaKP5vssLMcdASB0rhvFl3qM+qIl5Z3/ANtlAVY5kO8A/wCxXZaPrHibTtSfV9IeC2vruA7zFbqo2ZzjaK5298YeI7fxbcavdzyR30gUSuUGSAMD5T0GPShcqeho+bqd98K/htfRTw6hrkZWaMiSK1znyATy7/7ZHAHavpned6QGEKm0LjOQBjpXnvwd8aad4l0oWckMNpqinzHiDZ88f89ATyfp2r0a8mS2he6lZEijUtIzHGB65o9DN+Z89/En4earpjzHw4Y5bNnaZLSdtqoT1Mb/AMJ9V6VxngTwZqPiNLyabV9J0a6jm8qRJlDyOOpYEHmvQ/EPiRPiNNPFCNR/sC1ulgMVmp3zEgne57IADXDXHgdobjFnazytJ5jkgkGBc5RvU5XqKl1FsaxpyauczpHg2XxN4kmgl1yBbOGZk3McyyYOPkT3r6b8B+CLXw/a2C2tt9mihJZYz98cfec92P6V8k3Vq2j33n2M8yDdkE5yCD1B7819PfA34hSeKrN9O1PBvreMNHMP+W6Dg59GHenoyJJpHpCQMLvkEqoI3Fs9exFfN3xvufBA1aa3hsjqWpYOXtH2eS391mH3v6V7d49v5Mf2XYzfZ7maBpZpt23ZF02g/wB5jwPxrxnSfh7pOpX76hr6S2WksmI5LJvn35wARydrDPPcinzqOg4UnLU880i/i1Xwtb6FLoUCC1kMsd4v+sZycKjt/F1xivT/AIT674e8Pakuh6nog8PahMQrXB+Yzk9i55ANXz4b0/U0u4tIge00tDCljATtlDqTmTnqCOSTXnfizRb6eHW7mS7luY7CUxxPOMSlB147c1mp3ZtKlZH2DCqrGqxgBQMADoBWPrkSS6vpQlwULkEH/gRrjf2f/FT+JvAcC3che9smNu5bqyjoT+FehX+nW99s+0qWCjGO1adDlejOe1OW4iS2WzMQllmEeZQSuME9qizqwkOVsXXdztLA4pdYSSUWCwymKT7SuJAM44PY9as20c0bSiecT8/Kdm0imIdcypBE0jsAq965j7OBq5E4d4bmXyXQHZx13Fuwz+orM+OOqy6L8O7q9gYq6XNuCR6eYCf5V0VxcwXvh631ZJk+yXkCuh2bgDjgsB78VE2+htSRiahpK3OovPbWcIs4G8u03T7RCccs0Y65556mua8UaDbaho00c0ALbGJlU4j284O09CMY9eldLqc9r5Uhuxc2t59lV3bJQAjoxHdR6HmsPxxdWotYXiEjQRx+azKMK5YcZP45xWHU63sfNWh6pd+G/Ekf2FpOHyFXuQcgivsC+8SfaPA39qaefMuZ4F8pEOWLtxgD1zXx0UuL/wAQrHZyAyhnkWTsAATmvcvggy2vii50+7uEL2j26iPdz1IY49mZa6It2OOUfeuXfDfw+1GOG+stQ1LdNdTx3c1kG/dSnoS/fcPTvXc6N4F0vTje2kKKkF2p3xkElyOhOfu7T0FdRaQWx1W7EeLeViVc4HzEc7s9alju4Ps2bxoYpNxVED4J9/XJrG7Z1dD5i+NHhkafAupWESu9vKYpZok2gtx29q679nPx5JdFdCvpMhwTASfuuBkr9CORWj8cXVfDd0kkah3PBHBf3+nNeFfD2e4sL7Vb+2Z1l0yFLz5FyVKuAcfgauDbMasT6b+MFxq11p8Ol6DaGeadgJmD7AqHoCff0rjfA3gvUbHRfM1BWhuAzhEaTESofvMSPvNjOAe9d54X83xJ4UN/ci3uZ51gn/fg4DFAVIA92NdnbaVaW8EVoSk1uEKmCTDOsmNwUev0pSbHTSSR4xrXgLSNVlkvZoJYI5I1W2aUFQZB0I/2SMZ968ng1bVfAviSS50qV7aGUndGwzG4B7g9R719R+J9TtIraAgOxkbZDC0RBB7gL+f6V82fGeSNb2OOONxFGSitI3qOgHUDtg0oSaKqRTR9JfDbxbF4v8Nx3qKI7hG8q4iznY4H8iORXDfGKXWtT0LVo9AlEem6fKkVwiy7HlYjJAPYDI4rzz4D+KJPDj2SzMn2fV8W6h2xmRJNoI98GvVNK8ONYwXt3qCy6rBr10JbiBPk8ok/u8H1Bxn/AOtWkpPlMaUVzamHd+EL648C6S091bwGCJFf7Omx3kwDhyfqM+ted+PfBFsNPj1DTjLcsAcqEwyAH5s+wPQ19OXVu/mTB7aRkjMKSWmAykgcOG7niuY8bRQTWD2bQw2se54iUP3h94hgOmD/ADrJyaZ02TR4h8Kvive+HbyHTtWme600EKxkOXjX1B7gdcV9UPcwTWIuRMPs5jEolU/w4yGFfBnii1Ona8zpgxJJnAPbNfS/wt8RPf6DF4Tuon+0Wm1GkZvvRFgQMdehxWsXpqcso2Z5x8YvEd/ruvtFqcd/Boyofs0QXasmOjkd8nH4VL4H8ASG1tU1Q3Njc3JaVI9m0yRbe2ePSvePElja6hql4ZYCZ7eNlE7DKQxccAdM/wCJp+ogG8M0lu9/bCRZEXdg27CLGRjt6DufpWfOzoVNHz7eeGrHw9qM51ZpFd3BtLi3XDoffHIYevQ17D8G/Hra2r6PqUplvYFJhnbrcRg4yf8AaHeua8fCL/hGri4SVBeXUWd8qnzVCkg5P1Irxz4a6td+GvF2mmdG3xTu3Xh1KncAfwBq6buZ1ordH1h8QPFEPhbTPtTSD7RN8saP90f7Z9AK+bdR8OeKvGviSdtTcXEay4Mgk+XH/TMd8Cvbri9tfGFnJfv5MMDWimOOfDDJY9T0AGOTWnYaLZwQWyxliFiRWmXKpubocdQCT19DRJ6tBTgrXZ4lrvwyt006O20szedvC/vPuv6r9ecg/Wub8C+LNS+H3iV4pn8633FZEBwHHqDX0VrlvaQOPtEog+Qq0MkRzK+7jB68ZytfOfxP0UWF7HnP2hYiNjDGFyduaUZvYucFY+u/DWuWniLRbe/sJN8Ew+hB7g+hFeS/F7Wte1K2nsvDyFtPgk8pn37Wlcdv9rHpXNfBDxgNC0yO3mVmtdTmKQbmwY5FADfXORXpPh1vPgs7LUo4ba0ule4Ut80kkgyzEehxVSlYypwu3c8T0f4cSGdL3VJB5+EdjInyR7xkEjqfwrk/HuhnS/FU9nDGRIgDxzoD5bLjI2/5619ZCKC6ugbma32RrsKod7yKehJ7AE9MVx/i/wAPWgl8y6aLykaRVtmBDSPjOM9AoHIrJT1N3BNHFfAn4kmwu49F1eVhDKwVXJJCknAPtzxXunxB8RweFvDk2pyjdMp2QgHq56fhXxbY2rp47sI4mzDc3YhXac4Vm2/pmvdNf8Z2+vX+g6RerHObTU1t5EVsiUoOd3pkitlLTU5nDWxzd14D1jxls17UNRa9a4ctOqoQIVAzhWPGB39K2/Evg2zFrb28tu6QpDlI43LOy4xknoF7/iK9UtpImj2XVy9lHN8r20ceIlyThVx3A6juaVrG0vTOZHkSLzFCuyje5UDbxgEYwTjp1rBybdzsjCKVj5M8QaRe+FtQinKSwKp3xMT864/vY719I/AL4gT+K9Mm0/Vn36haqHSToZI+nPuK8x+LUMTLcAQhJZZm81ZGywI/iHoCKofCq9fwxZ6nrFqCktpZxvI7AsDulKA4+mPyrRSOepA9m+I6X/ijVW0LTIJJLWIBrnY2xXY9FY9hXnMunLYDUIRcLp+lSRiFWkiBZnU4cYHQg8Z9Oa9h0yCK98L/AGue7NvBOfOupBhd2O5bsK4nUtP+0rFZpG32J2lmWZ1Ds4QjLL2UY796zqSubUYKxweneGtLv7O9msWSa8jj8zyZ0JilQZyAewPXHqK5bXtZ/sM6DLodounmCR5jJGdzLIP4SfSvTvCdhLLqCx2vmmJQxZF+USYydx9T0GK5SXT007QfEE7paBvPlxGRmSL2PpShNvRlVYI+htC8VrqfgC28QAKsklvuK9hJj/HmvnuLwDr/AIv8Vy3WuZgsTIZpRvHm465IP3QemTS/DrWNQi0zw5ZSxXZsprOSUuD+5yHI3Y9cZr3a9+wQR6mTppmAjV2kLbQ57gt1PUcdK1nJpaHPSgrnLX2kW8MMEk2krJAP3cNwo3bVXjyyBjIx1YV5/wCPPC0NzptxeQxTGcIjxqSC4THXPdK9ntlGpX1raSm683aVVXTPlxgDIf8AujOB3ziuM+JapHpt2TEkjRmKEywvsBXkMFHpjHFZq97nRLVWPEvhdqlxp/jfQrIy4zc4tphwyMedh9VPI/GvoT4vaxNrWkQ6D4dljmvrp8TJG+fLx2b07nHtXzh4ZtjP8WfC1pbD97/aULYH+/k/oK9i8MxxXPxA8S6hFdxyaP8A2s8UbwcMGwxwfY4PPtW99HY5OVcyudf8KvCMnhfRplgt7q0uQXa8klkDiZwny4UdBlsge1dJ5EVnAsgaQmAOJpAdzTu4GFJx97POO1JHqkdpcsiN5Gny4LXQf+IdN57A8jNUH1KfXtSmGjzrDHYhlluZFG0M5zhR0PQc1zN6nWk36HjvxC0NobRLiGOaOBVO6ByC0YJ5OOvJwa539nfVZ7PxprgCbxb2Mt4sROBmM8jPbIJrrPiNPeCW6l1W5truS3BEcsJwJFIwAR6561xPwrvXsv8AhMNcs4VnuPsa6bbQsP8AWSztgjHfCg1vHazOeoj2vStWHi+51e7USxi6aFAYJBtVFAPDHrjk1fj1W2lmDtaxI9zLEZJ7eI7go/hGeBjGc+9c/wDD/T4tE0+XerRCWMIqx5XaVXlRnpnjNbN3qurw2mn2tt5KylW3FAARGB0fPbnA+lZTvdm9JqyReutOj+1rMtrcyQXAMaTlsNtzlQO2R6mvNPiFdSJLf+TNItnJZ7ZMDIml3EFi3c13Wq+JNSu9HhsJIbaBk5lmUkhVUcE++e1eMfEjxW+ryRaPatGTb4UeWMB2x1+gp00t0KpKyOt/ZkvXsI5I3f8A4+tV8oD1UoR/Ovp0Z718ifs9TS3vxMttPtCJLCyjM8jju47/AJmvrutl2OOe5zNxCJjbsWKmGQSDHc4xipSMO31oPGM0P/Efer1sZnK/E/QP+En8B6zpaDMzxeZF/vqcivK/gP47t4tPPhHxNKsXkuRazSHAU55jbPTnp7176hwc14d8YfhTLeXkuueF4gLx8tNbDgTH1X/a/nUST3NYS6HoPir7ZAkUkITcrZklK7vMU9Nv868T+IF5qdwRYadDcvFJgNGozkZ/Suf8O+LfGUF5HoULXSXBfy1t7tflVvqelRa7rfi6fU5dKeKSS+jO2VEfdgnnrnHes1STdzZ1XaxseB/Dbwau8aqtxfsAGIH7uLBBSMsOpLYJx2GK7bx34b/4QTVNK1y2mM3mM0N3IExt3/xe+Gwal+B2gam95Jf6zIpt7FSEgiH7tZSOST/G/qe1eleLbSHXdHNnc2xlSXMborAnBHOPfv8AUVq0krGHM2zP0PxBY+LdGXUIrnyyFAuIo/vLIOGBI52nqPrWVqN4kbKlzp7R/ZWLxzSvvIzxkHvxxzXhuo6frnw013dFPILC4bbBdAExyqezY6OOmKh1fxhqGqxZMupEZMUnlQkqCOwIrPk6o2jUtoyb4q+KP7T1FomeZliJO3+Hk5AJroPgx4Tv9T8I65eWkf8ApWrMLKHBx+6Q7pWB/Ja8gkb7VeSB/OdWdVMZOZW9gP619c/BSGey8HW1xqES2kZHkW1ug4iQdvc9yfWtIwsZ1J3Oc+Fup3nhx7vw1fzLDewyG3jeRsqh+9H+BUsAfUV6FqOqokUslrbXF3KN0uP9UwAOM57sCOvpXnnxi8NXN3f3OseHwZbyFQJ4E6yxjnj/AGlPI9jXFaN8UppLSKDU7p1ljBjO5tpYehP+PNZyhroXCZ7BqmsQ/Z7W+Ry6JHvjmnYESO3UDv8Aj7V81/EHUE1DXb15BlpiTg/w1va74zllhe3hms4IEYnltx59BXLaHPZ3viC1mvt88ImDGFVzJcsDkIB2B7k9qUYSTuxzmmrI76XRrzRvC3g822nrNdaXGdUm3RFiGdwyoT2+Ubvxr2vTdRTU/CkkNnPGLm0cSQknjB+ZD9Crda3/AA1aynQJGvVjW6vw0s4A4G4YCj2AwB9K+etZ1DUfh54oSN1aOxbKQSY3KY858th3KnP4YrRptWIhLU9kuNWuore2nnk8uOaZtvmvibcoOAPQDnHrxXE+LvEiRaVdpOBbu7qXiUh5HLHKlj0yRyfTNZF74/NxpuV03z03FhLF+8Bz1weq/jXmvizxBcarAHhgEETNuDE4/EnuaxUG3Y3dRWMS6sJ9a8V21jaHzJb24VFjBzjJxivYrS7g0T41TXkEJjsppV04yknazIqjePTLDFcL8GPLtPFtreFUlvwrx2kYHzM7cea3oqgnk9TivpP4i+Fk1L4dz6baokdzAiSRShQGDqc5J+prZI53K7NjWZ13RTpc21sp7TthJGPG0g/eJ9KxbjV42a/0/X7iKzuI0JjWFSiyoB93/wCsK8wtNeh8X6VBo2uObXXLB9s1vLgCYjglc/xdMVoeLvGel2twv220uBcxxeWvmpkgAY4Pc8Vk4vqdEZqw74kahBfWEUEAuFh8oS5YD90BwAD7nk141pUR1TxBqE0AMiW0LgLtPLN8uBj61d8ReILvUYJXsrSe3s2YDz7gkBh7A16n+zvpVhJP5tpGZ44MyzXLrxNMRjA/2VB/M1pGFtGZTqX2Lvwqlj03w1a6fLHHGE3WkyynOSpLYOe7KwIrqrbW00m+h0O5uru2a5h8uCUAPESByGJ9zgD0rlPjxp72F1e3qKyaZfwRec8a4+zTxH93MMdB/CfwrldK+JjrBBJewpeTRBfMUKG3MBjcPrjOaKkew6c7LU9Yu9St3sRE6iW72IZHZi+wg8c9Nw6188/E29+16jdZmZgMBUZ95ADevfNXPEfi95fN/szTpQ8rZYElRz61x9m0V3rsc+pv+5WRQUi5LY/gHqx6D061EYMqdRHo40l7HQPCQe0SWTTkbVJ8g5HmuMJx0+Qbvyr0eLV7e+s9L0CB449X8qR42aMsHWNuAW7ZDD6g12/gKya48MTzalAgm1Pc0yY4AK7Qg9goA/Cvnx9c1X4d+Kfs91GXQAwAuP8Aj4hXhcHs6jg+orSSuZQnZnr3h/VNTeAReILNLO8E5haWOIJHInUKmPTA5PvWB4x1R7e3e0WZVsVd1dTIHmmkI5LnsO2B2rl77x5Z3OmM9oGnKlpEhkYnDnuRXm/iXxBe3sG1Qtopfccnl8jnjrWfJrdmzqqxP4KWC7+IujNw0NrP9ok2/wAKplsfpivR9B0Ev4xtLzxLafYIzdnVAYo9nzFiDn1UZUn2zXB/A6wlvvFcUcETNFvCSykcBc5K59WwM+gFfTPxY0qa+0ezvbBRLeadKXWPPEkTLtdD7EH+Va26GHNZlHxBc6jMmoHTbuOCdS62twwBVWxzgdMDOQaWPVrlNMtn1SSFL5YTbtOzFzuPoe5x3968p8K/FCPTUk0fWLdrq1tJiIhL+7nhx/CSeuOnNJr/AI50t4ozYrf8y+YEYqADznnPvWLpyvZHSqqtqZfxF1KO/YWwKsgUoh/uJ3BPpU/gTSdR1bwvd2WhtJJcardgOxwP9FgA9fVj09q8+8S+IIrxz5a/ebJiB3c+rN/EfRRxX0D+z3p11bxT3mqKLY+UsMEDcGNeuP8AeOdx+taRhy7mE53NfwbeNHo76LrEf2i7s3+zT2jc7mI4J9sH9a0NYil0LSbNp830Nu7MXI+aGE8CEY6//Wrmfi1YaponiaDxh4XX7QXTZeW68iUKOT9cVkRfFXSNY04L9q+xXWMNDN0B+v8AjWc4XNKdSxp6hILy0NzpUF6kkKoshDCIk5OeB3wea808Xxxw58PadOJL68fzbiUHLAMRl2Pb0rW1fx5H5NxBbanbQFcgtCDK7e4A6153pNpe+KdTlh0RZobPf5l5eucu3uzevYIKIU7asc6l9D2PRvAsqaefEGn3IfTdPj8oQFiT5SArJtA65BY/Wt/RNROpamge9VprHKeW43RsuAVkI75+Vga77wLZQaN4NsLCRWGIsOhXOcjp78V4J8QfDOr+E7mXU9JupJNNtssiKD5kUbHgD+8o6Y7VbhzGMKjiz1WDX7mzsb0wR/6RHIC00z485ycls/3PQCvH/iHr07zTwXkOny20sSFSGIa2cOWYqPfpn0FclJ8Q7m9sHhzPv2nCpHkfpXLyTNJNEkVvdXF/IMAygs2fZf5ZpQp66s0nUutDpvhheLa+PX1ycHzIImS1QnkzuNqAfmT7AV9Ft4N0nwz4NkeO5lhjvPL82aY5WCXO5JD7biQfZjXl3wl+Gd/BqEOo67GUu/vQ2zH5olbrJJ6MRwBX0hfwQapZS6ZPbqbSeIxkE5BXbVr8DFux5xDfWeop9imgS3urRPKubQSfMD1wMffQ9QfQ1h+KZFtdPaPSNYGl7ZUuHidcqzL/AHvUcDiuK+IngfxLoVz5mku17a2oIQu4WaBOy7j95PSs7w14b8TeLNAGo/2rpUdqhkEkd3MTKoXrle444qfZJ7GqraHKeMfEn2l5rO1+e2DO01wBgPIxySvtntXX/s/WFxqWtaVDBCyWFtdG4lc/8trjbhfwRcn6muZ8FeB7jxdqPm3mpW0GnIeVDAzEeiIOlfVngbwpF4ftbVbS1a2iSPy4Yx1RT1L/AO0etFuhnKXUp/GFpbDT4NRFs1xYKTFdCIfPEP4ZVA645BHpXif/AAmmp2AaTRp7S8jdeDKRkj0zX03LZC5SaO7DGJo9rFmyD7/hXzB8RfC/he616WHSIrxrwN+9k08/uj6kL0z+lW4prUUJtaIwtV8Ta3eqWvTbWQlJZwH4IA64FcZKxvbtrXRI5rq6u22PPt+Z/wDZQdlroPFcmgQ6Xo0UWk3umX6xMs8jHcbtTwHJPQ8dq9f/AGebLwVMuzSmkXWAuZRdj94R32e1LSOiLbfU6z4B/DqPwdpTXlygOqXCbZXHb/ZH0/nXrlIiqiBUACgYAHalPSmYt3OebBHPShsHfVPU7iSCCJLZVe6ncRxB/ug9yfYDmqzpqVkJJ5bxb2NBukiMQQ47lCPT0NVYk0FOTxXA+M/Eeq6hqh8M+EWC3rqTd3pGVtkHXH+1/Wu11W9Sy0W7vi3yQwNKCfpkVmfDrSbXTNBuda1B1jFzGLiWZz0QDOfxJJqJOysaU0m7s+b/AIhfD+ewkZf7akvNXK+b9jklzcTr3IH05xXmF1c3MEkNwpuFZBs3SBhnHbmvqnxr4R0q/wBQuvifomqNf2cUf2oW0anLyR9F3dVXPUVx2p+f438K3UPiG1sodQe3F9A1oBtVG+6eO+R9ahM3cE9TU+AXxLjv7aPQdVkjikQbbfdgZ/2c9/xr26a2jGx44k3Idw5x9ea/P+wluNMvhKhZJYX+8p6EHg/nX2N4V8YW/inwnp0UVyv9p3cccM0Y6oSdrH+dac1zncbOxR8VtqniJp7bwxaLFp8hIlu7iMPHK46lFP3f97vXkniqHxx8OtNES36QaZfSv/q4gVLkc5JGQSK+wNH0+0s7Ty4IgiqAAPYcVi+MdNtNR0q8tbyxW9geFyYSB8xAOAPQnsazc5bnRGMXofEngXXl03WLaK7sUdJ2C5cAM/8AsrIfu19keHbzTdb0G1fTAYII12iIcNCehU18eeN/DT6ZoFldpa39rIty6GCZt8caEAghvqQD7133wJ8Z3dnrFtb3twr29zMLWdfRtvySfU9DW0Zp6GE4NH0ReW1vbJdTX100agB1ncYEe3pg9z296+cPiDDpviy6v73QvDcZNrkz6uH8qOUj/pn3Ne1/EGOTXNR0nw9FO6R3kjGYx87UUEsfrgHHvWavhfTriVnTTw+mFUtbK1iyJYtudxbsy5yc9zWcpWLpwvqfPXiHXfDuq6CyaX4XtNFvi6ZuIXMhkUDDAf3STzXf/BK28N6rqFvAyxW88CAbmYGScZ+4D/Dz19a73UPAmjAXtt9lsW1B5dv7tNoKnkK4x8vyn88V88+I7KTwj4rlOmTFoVlJjlRvulTyPqOhojVuOdK2x9rS2chu2lhZERlwGA5QYxgD0rlfFnhzTdR8NsutJBc2ez98WcIQR0dG7MP1qv8ACXxwvi3R5EnUJf2gQSgHIcEcOPY1zHjCUeLfFd5puySbR9MI8+3iYgTzHgKSOgz1PYCqk0lczhFt2PEZdI8LWPidyNc12fQkDCWa1tysiHHygEcHnvVHxXpHhxNW02LRdUvH0uaEM91MPMkV+67B0xX0TF4G062sbK1hv7pYLj5pLOzUP5jtxsMhyAoPb2rhfin8Po7WEzWrwRXFqVUQwrhUXb19evc+tZuqb+ydjrvgd4L0W1hXU9NlW4VePPkIMsr4/iH8Kj0716jLZ3DJGsm774yC+Q/ru9jzXyP8LvHt34Q17fdCV0J2TQZ++PUe4r67k1ixl8ONq5dZLH7P9pDA9VxkfQ1ommrHPJNPU8k+L/grQmhN5ql6dKmQfuNRjwSwH8Ei9Tjs1eL2xF3AIrjx7IoR28mN7Zm3YHGGPQn0Nei+HG/4WbrWr6lrB82aLEVhaSMREM9HbHXHHHvzWsngHTrbTLmOKwuQDcbLm6lX+P8AvIp6jPy4HbBqfaJM2jSbR474T02x8S6gG8RaveNIrBVsv+eh6cueFBr608IeGRoWhW8VskYkchpEgbCKMfKoPcDqT3NfK3j/AMOXHhrUop4POiUkEiVQsin04r3D4EeNjeL/AGBqEu+5VPMt5P4ZExyB9PSrUoy2MpxcT0q60h9Qt7yG8CSlj8gk+ZTkYKkf3SK+Uvin4Y8NaNqzro2rzQXKv+901F8xYeedsg7e1e7/AB18Wy+H9JSy0wzR318hDzQLuZY/QD1PrXkmq+ANOvEkuIZLuwsYo1Iup2yZzgl2IP0x7E0SkloyqcHJaHNeNdN8IW3htLvw7r2palcNcLHLFenYYkI5YL/FzxXb/BPwd4b1C7gezvnvL8Lukkul2GFe4iTufeo/Hvw4t/8AhF9DfRrESS3TxpFsfc1wpGWfd69D9M15zHPqfgfxWbZptstrLlGQ9D160lJMcoNH2qLAQpLGqIIAm1CWOAMAAfhXG/FDw7oU+gy3GvC3+wgBXMj7XJxw0R67/bvXReAfFFt4r8NQajEcH7syn+BgOR/WvHPFGpR+KvFy/at728UjJpunbiA6g4eXP1obityKcXJ6HjcVp4Ri15/M1DWjpBDKsgjAm3dvYimyWXhWTxW0C3OoT6MArRyLhZ5DjkNnpzXsegeG9G0nToG1vdrs19dZg8i2LqkZJBJxwCCDz7Vxfxm8J2Oj/YprC2Z9p2SXSJtVgRkAjtgd/ekppu1jaVJpXPc/hP4f0c6EL3SjaCMDy4IIGyIBxu8w9TI3c+ld3HYf6crTGNg8bIYx0YHjGK+T/gt49m8La6kE53adcEJOPQZ4ce4zz7V9FfF3xOfD3g2W4tXX7TcfJDJ/cBHLD8KL31MGnex478b7XwgNTe2dGvNUQ7Vmsn2SRf7EvZ8evWvP9El8JR6VPZ6hody2rxxOYr2S4IV25Kkr044+te0+HPA+mvpFnHet9v1O6WS5iuZFCeSCm4u3sOBg/hVPXdG0e10bUrq80si1VkeSHyx50J25Eid2Rj296XtToVHTc8x+F9x4bGoQyX0SJqkj4/tO8JkSLP8AEsfTPoa+tdP0a0tbO3jsJP3IT5pD8xlyclifUk18eeMtNi0rUbXVNJQCKbbK0DphE3D7gHoRn6V7X+z149m1bzfD98zSeVGXtHc5YKOqMe+MjBq46q5jNcrPT9cn0rTPD93LrdyIbSM7pJDw6t/DsHdvTFfNXiK0TXtQnvdO0qxsoJCVLyfLLeKCPvoOF98V6R8YotW8TanPbaVPZ29vpij95dPtRXOct7kdqm8H+CtM8P8Ahaza/uL3VHuWSOSeODIB3Bjtzzsz19amVRx+EunS5ldnhviK5Ecdt9m8Mx6IybvMlsycyqw6ZPtzXrnwQ1zRtVvbWxuYLe2CAvZ29sgWCRxwS/cyDtnitjxZ4XFtf3KiGR7OdJN0bLumJ6EwqDgdMjPavnDVYX8L+I1NpeSKEcneuVZSOpx2YUlU5typ0rbH3a1miwELvcAggbuRj0+leVfGPxzZaHFDpWlQrcaySFWQjiAt2I/iJ/u10HhHxjPefDBdXvSr6jBAwY9PNYD5XA9CMH868l0zwfrtx43ivbq9MGp+T9sE13CXhG8/Nj1kx09KpyUVczpwc2c3oFpq82pw3ulXb22qXiMsjSWqAEg/dC+lZ83inxZ4c1y4uL57NppHy7rCpY9uGHT6V9H6X4UsNPgAtrUwMFldbiKQO9w5wS4P8BOPpXlfj7wlp1l4fnitZRNeGdp55gpbgj9B0/Gs1Ud9Td01bQ9B+DPjjR/Etj9hEUdvqcmZHRn3G4x1OTzkelejare2+k2Ut7dPHFaQLlyeMemP5Yr4l+Hk1xY+O9Jht3aKf7UPLcdVlHQfiMg/WvoL4v6vb+KLXR9KsZLm4spbhnvY7M7ZPkXJUE9wf51XNoc7g72Rga2Z/idPcX8lxdpo9pc/Z44owAkWBks/r2rmv+FY2cegzXsWp3TspZLi8jQplyfljSPvgdTXsPhnw5Bpnh9LbTYhpVjbt5xec7nkPUK4PJOc89DWx4o06O80WISeZA8zRmKK3cLsYfMWGeM8ZrLmu7nUoRSsfIFhFd+HLyO5tLq5ihWUqk8ilXXB+8F64r61+EfjdPF+iss7D+0rQBZsHiVegkX2Pf3rw/4radEqxyRXQmu0kbzNw+aTdz5mey/1pPgRrT6DH4ov1g89dPhSVY920MrttYE9hnBrVO5hUhY9g+LGu36tJ4f8MW013qcsQlulhP3EP3RnsT39q5nwP4MfS9FW9lv1kvGjaW6tHIU27NwSTnoozW14OvP7RvtV1xWWKa/lJ3ZB2YUAAE+lWPGsNnPpVpZQtmSJFVp7h/38/wDFtIA+bJH6VnOT1SNqMErMxdS8Oabc+GbWOT+z7u0jVluJnTBiiGSGB68fzNeHapbT+C/EVrPp10RtxLFID8wHv7Gvb/JtdQhlsr2589NRtlW4ulyptQODGAOC3AJNeR/FU+RPBDuDxW4+zwOw+ZgB94/WlC+zHUSPqvwH4hj8T+F7LU0wGkXbIPRh1roTXi/7MV4ZPB9zA7ZCXHyj6jNe0Ct46nFJWZx1/wDLe6ZO2BGkxRj6FlIH68U/WZ7u0V5LWzS4RFZpd8ojKgD3ryr/AIXd4dmEkF5pd+qMuGBHH06V03gXW9N8cWV5dWE+ry2VrOImt7sjBbGQOOWH1qnqidiP413kqfCPVbi2DIZUi3AdQhYFv0rR8CeINN1D4SWz6nOiW1vCbG7PUqf4SAOuQQRW54i02LV9BvbC5jJhmjKMuO1fM/hPXLrwLrmq+FNZheZB+7aBm2C6jHKMjfwyKOVPfoaiV2a03Y9/0a+sfDGnaDo2m+Zq2j6jHI7ai43biOBHtUYBxnrjp61w2q3vh8+Gr3/hF9PMBuwxSG1j3SSEhsEKO/yk7e1U/DXxE07R/AF+vhtJzLZSyu1jqMgS43sc7sdGXntXkvirx1e3Z02/0yWG0eOQyl7NPJdJmGG4HUEEjPcVCTZvzJHJahew6hfpDpWnrZ+fHFC8aNu8xwQC3Pcnn8a9u+G7Dwv4vutO1C4Vvs11B5OEwAm8q/PqC4/WuK+DWnxa58ShrGqQwLHC4lit0GFkn6IoX0H3j9K9L+OHhd9H0ptY0mSaW6QM05c5+Qt82MehINXbS7Mb3dj6FsrvBKsQF4ANeYeKfEXiG0+KMll500OmFITZW0dtvjvQxxJuk/gZRk/hXOeAfira6ppEBv5PKvY1Cy5PDEDr/iKXxb8UbK0tZvJ1KLp8qqckn0rN3W5tFrc5L9pPUEubV9OS7t4ljVZ1jfJe4bdgqnpgcnPWvKvhVa3F3f6y8UTSrbaXLclM4yVKkHPY+9Yvi3WbrXdbe7upGmklyqJjO1c8CvZvgN4Ulv8AwZrAiKpe6y/2ZXfolrGcuf8AgTYUfQ1cF3RnUkeh/CRH1TTNJ1MTPazx2BcFTvYEuwbOfcc/WvRZrxotGdYLdY70wMyC1K7yuSWIz0+vqa8W0K+Hwy8UPpWpHzbZpmd9v3WglwHC56lWCn8TXp+qwWs8lpcRy+ZYm1eGFocKkqsQcFhyMY+77VM9y6bVrMg1PVEg1dEmj2SyQKQQDJ24Ldgeo+tfPHxoRTd28rMi3BUuyKMBc9sevvXquueLYrJ7y3toGjhaPYsrnPK/xe2fT2rxnxDcyeIdRubm6lzaxDdNNjiNB2HqT0AFREub0Lvw116+8Pw6VqdrK8BvbwaYSqbgwypwc9+TXsXw88P6po8/izVNT08XCXly7Lab8iZO7Fu2QelcrceCNS1bwfpttp8UsUloHv5zFgeVNIoMSfVEC59zXpPgLxDD4r8Ky2QuNmoJH5dwobDnIwcfjmtJLSxjTa5rk+jWEcGmNM0zRy307XVqLXnyyP8AligP8WPw61k+MY9zLGj+eZgZZWEvzONvV89CMYC1LqU93p2n28c0aX9nYWnlBI3KNC4PDg926V5v4n1iWFZIbVmgR0WaSUtvaVxnGfQ81jbZHTfqeY6hbQ/8Jenk4w0pAB+hzXrvhbVbu90jUvAJkj+yx28Sq5JDqJSCVJ9BmvLtB0Y6xrdhvBVru4EEBJxuZj8z/wC6oyTXp1/Z6jpnj291+KFxpOolbSFWj2qVjAMJz7lD+dbpaanK9Wd/4e8Px+EdZhsbGGH+zfs4RZUXLCZuMuSc4bA+b2rpby2EOp2kkJvJrgxx/uJHJihUkgyZ9e3uDWffvaaxoth4j0+WKS5YKZHLeWCqn5kf6ZIA9aq+JvEscFmkcfnDzEfeI5OVBU8Oe+M8Adqxa7nSpJrQ8d+MMU/mzwmGe5mgYu6oPMEShsZLdlG4DPqa4fwFfXWl6695bsCdMha/jc/d2qw3A+xBro/Fdhbm+jOkXN+IZo1jSFZGyAOocnqMjPNSeCdP+1aX4te0xO/2MaPbqE3bpJW3SEAdQFUmtIbGVXc9Ih1C48U+IrLWFdUuW0gtEkK7l3s+DjPQADqa7SG2hutLuYNQtLKMXK+aROu8SR7lG0v/AAjOc/UVwfwxtfszQ6VqVwLd7WGTS+F2l127kVgeRuU5Hrg11djFBHo0lkLuaC6MZjkjnTduKkkv7A8HHtSqMula1iz4gsbVtMtLe2jQWVqfNV95UqnIynOVwOPevnT4qLFc+JWkS2WElVBCksW9GH1r2LVfEcs9tDHqs9tNevACbiL5cKvIyo/iPbNeQ3xbUtRlvLomK1twZJnXBZB/CM92Y4AH41MdWOdrHX+B9d1DwfdWGi28tuLXV5JY5N4O7MeVyn5jP0r0fWtG0mO68ITLiO9gt93nEgKimPfz6/NzjvmuBudDv7afw/qAV5ovDtuJrh/J375ZW8ycZ9QrAe2K7sXyXBs7WK2juJNP/wBZKSCHj25ixn+8pHPbBrSeq0M6TtI7HQ1RdD06G0tjFKxAlTOHRmO4g56KeTXA+OxdxadqA1UWrqszBltMf6tRhd69eB6V1EOvS3NrbveNPaTR4lzEwxKe5fvgf3fSvLfiP4pgv4rhjFKtzn5TGcJk/ePuOKxjrsbPTc8m0eFJfHelWsIR0urtICFHylWYDj8K9b0mSTxxFLY+ILqa+tdHvJ4kt4k2FgilVQ+uOD715/8ACq3S8+JNne3ITytMSW9KoOpRflUf8CKj8a9K0Dw9e+HZbpdUF3FNf7tQZvus7jPnBD67G3f8Brdp2scya5ju9B1f7bb213bSSSQWWFmVYhukUHYyZ6nB28fWr1/arF5RMUStPGBHmPmIMwMink8dwO3Ncxo92tgskEdmZ7FWxEsMmxZ943Fxjk84qWTxG1toBeK3VnEubh3k3M2FOQQegHAFc92zr0Wp5r8WJIrmWeVmtnudwhVY8gLGOOP9r1/KuU+HRu7HTPF2p2L3EDadDCUltz86bpNpx74NTfEDXlvnti4Q+USqSIOcN0yB1J9q634c+E5b/wADtosAJ1LVrz7TeL5m39xD0TP+8fxKmt4XOao0db4D8Sx3z65p+o2Ek7x20NyHKb3YSRLktnoc/wA69H0y+F3bwpBqscSWMSboxCQ0S8fm56EdBXA6LaReHL6/t7xDFdoIrOZxJ82QCbfcf7rKSuf7yCtXQtUlsp53a3klk85TJL5YG7Ax3PDHp+tTNWZpTalEr/E+O+isVj0+XVhfRyPNNLAwRnyP3b7jx5YY8r3rwH4jIDqJkvZLeWWSMNI8K4HmYwxb0JPFe2+Ldf8ALtbiWZpLI3TtEtrI27OGByuOQP0rwDX7ga9rq2ljGzyT3BjaRm+8zNySfpzn0FTFNvQKjVj06zkl0+D4f2USea11onmXCl8FEBfBI75HT6V7J4vmWQW0Ea5Fw6FXhCkoq/Md2ezAc4rjtD8Jf8JOLvxPpssIWBUtrKIg4MduMKB7MQfzqW0ubLUprS0EzpdSrvtJC+0mBvlYj1kj5Ur7A96ucbrQilKzO3tZ7eXTIZ4J4ZvPUTEKDGsSluQcevpxmuI+IE6L4fR1tXtoA5LvCc+ad33SDyQRg1YutQudOvmgt7VY0gcxI8r5WRAONw+ma80+Ifi61Mc1uspW9C7QFbdtHYZ6A4/pWSVzaUkjnPAVsb34reHooV2mS+SZv9lQdxJ/AV6N8P8AVo7rxt4i1AM8umPfSmzj24bazEDH1KEV5P4F1SS21ubU4W/0wQtZ2iDlmnlGzI9lUkk19H6r4T0vwp4RtNQtWuYYYY0S5dfnMSkg+ao9VcBvpmtuXoc3PZ3NBvEEFjrrS3RhLwxlJIJZt2AxyG9Mjpj3qK01ULpnm75PLiWQs0g+Xc3HQ8kAHoK5M6rpmrXjC6ktYtRiYSHoUkIHyyxnoyHrj8Koa7rEVnpkdtK0bx+WY0cN+9APLMT7ntWLg0dCnFq5mfEu/sjJKunMzxeWI53dcfvB0A9gD+tch4Jcw+CfEsVqu+41++g0hUwSRFgvM4+gxz2rnfGniKW7nkjAcRZGw5+Z/bHpjvXpH7OOmX1/ruk3s0Qj0+0EqwLt/wBbI3+sk+gAC5raMWlqYTldnY+H7dNJ0K2023PkptVkIJONp2yAZ6kMAfowNVpLxEubqW5trye6tGVoUY4UgnBUH+8TzuPvXT/GaO50uRdTtlIsJF3PJEm57O4QfLMFHVWX5XXuMGvLdK+Kdh9idb2ForiQ5cowKOfYHkClOF3dFUqqSszuro3+hX9m97ZRvayK8kiRv/FjhRntzz614X42vBf6z9ntoBGGZmILZCbjzj6VreIvHAvlMFvPLufCgtJuYZPQda5m4sdRuo7yDT7fzJ0AF1du2PJQ+g649TThBrVhOpc9w/ZWvZLp9ajUE2cMiRxHHUgc/WvogdRXz18J/GfgfwVpC6dZ3t7fzRoFd7e0Y+bIeXf8+B7Cup8RfFq1n0O/j0vSddileB1S5aIJ5RI+/wAnt1rRI55as+br3VTaj55ARjuuKzrHxb9meVvtmowyu33rSbYuB0yPWvaLz4R+IL2Mo+u6POp/56WZU/pXOXHwA10M5TVNIY5+7tYCpdx6HCD4jaxbn/RPEOtAEcbps/zqlNqp8U61p03iLU9UuBGwQOsAeQLnOBjk+1drcfAbxao/dRaTPj+5OR/Ou1+DXwnjt3SbXJ40uZHaMKpyJGHVEbsAOpHWht3uxqPY8613wzbas93qGna5EC0hQQ6jCUm4GOcD9a5i08GapfXn2Kwmsru6EpV1huFCKuAQwOckf4V9L3mn2s+qWul6bJFplvDHJHI80QaXCn5kYtyD3B714Z4i8Lanf3Oo6nb6d5cdvKFXyDtlTGcEAdenJqVNXNXTaR6P8CPAX9k6hdavKxnaBGjExUhGkxysYPUDu3evUdf8zUY47c28LsTzDKf9YhX5h6cgmvGPgr8UL601uLw/4lujNayHy1kmGGgc/d57qehr6Iv9kMDTu8aLCDIzOOAB15rVWsc7vc+T/HPw61Xw7cy6p4XSa+0dycCIbpIPWORO+Oma4WOyu9VzPH4fuZHjfEjwbgM4zyOcV7B8UvEGs63cNJpML2GnzzfZgYZNkk8m3IEnvisywtNB0eOEf2tINTABe9hZmgRtvRgeGYnjFS5LZmqg2rnkljZ3+rXbQaZYSGRiQxjBP1LOegr6t+BOkyaB4RW91OUyy3TeUsgHy7VHAUf3fT1r58tbnUNB1DzpfNNncSF9jDZHMM91H8NfVvw78UWHi7QIZbeKOCa1wj26DCxnGPlH93HSmpKWxnOLW5yfxY8Jx+MEkS3U29+irJazPgKWI+7kdmA/MV4ppfjnxD4EupdJ1BpoHjOHtrhdw+uDwfqK+qdYfTtKs7q41GMR2HlfPJknbj+EDt7Y718yeOfGt5401BdMsraA6cCVSS6gDThPUvjP4Ck7Jjjdmfrfj+LUFkZ9MtJHxk4idfzBOK53T9Tv9dvolt4YJ4rdt8Vig2xA9mfHYdTmuy8TX+vXfhe70me4s7ywihiIZLYRSbBjaVIGWXpnNP8AhX4j0iz1K207xDaRxWRcFvs8YQuR0MhH3lz1FEGuhUlJbn0h4DtxZ+ErW2vZt11OhknduC7OuSx/Dp7AV89eM9O1bwJ4mfxFobuLGd8SsmdqP1w3ordQfevqCWxtrxvP4kWRVKlTgFduAB7EGuP8cXei6D4aN1fOgVE+ztazpvNyP+ebL6+h7U5IiD6HjUXxZtr+Jk1O2iWcgkuJPLYn3IBU/jiuS1zxdo8p3R2hkducSzFwPbAwD+JptzpsK62NS0zwfai1IZl0+aZpEYEdSf5AVna9c/YdQsLt/Ddvo0XkFJLdPnR89W5yVJqbRbuatySsX/h1dan4g8b2pgjyMiJpscQRnqFxwGI4HpzX1R8Q9IttY8FS6T5qxgKhi2HlSo4K/Tr+FcJ8AV8PahayTaYsUNzbJiO0QfLFuGDJk8ux9+lepS6bFb7HaTaqlAW25II7+2apJoybuz5RsfEereEJtQ8P64rNC2RIjglJFPRuOx67hzXUy/EWwl060jj0yFEjGxWhulbJx1OeRx611/xgTRJTJoLacdZunG+OC2bbLZnqMv8A3ec4rxLRvC8UPmHWPDd89ur4acymJ0z0G09ealxjszSLl0I/FPjZ7yGeCwiitFfO8wvvYj3ft+Few/svQSmyaR7RYIIsyxu33pGYYLn27D2ryLwpoen2esSz+IdJmmjEpWOQygwwkHrIg5IFfW3hjQ7KLQrRtPuo7hZVMrXUJwspK4G3HRR0AqrLdETb2Z5d8fdMv7LVZfEejAzI8CJeJGeRsOVlGP4kP6Gud0r4qRX2mi08RwSx3UiKVukwjN6NzwfrXvp0iE2d1byTxiRSJVcr9w4wWbPUEcHtivlz4lJ4d1TxFZWWjwXjzpJ5ZEEo+ynLchM8gH9KJJNajhJ9C/468R6ReWlw9vLPBL8qqzhEGR2ODkjHpXCyeIZLy60uytLUXMMUgdbdQVE8g/ibufqe1a3xH0jSLOztotK8NXOlzNNuln+1/aVljxwqnse9d38DdE8LaldR29kpt7plzO91JvmnUdUiPRR698URStaI5ye8j3HwHbgeB40vzEpvUdpQT8rFxz+HNfM/ih9Z8Da9FbyO4gjQxW0xJK3MIPETdiydvavq86VHAsrKyrEQ42AZCqcdB9BXK/FWy8PL4ckutdS3ewZQDCfvSkD5TEezj1o8mQnY+dG8cXlzdGS0ktXYqSweTa6nGDgH2rkPEur3NxO4nvVIYDEMJ3N+J6Cu50vw9pGp6nJr48LXF5oEiNGlmspSR2HSQYrkvES+G5PFoA0i507SQFWOxaUqwP8AEHfk8+tTaN9DVuR1PwR0rU5tWsCtk8Njcyq09y4x5iqfljT/AGd3JPfFfRPxh0i41nw9bvpFykeradOLi3bd91sFSD/snofrUfw00/SdR8PQ3emtGLdIxDBAjbvsyjHBP97jrXXx6fDHf/vGDCVWXYw+8D/Dmq8jJvU+OW8XXNpqLW2ox3GntayOPJBJERIwyFeu30qp/bk/2EQxarp6QuWJwzFj7kYyTXrfxT0zw/4j1mfT7LT4tUv7IfvNQWXyvs6/3XI/1hHSuLBsNE0O70hfCmmXeoQWrn7e2RcxK2cOVPoDxSajfXc0XM1dHnfnTLayXdgJbkrIIlvJRjazfwxR9S3v2r6O/Z+0O+0n7TqGvsYp2t0AjY/6iMfdT685P1ryL4U6toGiaui6nYQRXrMANRuAXaDP8Sr0/Gvrqy0nT5LCA2zeZAYwUmBDF8nO/PqabRDfQ8x+M3h+91GRdc8OoJ52h+y3Nq3AukHOz/eH3lPrXiGn/ErUrSI6ZfCSYq+Cki4lQjoD0ORX1jr1/pWg+H7ptUMnlKeIyf3krn7uz3Jx0ryfWfBOpeIpLTXNa0+GKVXBijtYF88DkhpCfvEYHFRJrqXTu9jwfxT4jbU2N1O96QhKgMCoXPbJqXwB4T1XxZqIntg9rpafLNdhSqop4Kof4nPSu68e2+r6v4Z08trWnahJbztKIZYVjfIyMEDuMdK6X4T/ABLtp9a03S/FNssQUCOCaJQsMcvYsg9ex7Uozv8ACOcWtWeu+BEtvD/haz0+KFhsGNi9EzkKpPrx+teQfFbwVrXmNfeHQ0sBkNwbLA8wMCcvEfUcggda+ipbKHySscMbNjaA3Qj0/U15Z8RPF09/cDwz4TWGG9iOLm9l6WWOu0+o7mqTsjON29DwjRNU8b+J7mfS7Swv725gj3tFL8jqucZ+asPW/DPiqXVbjTm0lzfwlFngidWlVmGRnn0PbpXo+keD7467e3Dalqj3FtK32nUJ2McDoAPnVgcsMnABrjfGlqNG1R7uO31GK588ot3I7KZABxhs8mpU7uxs6ckrno3ws+FR0WSOfUlSXV2ZFeKM7haIx5XPTeema97xJqUH2O4hjWzmjKFQp4G3ivKP2fviONVY+H9W8n7TjzLa5Aw03qr+rD1r1vxXq0eg6W+oyPymESD/AJ7OTwg/2s1Wm6MG23Y+Zfip8M5fD8z3ml6lb2cKkkW91IVAB5zCe4/2e1c7oOgJqPhC71e48XRQ3drFIzWLRElivQBz616h4p8A6z4u8Q2kvibVZ7aW8V2gjhi3pbEDIVvb1965m+8GWWl+G4dOWO9vI4WM9zqXk/IyuQAoX+QHNTKolaxvGjJrU4r4X+DdK8Rams2va194hl09FPmz/wCzuPH5V9Z6B4XbT4l8mKO0URJEkEXAjQZ+XP5Zx1r5H13RV8PXQlsnkexdyyMAVkVQcBs9ue1fSvwJ8bz+JdFm03U5DLqVgBtmP/LeI9GPuOhpppkTi4nX3draJp9/PqksEVqqDdMXyF29znv/APqr5K+Imi6Zqd99v8PaK9taNN5b3PmFUlJ6MI+qg17t8RdQj1rxXPoxDtYWMQkuVjPM8p+6uO+OwqpYeH9P0/SzcaoLi3t7PcW875JpHOBznjJB4x6VEn0RVKnfVnmWhW95YQhdP0LR47+1VZDcRwBiAOmQR1NcZpM8F54vvWv9Qubdbt2aZUQbt38ivtX0Nq974f0vStQttFeW0nQq01wIvNwvVm5Pzf3eOhNfPnxFsvOSLXNOsJbBGclPMcGRueCw7fSq9o76lSpdiXVrTXNLec2OrWv2LqjxzojMP90HNc3PeajdR7bjU5GboAZWbP4V9Q/B/wAIeCvE/gbTdXl8O2Ml9IpW5LlnPmjqeT3616XaeEPDtnj7LoOmR46Yt1P860uc+iZ5p4D8eWniqy0qW1lEU7XAjnhzzjaeK9AvWK2d3Ig2yJG7KSM4IUkGvgnQdYutEv4rqzdhsYMUBIDflX1X8PvFuj+MdDuJIZrmK8igYyQGduu08YzyKE+ZEuPKzvX1CG30OG8umUeYkYJ6Au+AP1NZ0VyLDXDDBpy/uYwgmdguXJ+7Gvc5P5VyHxke5t/g009pkTW72svHbawOfzxXU+DPFWmeI9L0vXk25njMMg4/dTdwfTPY1FRo1paajr+8tNO16K2NrIbiSORTcXEWUuiOdu7rhecVyXiGK20eO1mvLmUTtAyeXAw2EF88DvwevpXea5bxXcplSaYNZMxWOQfISy9QfYV534k1O30rF/MwngjgaNZXIY54Ik+h6Vhy3Z182h84+Moxpnie4MUgYJKSCpzweRj86+k9X8ZJcfDG1CTR3GpLAvnx55+XgbvYkfpXzTcW83iXxLZ/Z48Pf3YVFAxgFufwAyc16Hpmo2Fl4ojsWkePTtSm/fysPmADsqMPTAJrVO0bnNKzkeqaLZnUJLu2MukRrpyJI0ssRzNKQTJ9RziufbRY9Rs59RhU2LPGJDC6ghyDyNpGB6gjmvRPEthNpctvPp2nrc3DMSseOMbeST6cZI78VRtvsmoaUupXVvAzbDIU3E8ZO4Y6VlJts6otJHlHxA023m8LX1zMCb5CskEr9DFgYUdh3yK5/wCDXiqbQda0u7EhFlJeCxuVPQo4+U/gSK6z4teILHUtBltbIp5jMDjb90Ht7niuC8JaEL3SI9OB2T3zT3FuAfvtGoCAf7zA4+lVTsmY1Vc+jfikTqFxZ6Ybr7PbKpuJXwWyR90cfpXOeGrJLPV9P8QXti1xY2cjsBBGFIdl2j5SOcZ9eScipvCDmz8Ltpd4VuNdttOQyxSHzSGMjcH16rW3ojW95oM9uzIJI4Gee2m3LJ5gkxy3Y8cEe1OpJ30HRSUdTlNRvpPEfjA3iaa1lp6yCGGO4hOWAVvMJUdM/pivE/iZapp2txy6aNiMxIAxgMPTnpivoWVo3iaVb25kumcRMrjEkecHCv2XAOT3Arw/4smCTUo4rYW3lqzMxiO4bicnnv8AWpgy6iPcf2c/GkniLw5Ppl65N1YAMjH+KI/4Go9b0dvGut3l/e3KR2kEjQWULqSrhB88h9gT/OvCfhZrd54fuILnTrgxeb5n2yNeSLdWXcRnqeSAK+g7S4im8NaMLMI3ntxuYgkyZyMD2JzWtT4TmpK0jJ0nRdJuLJpk067zaqPMm80BRLu2/Ko/hP8ACppPEnh3TNTtJUks1fU47YwyI7YLseu7P8S8c/lWvZhIIXis7mXNvdSvEqthFRByCcnOTzk9TWZdXK3Fi+oakWmhnkMYmRdpb5MEuRwDngEfjWFzsaSPn7w9rGo+BPF/m2MpT7PNgpn5Wx1B9QRX2PL4mguPAv8AwkFmBsntfNRTzhsdD9DXxT4wcvrE5G5wXCK/XJ6c+te4fDnUp77Q7nwldc2ME2IpAcZ6bxn2JrohJ8pxSiuZHoXwj0OO1jl1XUrWOTUL0ecHaUFkXsNp5pmtWl9DresXuu6TaJaw3kZtpy25r1Su05H8IAPXHar2vvZ6dptnAFIvWu0jWaNeVXPXP90KDxVHXdVkvltHMyIXhll8uOJpZPLBwCc8bcdutc7bOyMVueRfEnSbTR7i3k0qaYm1mZo5ICCFDclW9VzxzXS/ATxoLfxINCdmSw1FWeCMn5YZx94L6BvSsHx1fQXmlyxJHHJeNt2PE53Ki9N3bH61wfha5ksfE0N7ASZbBDdqnqQQAB9TxW0LrY56qTPpn4unUdWtzomj3C2wFu097N/GIycBB9eSR7VzPw78H6Na2Nvc2ztJe2u9GleEGFl4wwPdzkEelWtK12XVm1jU5ZGivrkRosURH7iXaRhs/wB0kce9N+HEif2OY9bihayhhkt9o73Ic5xg88AEt9Kmo9bMujFKN+pPrfhq21q5iluLSO20OOGQSIBsm3nHzn0UnOK8A1cXngnxHjSZy9i8onik/iRlOMqfXsfUV9TagJG8LAK8DT7dsk1w2fJZRlUJ7j+pr5u+JyWD6pBFp0PkNBb7bhACFDk549+tKm7O6HUSa1PqT4ceLYPFvhG21RWCSqDHcr/cdRz+B6j615teWMHifVNa1vxQsq6HGrW+l2ag4ZicB/YEkc+9cJ8LvEeo+G9G03T7eOFrPxAs5dnzuUx7l+T36V6N4kvRc+Arb7RdXTNut0hS3BEcqnbuXjr6c1rOVttzGjC8tTq77RYdDt9Ga7vHPkqqm2CgLjac7QvcfyrzPxd8OrHxFpVxfW9iLRyHkW4EnmtK2emfSvQrm8XydmmzpI0UMcfnTRlnEjHayL3BA71m+KdWgs9LaOS5naWG2a4LQJtMAXKZI6ZP9M1ilrc6X8Njwz4M+M7nwd4ohilLrp88oguYWzyCcbsdiD+lfUvj+/ddLt7Czk2zahIIxKoyY4+rOPfFfF7p5+s2Zu5WiM84MsjjkZPLH8Oa+gvC3ii68R3unC/XyZbeIi1YKRuj2/LKfUEA8e1bvSNzk5VzHQeDfh5b+HNRvdQt2k1C7mD+SzDO3byFYHA5/PNVvEvh5dT1mLUJWuUv5UKRwJCqPESMYOfvKcYJPGK6Ia8BfGycCJVnYGSViDFIADlSOuQeFPOTUfifUJbV2itZL+L7QhY37sMAkdCP4cdPrXPc60fNHxG0P+ztRMy27WzqdrRsPm+8Rk+2c49RXq/7MfjGeaS88M3kjNGi+daBjnZ/eQe3cVy3xi0qz0tLMNNd3N5cOGnd5NysOxP9MVxnw31K4sL2+n0xvL1Z7yGGwYkBS+G3Bj2BWtoaI56sUe8+LEufGXjm/W0KXFt4cEbfZXk8pXdjy2/oCMd69Gn+2Wmg6dHLPNvI3XFxIys/QnywR1J7EDoK8rFitxpmsFYJmmuX/tCf58JuVQQD/ez6HjmvTdC8R6ZqWnG9imUrBCq+WxA2fICVI6fjWcnqzSEbRVjyf4kaTBqPgOztvBSWtvFFKz3TSbfOyAThmPOS3U14f4nhvIbOw1O5wtzOpZzGfvEHG4flXrHxEu9MOpzvcJ5McgYOmCN4J/hxjOB+tebeO7u0Gn20MBlazt4/LiaRcNjsCP60Q2sXVtufTfgPxVNdfCa21K5l33kNsE3nqxIwp/L+Vcj8P/Cd4sNomoWsV0daaWbUJzJsa3t1Y7VXuzM3J+grzSx1s6dZadbJceUul6fBbzwhzi4aUEg46fLXsst1NCbTUbm3guYo9txuLlEWIr1BHcccd6urZJIxox1bLlzZzNDBptlMXgltvJuWllAjeNckDHUNjg15Z8SI31GymnkhaWawxN8o2xKgz9z+9jOCT6V6hrp0q906TUrbUGRXKN5qEBMNyYwe5HU+5rgPHTy2NgFtlgNvdLsKMxO0dSMdhnn61l1sdLd0eb+BI1Xxbob22Umkv4gkmcHLHkfTNfTs2o6f4r8baXbQTrPFpLzyXCYOFuE2rtIPcZr5N0jUBpniXQ545UMkeoRy5b7owwx+pr303cPhP4twWweOKXW4prlnY4HmyMAD7DKj861Wxyte8meo6NDF/aOo2qW9wA5kLXUrMTk4yqE9B9OK5DxUs8d7BZykyFy0UbswWORMj5SOmex7961bJbqH+0Irma6a9KP5LM58sFmJC4H8QrG1e7gunt4rVPPb5oVjU5S3k25OWPqcn14rI6I6O54/8YdFm0i60+0uQkkkkRMbRDAADfMD+f41e+F2vDwnpOs6pGsUt5aLB5Fs7YM5dirIo6k4549KyfHMMsVzu1S/lu7iDKrLK3ATGce2K5zQLie+8U2h0u2e6ltit2I0XL+Wp2nj1YMeKuL7GVTU9r8BtLc6x4i1fYouJpldJHz8nAyV9+1GveIo9TvUsZNTLTORHsuIw4QHksTjGD+hqTwFqcctlf6fdwmLVrKUrPbONriIn5Tt/nW1o9toUc2oTXK24vJJMs8x4aPHAX0A5/GpcZJ6mkJRsczc2VxeaO/2O180JIFRVkULbgrhlXHUHG7PcmvJPG0l1FoE9pqECJdRTEs4OS5A4z+FemPPZaALi6a6Jh8x5LdHOBg5wT+B6V47rWpLqbPfzxyx6TG52BuXupAeFX19z2FEE7iqTPfv2X7t4/D66Y+OI2kKjs2Qf5Gvcq+bf2RLa+uLjXdYu2bypztiU9Mk5Yj26CvpGTlGHrxXRHY457n5pKQwHI/Cr2kapeaNfC602d4ZQMNtOAwPUGsK3nKEA9KvLIGwR0qbWLvc+pfBfjbS/iF4PvPD1+ywXstv5QjY9SPukevNeO6NrGq/DrX7zTrlWbTZH8u4gcHaw/zyDXA2d3PY3cdzaStDPGcq6nGDXquk+JdK8dRJY+Jitrq6DbHdbcrIPRh3H6jtVW5ncle5p0NmXxJq9xG8nhjX4LiArlba8k/eRnpwT1GPWvOPE9z4kv2C6q6eWv3gsgWM+5FdHq/wq1WAmWyheWEnKyW37xSPw+YfiKpWHwt1q+mHnRXKx5xulUoB/wB9f4GpUSucx/AtxKviq2isN1zcurRB1HCgjBVfbHU+letePPho1n8P7TW7OOU6tZxq0sO4shVWJYAfRgcexrr/AIVfC+Dw7Kt7corTYwpx/KvXGgjmtngcDa3TI4z7+1VboRzaninw7+J+n6poUNlrtzJA8cYgW7Y5Ur2jlx0I6BuhHWrWsaZcyWzNp2yaxB3QQ28oKJ6nIPNcn8RPg7qen6jcaj4MUvGxLPYK2Hjz/czwy+3avKbtNX0/fbXelX8MuecxyRnP/AeDWbiuu5tGbWx1fiWFob5m8QtbW1qDhba3cSXU/ooA+7n1PSoPh9qMt98YfDUbrHEjXSqIIvuQRhGCRg98ck+5NZGg+C/EGtKrWVhcWMDf8fF/egogHqM/MfoK9U0XwHB4T8c/DOe3kd1nvZUfevzykRk7z6ew9K0iktGZznczvH+vzeFPj3dSwKrQtDFG8ZO1XVl5BP8AI+oFeiRa/YMkd1bOs9sATMJPlfOOFf3zz/KmfE/4Xw+KdU1jV5pijuqQKAmTCVHD+47EelfP+vW3iLwjcGy1y3lQAbYrgMdjr22yDgj2NS4X30KjO2x61478R2zX9tdWNyYPKjYSAAbZAR90ivD/ABFfS6jqkcduFZphtCxjAH0HYUy6vI5Ixcul6EPy53LsPtmr/hXw7qniaZodGtmtLHG24v5AdqL/AL3c+wpQgkOU2XtI8O6jqaFdK0+W4t10uQQunAASQb5Ce/PGK774S+JILnRX0u6kRLmKQpbzSjOGHOzHY9x68ivavht4ag0PRrWHyWWBYBbxo4+YRY5Le7Elj+FfPPxT8Eaj4K8W3V7p6K2m3b5G/wD1ZJOdrHt6g1UlzERk0zvdQleA3XkySJE8xkP2fAJ44Uj2Ncvrvim6t9AaxEYCFSz+Z/eJ6j+Vefz+LGubbZJf39jKOzL5qn/gQ5P41mX2pW9w7+dfXF0rDBWOMrn2yelRyNM1dW4pmgm1COZlJt4nWSQg55zwv1JruoF1vw7oMPiMW0htFu5jNKsgKHe69R17d+lc78PvC954z1u1t4LZrfRreVWk2ZIz6Z/iY/oK+sb/AMHWN34NvtDaEeTMCSq98jBx78Aj6Vduxm5amFa31t420S2a0uDAiBZSUb5lcDgD271l2E974eW7mWO3vFlO0K7+UyMp657rz09a8X1m21j4Z6uloZ7nyHBMcqjCsM9ieD9D0pt98SdTuoAk7o5AKqTBggfgeazcHuaqrZWNDxGq2VtdvNcrJcXDmSZl4Qc52j25rlfCxn1DU7+OziyZIldgzbSsauDwfUnHFZV/q95qk8auJLi4Y4Vdv3ifRB1r3L4MfDW5tFubnXIj9pulQzI3PlIDuVD/ALRIBI7AYq1G2xnKd9zD0W8m8LeONVsNahaAXmJ2jm+bGSdsg+nQ16fpklta6vJe2tlbT21xDh7NThUbH3wenPeqXx38AXOufZNa0PI1a3UmNc48z+9Hn36jPuK8HsvE2pWkzWokvLO+VthgCZGfTaeV/lRKCbKhUsj3PXtVjbwjLBCi/a3BSWOXJRlDfdHoRxg14R4yvxNK4iRmnkyAudxH/wBYVS1/VdUnvDHqGoyxvGxBhMbBlPqVp3h7RdQ8Qas1jo0dy0rL/pV5cDHlp3J7KMdupohDlFKfMekfDC6Fz8H/ABlfeWpl0KErZOygtDmMklT2yefxq94J8TN4j8G6Vp0t2YbizCswTgzKp+Uj+R/Cp/hv4dnsfhd8UtHEUqySukMKScM4aP5T9TkH8a8/1Dwlr/gvRre8nsZzaI5S6iP+ss5B0OR0BHIPQ96rkTViYzcXdHr767aLYzfbElNwrKhuEJJj4xtx34Lc9zXI+PPEInubZIpZEjjiIYlv9eWxjf6nqa4O58TyXNm4tdaeEuP+W9vlh/wJeDWARJcobf7ddajtBcpbQnPqSWPao9m1qzV1bodZxy33iAs7GRmuFhXPRnc4CD869DSbUvBereE57i2mgb7OY4mdwyzAMwZB9e2am+DngK/1XVLHWtQtmtrON82MDDBdu8pB7Drk9Tiva/i18P08T+BoLK0jJutOPmQBThiO4B9e9WlpYxctTmrzVLPVdEk1G02zASowTzMNLjrkdn7euaq33iKdrOVlmSCFBt+yyJnzcDG1j6EfrXismpXGg3s9jrEF55qHH2qA+XK3pvQ/K+PXrVO41qxnkYz6rrbpwdgt1ByPfNZ+zbNfaFjxv4gS81O2jWOQkR7Il3Fyp6bV/wBmovBtheXmvafpOnJF9thuEnlJb92jlgApYdOuPxrKgknv9RS28O6fOLub5BKx824fPpjhK+mfgf8AC8eGbFrzUQGvpsNJ3Absue+PX1NWo2IlLqct/wAJFceGrqfwf4iMcd6EQR3Ck+U6knAJPPHKk+wrVlaO1tr6ETtaPeusg2gGP5QMfVTjoK6X43fDVfF9tHqFk6wanAu1JG+6f9lv9k+vY185ajeeKfCkx0/VYZ7Ro+AlwhMZHqrdCPpUypp6lQq2Vj0Lx3rcWr3Udzqq26yIgVYkbemcY3KO3415J4ouluZjJI5eFMIo9cf55NR3esXmoTKMRM56KgLE/gK9G+HPwh1PW7yDVPFFvNbaduBjtpBtmuj2UL/CnqTS5bA53NT4f/DCTxF4G/tn7XJb3s1v5zQPHuDkOSuD1AIFanw58dRW2ltoniKJmgt3aIyBdz2b9Crr1Kdw3YHFfQmgaYumWCwhUBI+ZVHyjjG0ewHFeQfFT4RHUNQOseHrkWGpnhXJKxzeiuR0bsD3FW1dWZnGdmZNx/Y1xpwv9LvrOa1JJUNJsCkHB/d9vXpXB+OdcgkuEis7htVuwuxBEfkjX3PpWXrPhTxtp8jDUvC8k75x56W4kDf8CXrV7Q/hj418QuqXFn/Y+nn78lwBEoHsg5b6VCppGrqt7nE6RYSapr1vHAUlljnimuJ84jVQ6jYv4/nXrn7UNrdf8LK0OaxiZytiqBV6sdxJUd845r0vw78OvDvhDwtcPMFe1gT7RdXlwOZWUghvZR2FX9Hl0Tx14zfVLG6jvrSC3jijlVPuSjJJGR1xiraMuY8q8I/FAO1qmsLc3Qh4aWJgJj/vqcbiMYyK1tS+IGkvbzC1s7+a5MzTDbCIlPHVmJx7ZrqPiH8FdI1u9N7avJp14xJa4t1yjH1dPX3Fcno/wG8uSf8AtTVoL2F12xkB02H1IB5+lHLF9CvaeZ4/4t159SvX89IXZnBS0hcyKG7F3/iP+yK9x+Anw5u9Gjk1fWkZdVvlEjq3DQx9VU+jE8kdgBXT+BPg9oPhi5ju4ke/vk6XV0BtjPqi9Affk16lBClum1M8nJY9SaXL3JlPoeA/Hzwfqll4it/GXhiSWC7ZQszxdQ4GMkdwR1rzpPilNJCYPEWh+dcjrNaSeUxPqVPFfYlxDHcwNDPGskTDBVuhrz3xB8KtD1SRnNnC4Y52n5SPxxg03G4ozsrHyfrHifTrmSSS20S6mmfgnULougx/sjrWn4I8F+IvG2qxT3LSW9mg2mTbsREPVUXsMV9HaX8INBsZhKulxFweDJIMfoK77TtKtdOiRY441VOVVF2ov4d/qadug+fqVfA/h+08M6HFZWkQiVVAwBg496XxZ4o07w1pc19qVwkccYOATyTXP/Ej4h6X4L0x5ryUPOw/dwqfmc/Svjr4geOdV8bai1xqEhS1DHy4AflUf1NWlYz1k7nn9SwylOO1RYoqNyjTjYOoYHFSFeQRkEdxWUjshBBrRhm3oMjBo12KPV/hn8WLrw/cRWWv7ruwBwsp+8g/qK+nPDupaTrdtHeaYY5lcZBzuIr4SGGHIGKvaTrmqaJMJNNvri3HdY5Cooi+5Modj793YIyDn6U7II4zXy74U8b+ItSsw0WqXiOMDLTH/A11aeJvFttH++1Muc8MJuf1SrSv1IZ7wTHIgSdQ4H3T0YfQ1Wns1nYAXUgA6B1DYrwab4na/YEm4uHlA4P3T/7KKdb/ABovzwyMT7xIaJJbMV2e6Po9sGWS4Z7llOV8z7oP0ry/49ySxXvgV4J5oJDqMkfnQnEkYZQpK+hwTiqlh8XtQmJH2W3YD+9GR/JqyfFGvS+MVs5bmNLcaNINQHlg5f50BHJ9KT1V0VHfU9j+H1l/ZlhqFqNQ1DUU+0bvN1Bw8mCg4yO1aF9otvcRNEqQvbN962uEEkZ+meleaQ/EmPTtSv0h04ywSlZgzPsYHaBjAyO1WP8Ahb1ssYd9Jm59JRRZivY35fh5ojZVNE02Nc7goXKBvUL0roLDQoIvL89Y2EX3IY0CRr/wEVxY+K+n7QzaZdAYzxItKnxd0neVOn3+Rx1T/GnawXbPTelVdW0201a0e2voUliYFSHUMCD2I7iuKT4naSy7vsd+BjPRP8atwfETS5gMW18M+qp/8VRawXOI174AaFdXLy6dcXlgrHJjhIkT8AeR9Kr6V8ANGt7hJL24vr9R/BJiNfxxXqEfi+xblYrof8BX/wCKqxF4ms5eAlxz6qv+NTyXK52S+H/D1jodrHDZW8MKRjaqRrhVHt6n3rZUYwRxXNXHi2yhvIrdorks8ZfcFXsQPWrUPiO0l+6lx68qP8aqxN7k2s6DYazbSW97aW1zbucvBOm5SfUeh+ledah8C/B08jvHY6janOfLhuDs+gzXop1i3wDtm/75H+NSR6zA3QTc+w/xqbX3GpNHLeF/hroHh59+jaTFay97qc+bN+BPT8K7W0torWIRwrhAc+5Pqagj1KJj0k/If40438X91/yH+NCVgbvuXJYo5oWimXdG3Uf1HvXIeKPh5oXiUZ1jTYrxwMLcJ+7mA92HWuj/ALQizjbJ+Q/xqQXa4zhqfLcV7Hk9p8E/DNjrVtdw22qzvCfMUSXGVVh0znrXotloEMbO0sMUUbv5jxRgZkb1c961orkOzH5scdabJcqDjDflS5bD5jzV017/AISvxRFYWumnRLjUrYXU80pWZcKmdijg9sZr1DVtPivS7jasxBQsyhldf7rjuK87F6sdx4vldCVj1O2I9eVWu+/tKPYrESHIz0H+NMGzzTXfg34X1C6aWbQZrWRjln06fajH/d7Ve8I/C7Q/Ds88ulaZcLLIoV5bqcsGX0I7/Suzm122jGSk/wCAH+NZ83jGxgLbors8dlX/AOKot1DmexvWNjHagsDulbgsRjj0A7CrYJBBHBrjE+IWlvuxb3wx/sp/8VTJ/iHpcPW1vTxnon+NC8hF3xb4F0PxOmNRsYZG65I2kH1VhyP5VwS/APw21w7Ml8IweEWcYP410Q+KelswVbC+yeeSn+NSTfEizhVSNPuG3dMyAUWsO76Gj4U+H+h+Go9mm2MNvnhnX5pXHoXPOPpXXRqEAVQAqjAA6CuW8F+MrfxNqN9ZR2ctvPaRrKxZgysrHAweuePSutCn2pJA2xpPbAIPBB5BrPvdLt54TFtiaLtDPGJUH0z0rSIx1xSbc0WYjDsfDtlYlWtLTTbdx1eG1UMfxxWtFbRxMXGWkPV36/8A1qn24pyjkCgLjFPUenWhypVkdVZGGGVhkH6iq9tPnT5Lojs74+meP0r52vvjdq1w8S2oa3dzyoRCv0zjNAH0GNOtT/qJbm3XOdkcnyn8DU66bbjEhEk5HeQ5/SvniD4keL7wExXcSLkEDdtwPThatya/43vI90eqpET2Fw+P/QKdkOzPcvEB/wCJNdbkBQAZDLlcZHUelYPhBl/tnUH+Tcs5RiqBBwg7CvHtW1bxRplibvUdRhuI4cMEDO2988bsnke1c9D4r1TV768llufsep3E4neW2jzGYwgXbsJHORnNK2thrY+s/NVPmeRFz6sBVWXU7CIlpLyxTHUmVOP1r5P1HUpAzG91fUpeOQkKKP1JrHfxBpyRlPN1h1IyRvjQH8hVK1xcrPrufxXoVuSJ9b05T6GYGqcnjfw1GcHV4HJ/55qzfyFfI/8AwlGmEALZX8n/AF0usfyFPTxCkz7bXTYwO3nXMjf1pOwKLZ9Vy/ETw8nCz3Un+5bsP54rNvPiroFuwVYb+VmGRhUX88tXzml3eeSZhY6UB7qzH9a0Lk6tb6c9yF0uNFAOEg55/Ci8egcrPaZPi9ppD+Vpso2n70tygH14zXnnjf8AaCa2SS00jToWnIwJTKWC++MV4v4l8VarLPLaG42AfKfLUKP0rkmyWLOdzdyaG10Go9y7rus6hr+oyX2rXLzzsc5Y8D2A7VnMQB7UrMAM1QnmYtgcCpW5R//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Minimum inhibitory concentration (MIC) determinations can be made using standardized panels of antifungals in a 96-well plate. Wells of broth are inoculated with a concentrated antifungal solution in serial two-fold dilutions. All wells are then inoculated with a specified amount of the fungal suspension of interest, suspended in an equal volume, and incubated at a given temperature and for a given length of time. The tubes are then examined for turbidity, which represents fungal growth. The MIC is the first well that is clear or that shows a significant diminution in turbidity relative to the control well. For example, the MICs for rows A, B, and C are observed in A9, B8, and C9, respectively. Row H is the control well.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael Pfaller, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_16_3337=[""].join("\n");
var outline_f3_16_3337=null;
var title_f3_16_3338="Diagnosis and differential diagnosis of systemic lupus erythematosus in adults";
var content_f3_16_3338=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnosis and differential diagnosis of systemic lupus erythematosus in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/16/3338/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/16/3338/contributors\">",
"     Peter H Schur, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/16/3338/contributors\">",
"     Daniel J Wallace, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/16/3338/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/16/3338/contributors\">",
"     David S Pisetsky, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/16/3338/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/16/3338/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/16/3338/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 4, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic lupus erythematosus (SLE) is a chronic inflammatory disease of unknown cause that can affect the skin, joints, kidneys, lungs, nervous system, serous membranes,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    other organs of the body. Immunologic abnormalities, especially the production of a number of antinuclear antibodies, are another prominent feature of the disease.",
"   </p>",
"   <p>",
"    The clinical course of SLE is variable and may be characterized by periods of remissions and chronic or acute relapses. Women, especially in their 20s and 30s, are affected more frequently than men.",
"   </p>",
"   <p>",
"    Patients with SLE are subject to myriad symptoms, complaints, and inflammatory involvement that can affect virtually every organ [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The most common pattern is a mixture of constitutional complaints with skin, musculoskeletal, mild hematologic, and serologic involvement (",
"    <a class=\"graphic graphic_table graphicRef70386 \" href=\"UTD.htm?29/29/30173\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/1\">",
"     1",
"    </a>",
"    ]. However, some patients have predominately hematologic, renal, cardiopulmonary, or central nervous system manifestations. The pattern that dominates during the first few years of illness tends to prevail subsequently [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The approach to the diagnosis and differential diagnosis of SLE will be reviewed here. An overview of the symptoms and signs that can occur in SLE, discussions of particular sites of involvement (eg, skin, kidneys, central nervous system), and the treatment and prognosis of SLE are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/31/41464?source=see_link\">",
"     \"Overview of the clinical manifestations of systemic lupus erythematosus in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/38/41578?source=see_link\">",
"     \"Overview of the therapy and prognosis of systemic lupus erythematosus in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of SLE is straightforward in a patient who presents with several compatible clinical features and who has supportive laboratory studies. A good example is a young woman who presents with complaints of fatigue, arthralgia, and pleuritic chest pain and who is found to have hypertension, a malar rash, a pleural friction rub, several tender and swollen joints, and mild peripheral edema. Laboratory testing may reveal leukopenia, anemia, an elevated serum creatinine, hypoalbuminemia, proteinuria, an active urinary sediment, hypocomplementemia, a positive Coombs test, and positive tests for antinuclear antibodies, including those to double-stranded DNA and the Smith (Sm) antigen.",
"   </p>",
"   <p>",
"    However, SLE can also cause isolated cytopenias or single organ involvement (eg, nephritis or pericarditis) or may first be manifested by an incidental laboratory finding, such as a biologic false positive test for syphilis. Such patients may subsequently develop the characteristic multisystem features of SLE over a period of months or years.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Presenting clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;SLE usually begins with one or several of the following features [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/1-7\">",
"     1-7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Unexplained nonspecific symptoms such as fever, fatigue, or weight loss",
"     </li>",
"     <li>",
"      Photosensitive rash",
"     </li>",
"     <li>",
"      Arthralgia or arthritis",
"     </li>",
"     <li>",
"      Raynaud phenomenon",
"     </li>",
"     <li>",
"      Serositis (pleuritis, pericarditis, peritonitis)",
"     </li>",
"     <li>",
"      Nephritis or nephrotic syndrome",
"     </li>",
"     <li>",
"      Neurologic symptoms, such as seizures, psychosis, cognitive dysfunction, stroke, or headaches",
"     </li>",
"     <li>",
"      Alopecia",
"     </li>",
"     <li>",
"      Phlebitis, arterial",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      venous thromboembolic phenomenon",
"     </li>",
"     <li>",
"      Recurrent miscarriage",
"     </li>",
"     <li>",
"      Anemia",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    SLE should also be suspected in young women presenting with purpura, easy bruising, diffuse adenopathy, hepatosplenomegaly, peripheral neuropathy, endocarditis, myocarditis, interstitial pneumonitis, or aseptic meningitis. A positive Coombs test, hypocomplementemia, and immune deposits at the dermal-epidermal junction on skin biopsy are other findings suggestive of lupus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Laboratory testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory tests that may provide diagnostically useful information when SLE is suspected include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Complete blood count and differential",
"     </li>",
"     <li>",
"      Comprehensive metabolic profile",
"     </li>",
"     <li>",
"      Creatine kinase",
"     </li>",
"     <li>",
"      Erythrocyte sedimentation rate",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      C reactive protein",
"     </li>",
"     <li>",
"      Urinalysis",
"     </li>",
"     <li>",
"      24-hour urine collection for calculation of creatinine clearance and for quantitation of proteinuria or",
"      <span class=\"nowrap\">",
"       protein/creatinine",
"      </span>",
"      ratios",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Autoantibody testing is also indicated. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Autoantibodies'",
"    </a>",
"    below.) Those autoantibodies that are routinely assayed are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Antinuclear antibodies (ANA)",
"     </li>",
"     <li>",
"      Antiphospholipid antibodies",
"     </li>",
"     <li>",
"      Antibodies to double stranded DNA (dsDNA)",
"     </li>",
"     <li>",
"      Anti-Smith (Sm) antibodies",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Measurement of serum complement levels C3 and C4 may also be helpful, since hypocomplementemia is a frequent finding in active SLE.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic imaging may be valuable but is not routinely obtained unless indicated by the presence of symptoms, clinical findings, or laboratory abnormalities. Examples include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Plain radiographs of involved joints",
"     </li>",
"     <li>",
"      Renal ultrasonography to assess kidney size and to rule out urinary tract obstruction when there is evidence of renal impairment",
"     </li>",
"     <li>",
"      Chest radiography",
"     </li>",
"     <li>",
"      Echocardiography (eg, for suspected pericardial involvement, to assess for a source of emboli, or noninvasive estimation of pulmonary artery pressure; and for evaluation of suspected valvular lesions, such as verrucae)",
"     </li>",
"     <li>",
"      Computed tomography (CT) (eg, for abdominal pain, suspected pancreatitis, interstitial lung disease)",
"     </li>",
"     <li>",
"      Magnetic resonance imaging (eg, for focal neurologic deficits or cognitive dysfunction)",
"     </li>",
"     <li>",
"      Contrast angiography, which may be valuable if vasculitis affecting medium-sized arteries is suspected (eg, mesenteric or limb-threatening ischemia)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Biopsy of an involved organ (eg, skin or kidney) is necessary in some cases. Typical histologic findings in various organs in SLE are discussed in topic reviews devoted to the particular sites of involvement, such as the kidney. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/3/27706?source=see_link\">",
"     \"Diagnosis and classification of renal disease in systemic lupus erythematosus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Other tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other tests that may be necessary are typically dictated by the clinical presentation and associated differential diagnostic possibilities. Examples include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Electrocardiography in the assessment of chest pain that may be due to pericarditis or to myocardial ischemia",
"     </li>",
"     <li>",
"      Tests to assess for pulmonary embolism in a patient with pleuritic chest pain and dyspnea",
"     </li>",
"     <li>",
"      Diffusing capacity for carbon monoxide (DLCO) to assess for suspected pulmonary hemorrhage and to estimate the severity of interstitial lung disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Diagnostic criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;A useful approach to detecting SLE and differentiating it from other systemic disorders has been the use of a questionnaire (",
"    <a class=\"graphic graphic_table graphicRef51827 \" href=\"UTD.htm?15/41/16027\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/8\">",
"     8",
"    </a>",
"    ]. If three or more questions are answered positively, SLE is a possibility, and an ANA test is indicated. Testing for antinuclear antibodies has replaced looking for evidence of phagocytosis of nuclear material (LE cells) in a blood smear (",
"    <a class=\"graphic graphic_picture graphicRef62681 \" href=\"UTD.htm?41/12/42191\">",
"     picture 1",
"    </a>",
"    ), but LE cells may still be noted incidentally in body fluids such as pleural or pericardial effusions.",
"   </p>",
"   <p>",
"    Most clinicians rely upon diagnostic criteria for lupus that were developed by the American Rheumatism Association (ARA, now the American College of Rheumatology or ACR) (",
"    <a class=\"graphic graphic_table graphicRef73334 \" href=\"UTD.htm?2/47/2813\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. These criteria were developed for the classification of SLE patients when SLE was compared with other rheumatic diseases for study purposes. The criteria were established by cluster analyses, primarily in academic centers and primarily in Caucasian patients.",
"   </p>",
"   <p>",
"    Whether these criteria apply to other populations has not been established, although they have been used to demonstrate that the frequency of SLE is higher among Afro-Americans, Afro-Caribbeans, Anglo-Asians, and American-Hispanics than among Caucasians [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/11-13\">",
"     11-13",
"    </a>",
"    ]; SLE is rare among blacks in West Africa [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis of SLE is made using the ACR criteria if four or more of the manifestations are present, either serially or simultaneously, during any interval of observations [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. A positive LE cell test, used in the older criteria, has been replaced by the presence of antiphospholipid antibodies (",
"    <a class=\"graphic graphic_table graphicRef73334 \" href=\"UTD.htm?2/47/2813\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/9\">",
"     9",
"    </a>",
"    ]. When tested against other rheumatic diseases, these criteria have a sensitivity and specificity of approximately 96 percent.",
"   </p>",
"   <p>",
"    The ACR criteria have some inherent weaknesses [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/16\">",
"     16",
"    </a>",
"    ]. As an example, one can have a renal biopsy demonstrating lupus nephritis, but the patient still fails to fulfill criteria.",
"   </p>",
"   <p>",
"    In an effort to address these weaknesses, a consensus group of experts on SLE, the Systemic Lupus International Collaborating Clinics (SLICC), has proposed revised criteria for SLE (",
"    <a class=\"graphic graphic_table graphicRef86633 \" href=\"UTD.htm?1/31/1535\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/17\">",
"     17",
"    </a>",
"    ]. Classification as having SLE by the SLICC criteria requires either that a patient satisfy at least 4 of 17 criteria, including at least 1 of the 11 clinical criteria and one of the six immunologic criteria,",
"    <strong>",
"     or",
"    </strong>",
"    that the patient has biopsy-proven nephritis compatible with SLE in the presence of ANA or anti-dsDNA antibodies.",
"   </p>",
"   <p>",
"    The SLICC criteria were validated by analysis of 690 patients with SLE or other rheumatic diseases. In this initial validation testing, the SLICC revised criteria had greater sensitivity but lower specificity than the 1997 ACR classification criteria (sensitivity of 97 versus 83 percent and specificity of 84 versus 96 percent, respectively). These criteria were developed as classification criteria, which are most applicable to use for clinical and epidemiologic research, and the SLICC group has proposed that they may serve as alternative classification criteria for use in SLE clinical care and research. They have not been evaluated for use in diagnosis.",
"   </p>",
"   <p>",
"    Using the analogy of one of the old ARA criteria for the diagnosis of rheumatoid arthritis, we suggest that patients may be classified as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Classical SLE &mdash; many ACR criteria",
"     </li>",
"     <li>",
"      Definite SLE &mdash; four or more ACR criteria",
"     </li>",
"     <li>",
"      Possible SLE&mdash;less than four ACR criteria",
"     </li>",
"     <li>",
"      Undifferentiated connective tissue disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Undifferentiated connective tissue disease (UCTD) is defined as a patient with a positive serology and evidence of inflammation on examination who does not meet the ACR criteria for SLE or any other autoimmune disorder. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/61/42968?source=see_link\">",
"     \"Undifferentiated systemic rheumatic (connective tissue) diseases and overlap syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Case series have been published that summarize the outcome of patients who have UCTD at presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/18-22\">",
"     18-22",
"    </a>",
"    ]. Up to one-third have all symptoms and signs disappear over a 10-year follow-up period. Anywhere from 40 to 60 percent continue with their initial clinical features, while 5 to 30 percent evolve and meet classification criteria for a definite disease, such as rheumatoid arthritis, SLE, scleroderma, or an inflammatory myopathy (myositis) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/18-22\">",
"     18-22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/61/42968?source=see_link\">",
"     \"Undifferentiated systemic rheumatic (connective tissue) diseases and overlap syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Thus, patients with UCTD need to be followed carefully and need to be encouraged to report new symptoms and to have periodic laboratory testing to assess for the emergence of new clinical features or laboratory findings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Autoantibodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ANA test is the best diagnostic test for SLE and should be performed whenever SLE is suspected [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28520?source=see_link&amp;anchor=H3#H3\">",
"     \"Measurement and clinical significance of antinuclear antibodies\", section on 'Systemic autoimmune disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The ANA is positive in significant titer (usually 1:160 or higher) in virtually all patients with SLE. Depending upon the titer of the ANA, the false positive rate in healthy controls varies from approximately 30 percent with ANA titers of 1:40 (high sensitivity, low specificity) to as little as 3 percent with ANA titers of 1:320 (low sensitivity, high specificity) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/24\">",
"     24",
"    </a>",
"    ]. The probability of having SLE in a population at variable risk for lupus is less than 0.14 percent if the ANA test is negative [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/8,25,26\">",
"     8,25,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Since diseases other than SLE are associated with a positive ANA, the predictive value of a positive test depends upon the population being studied. In a review of 276 patients referred to a rheumatologist for a positive ANA (titer &ge;1:40) without a diagnosis, 52 (19 percent) were diagnosed with SLE [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is a group of patients with fibromyalgia-like manifestations and a positive ANA. These patients differ clinically from patients with definite SLE and generally do not merit the diagnosis of SLE [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/49/35608?source=see_link\">",
"     \"Differential diagnosis of fibromyalgia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Antinuclear antibodies are also present, usually in lower titer, in a variety of other disorders (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28520?source=see_link\">",
"     \"Measurement and clinical significance of antinuclear antibodies\"",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Sj&ouml;gren&rsquo;s syndrome &mdash; 68 percent",
"     </li>",
"     <li>",
"      Scleroderma &mdash; 40 to 75 percent (especially with a speckled-pattern of ANAs)",
"     </li>",
"     <li>",
"      Juvenile idiopathic arthritis &mdash; 16 percent",
"     </li>",
"     <li>",
"      Rheumatoid arthritis &mdash; 25 to 50 percent (especially with a diffuse pattern of ANAs)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     dsDNA and Sm antibodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two commonly obtained autoantibodies that are highly specific for SLE: anti-double-stranded DNA (dsDNA) antibodies [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/28,29\">",
"     28,29",
"    </a>",
"    ] and anti-Sm antibodies [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/10/1192?source=see_link\">",
"     \"Antibodies to double-stranded (ds)DNA, Sm, and U1 RNP\"",
"    </a>",
"    .) The sensitivity is much lower at about 75 and 25 percent, respectively. One study, for example, evaluated seven commercial ELISA assays for anti-dsDNA antibodies; the following results were obtained [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/31\">",
"     31",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Sensitivity &mdash; 66 to 95 percent",
"     </li>",
"     <li>",
"      Specificity &mdash; 75 to 100 percent",
"     </li>",
"     <li>",
"      Predictive value &mdash; 89 to 100 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Association of specific antibodies with specific clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some autoantibodies produced in patients with SLE or other rheumatic diseases tend to be associated with certain clinical settings with a variable degree of sensitivity and specificity (",
"    <a class=\"graphic graphic_table graphicRef58564 graphicRef71307 \" href=\"UTD.htm?38/63/39934\">",
"     table 5A-B",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Antibodies to ribonucleoprotein (RNP) in SLE, mixed connective tissue disease, and scleroderma",
"     </li>",
"     <li>",
"      Antibodies to Ro (SSA) and La (SSB) in SLE and Sj&ouml;gren&rsquo;s syndrome (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/23/8568?source=see_link\">",
"       \"The anti-Ro/SSA and anti-La/SSB antigen-antibody systems\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The following associations have been noted between specific antibodies and manifestations of SLE [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/32\">",
"     32",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Anti-dsDNA with nephritis and active systemic disease",
"     </li>",
"     <li>",
"      Anti-RNP (U1 RNP) with myositis, Raynaud phenomenon, and less severe lupus",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Anti-Ro/SSA",
"      </span>",
"      with lymphopenia, photosensitivity, neonatal lupus, C2 deficiency, subacute cutaneous lupus erythematosus, and Sj&ouml;gren&rsquo;s syndrome; and",
"      <span class=\"nowrap\">",
"       anti-La/SSB",
"      </span>",
"      with neonatal lupus and Sj&ouml;gren&rsquo;s syndrome (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/23/8568?source=see_link\">",
"       \"The anti-Ro/SSA and anti-La/SSB antigen-antibody systems\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/57/24474?source=see_link\">",
"       \"Neonatal lupus\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Anti-ribosomal P protein with neuropsychiatric manifestations in some but not all studies. Other associations with different disease manifestations have also been described, but none have been described consistently. Anti-ribosomal P protein antibodies have high specificity for the diagnosis of SLE, although they lack sensitivity for SLE and lack specificity for involvement of a particular organ system or disease manifestation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27718?source=see_link\">",
"       \"Antiribosomal P protein antibodies\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Antiphospholipid antibodies with the occurrence of venous or arterial thrombosis or of specific pregnancy morbidity (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/29/27096?source=see_link\">",
"       \"Diagnosis of the antiphospholipid syndrome\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H49403701\">",
"    <span class=\"h3\">",
"     ANA-negative lupus",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the 1970s, there were several reports of patients who met the ACR criteria for SLE but were persistently negative for ANA by immunofluorescence (IF) staining [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/33\">",
"     33",
"    </a>",
"    ]. Although not recognized at the time, this consistently negative finding occurred because sera were tested using mouse and not human tissues as the substrate for the IF ANA [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/34\">",
"     34",
"    </a>",
"    ]. By comparison, anti-Ro antibodies were found in most of these patients when a human cell line extract was used as substrate for anti-Ro antibody testing.",
"   </p>",
"   <p>",
"    The subsequent substitution of HEp2 cells (a human cell line) for mouse tissue sections in the IF ANA assay has resulted in only a small number of SLE patients with persistently negative IF ANA. Nevertheless, on rare occasions, the presence of anti-Ro antibodies may suggest a systemic autoimmune disease, despite the presence of a negative IF ANA. As an example, in one study in Sweden, among 4025 samples tested for ANA, 64 patients with negative IF ANA were identified with anti-Ro antibodies [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/35\">",
"     35",
"    </a>",
"    ]. Of these 64 patients, 12 had SLE, and five had cutaneous LE.",
"   </p>",
"   <p>",
"    The very small number of patients with ANA-negative lupus includes selected patients with antiphospholipid syndrome; with histologically documented lupus nephritis, with a history of treatment with glucocorticoids and immunosuppressives; with positive skin biopsies and clinical features of SLE; and with neonatal lupus [",
"    <a class=\"abstract\" href=\"UTD.htm?3/16/3338/abstract/36-38\">",
"     36-38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the protean manifestations of SLE, the differential diagnosis is correspondingly broad. It is beyond the scope of this review to provide a comprehensive list of possible alternative diagnoses.",
"   </p>",
"   <p>",
"    However, in a particular patient in whom the diagnosis of SLE is being considered, it is likely that one or more clinical features will be salient. In such a case, referring to a general discussion of the diagnostic approach to that symptom, physical finding, laboratory test, or imaging abnormality will help assure that the diagnostic net is broadly cast. The approaches to many of the following manifestations are discussed in detail elsewhere.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Systemic symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The various causes of chronic fatigue (",
"    <a class=\"graphic graphic_table graphicRef56425 \" href=\"UTD.htm?4/7/4221\">",
"     table 6",
"    </a>",
"    ) and weight loss (",
"    <a class=\"graphic graphic_table graphicRef69495 \" href=\"UTD.htm?8/61/9181\">",
"     table 7",
"    </a>",
"    ) should be considered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/36/23111?source=see_link\">",
"     \"Approach to the adult patient with fatigue\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/35/2617?source=see_link\">",
"     \"Approach to the patient with weight loss\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Polyarthritis/polyarthralgia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Widespread joint pain or frank synovitis has many etiologies (",
"    <a class=\"graphic graphic_table graphicRef74266 \" href=\"UTD.htm?31/60/32716\">",
"     table 8",
"    </a>",
"    ). If there is uncertainty about the presence or absence of inflammation in a patient with polyarthralgia, magnetic resonance imaging of symptomatic joints may be informative. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/15/34039?source=see_link\">",
"     \"Evaluation of the adult with polyarticular pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Renal disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renal involvement is common in SLE and most often involves the glomeruli. The glomerular lesions include focal or diffuse proliferative glomerulonephritis and membranous nephropathy, all of which can be seen in other disorders (",
"    <a class=\"graphic graphic_table graphicRef62131 \" href=\"UTD.htm?34/13/35036\">",
"     table 9",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/3/27706?source=see_link\">",
"     \"Diagnosis and classification of renal disease in systemic lupus erythematosus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other causes of impaired renal function can be seen that are not directly caused by SLE, including superimposed problems such as hypovolemia, urinary tract obstruction, and drug toxicity. The approach to a patient with renal disease is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/60/35785?source=see_link\">",
"     \"Diagnostic approach to the patient with acute kidney injury (acute renal failure) or chronic kidney disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Cutaneous lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;A skin biopsy that includes immunofluorescence testing on both involved and uninvolved non-sun-exposed skin (the &ldquo;lupus band test&rdquo;) may help to differentiate SLE-associated cutaneous involvement from other disorders, such as rosacea or polymorphous light eruption.",
"   </p>",
"   <p>",
"    SLE may be associated with cutaneous vasculitis. In addition, many drugs have been alleged to cause a hypersensitivity vasculitis (",
"    <a class=\"graphic graphic_table graphicRef81148 \" href=\"UTD.htm?2/22/2414\">",
"     table 10",
"    </a>",
"    ). Small-vessel vasculitis can also be caused by infectious, neoplastic, and inflammatory disorders. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/57/30614?source=see_link&amp;anchor=H11#H11\">",
"     \"Hypersensitivity vasculitis in adults\", section on 'Differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following other cutaneous lesions are discussed in detail elsewhere:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Erythematous macules (",
"      <a class=\"graphic graphic_table graphicRef61066 \" href=\"UTD.htm?36/18/37164\">",
"       table 11",
"      </a>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/8/29831?source=see_link\">",
"       \"Approach to the patient with macular skin lesions\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Photo-distributed rash (",
"      <a class=\"graphic graphic_table graphicRef62152 \" href=\"UTD.htm?34/3/34878\">",
"       table 12",
"      </a>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/8/29831?source=see_link&amp;anchor=H3#H3\">",
"       \"Approach to the patient with macular skin lesions\", section on 'Photodistributed macular eruptions'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Discoid skin lesions, which may be confused with hypertrophic lichen planus or actinic keratosis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/27/9656?source=see_link\">",
"       \"Lichen planus\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/49/18200?source=see_link\">",
"       \"Epidemiology, natural history, and diagnosis of actinic keratosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Raynaud phenomenon, which can be caused by a number of drugs and diseases (",
"      <a class=\"graphic graphic_table graphicRef77253 \" href=\"UTD.htm?30/50/31532\">",
"       table 13",
"      </a>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/48/6921?source=see_link&amp;anchor=H11#H11\">",
"       \"Clinical manifestations and diagnosis of the Raynaud phenomenon\", section on 'Secondary RP'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/48/6921?source=see_link&amp;anchor=H12#H12\">",
"       \"Clinical manifestations and diagnosis of the Raynaud phenomenon\", section on 'Evaluation'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Mucosal lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other causes of mucosal lesions should be considered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/11/25786?source=see_link&amp;anchor=H16#H16\">",
"     \"Oral lesions\", section on 'Aphthous ulcerations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Abdominal pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Causes of abdominal pain are presented separately (",
"    <a class=\"graphic graphic_table graphicRef70233 \" href=\"UTD.htm?19/9/19613\">",
"     table 14",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/30/16874?source=see_link\">",
"     \"Differential diagnosis of abdominal pain in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Liver disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elevation of serum aminotransferases has many causes (",
"    <a class=\"graphic graphic_table graphicRef68475 \" href=\"UTD.htm?26/33/27164\">",
"     table 15",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/18/34090?source=see_link\">",
"     \"Approach to the patient with abnormal liver biochemical and function tests\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Lung disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;SLE may be associated with a variety of types of lung disease. The causes and evaluation of the following manifestations are described elsewhere (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/60/11210?source=see_link\">",
"     \"Pulmonary manifestations of systemic lupus erythematosus in adults\"",
"    </a>",
"    ):",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Pleural manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both pleuritic chest pain and pleural effusion, which is frequently exudative, can be seen in SLE and in a number of other disorders (",
"    <a class=\"graphic graphic_table graphicRef75028 \" href=\"UTD.htm?8/44/8907\">",
"     table 16",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef54055 \" href=\"UTD.htm?37/9/38045\">",
"     table 17",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/0/26634?source=see_link&amp;anchor=H32#H32\">",
"     \"Differential diagnosis of chest pain in adults\", section on 'Pleura and pleural space'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/7/16505?source=see_link\">",
"     \"Diagnostic evaluation of a pleural effusion in adults: Initial testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Pneumonitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute pneumonia with typical symptoms, physical findings, and lung infiltrate present on chest radiograph will generally be initially approached as a community-acquired pneumonia. In a patient with known SLE on immunosuppressive therapy, it may be considered a possible opportunistic or nosocomial infection. Suspicion of lupus pneumonitis arises if the pneumonia does not respond to empiric antibiotic or other antimicrobial therapy. Noninfectious (",
"    <a class=\"graphic graphic_table graphicRef63652 \" href=\"UTD.htm?37/21/38235\">",
"     table 18",
"    </a>",
"    ) and infectious causes of nonresolving pneumonia should be considered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/24/23945?source=see_link\">",
"     \"Nonresolving pneumonia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Interstitial lung disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Drugs that can cause lupus as well as those used to treat SLE (",
"    <a class=\"graphic graphic_table graphicRef56668 \" href=\"UTD.htm?26/50/27437\">",
"     table 19",
"    </a>",
"    ) and a variety of other disorders have been associated with interstitial lung disease (",
"    <a class=\"graphic graphic_table graphicRef64034 \" href=\"UTD.htm?37/56/38795\">",
"     table 20",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/20/22856?source=see_link\">",
"     \"Approach to the adult with interstitial lung disease: Clinical evaluation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Pulmonary hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptomatic severe pulmonary hypertension is uncommonly a feature of SLE. The evaluation of pulmonary hypertension and other causes of pulmonary hypertension, particularly chronic recurrent pulmonary thromboembolism and scleroderma, are presented separately (",
"    <a class=\"graphic graphic_algorithm graphicRef72553 \" href=\"UTD.htm?4/20/4416\">",
"     algorithm 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef62997 \" href=\"UTD.htm?17/22/17772\">",
"     table 21",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/63/2041?source=see_link\">",
"     \"Clinical features and diagnosis of pulmonary hypertension in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Alveolar hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alveolar hemorrhage is a rare manifestation of SLE and has a variety of other causes (",
"    <a class=\"graphic graphic_table graphicRef52374 \" href=\"UTD.htm?42/62/44013\">",
"     table 22",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/61/23512?source=see_link\">",
"     \"The diffuse alveolar hemorrhage syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Cardiovascular disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cardiovascular manifestations of SLE include pericarditis, which can be caused by a variety of disorders (",
"    <a class=\"graphic graphic_table graphicRef67851 \" href=\"UTD.htm?7/0/7181\">",
"     table 23",
"    </a>",
"    ); myocardiopathies; coronary artery disease; hypertension; and endocarditis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/43/30392?source=see_link\">",
"     \"Etiology of pericardial disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The differential diagnosis of nonbacterial (verrucous, Libman-Sacks) endocarditis includes culture-negative infective endocarditis, the antiphospholipid syndrome, and hypercoagulable states, such as those associated with malignant diseases. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/24/41352?source=see_link\">",
"     \"Diagnostic approach to infective endocarditis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/31/23034?source=see_link\">",
"     \"Clinical manifestations of the antiphospholipid syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/43/35514?source=see_link\">",
"     \"Hypercoagulable disorders associated with malignancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Central nervous system disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The neurologic and psychiatric features of SLE and their differential diagnosis are discussed elsewhere. Two of these manifestations are seizures and stroke. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/43/5816?source=see_link\">",
"     \"Diagnostic approach to the neuropsychiatric manifestations of systemic lupus erythematosus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Seizures",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to epilepsy, metabolic derangements, hypotension, and hypoxemia are among the causes of seizures other than SLE (",
"    <a class=\"graphic graphic_table graphicRef61807 \" href=\"UTD.htm?5/14/5355\">",
"     table 24",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/9/25753?source=see_link\">",
"     \"Evaluation of the first seizure in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Stroke",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of acute stroke is presented separately (",
"    <a class=\"graphic graphic_table graphicRef69869 \" href=\"UTD.htm?26/51/27451\">",
"     table 25",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/47/28410?source=see_link\">",
"     \"Overview of the evaluation of stroke\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Ophthalmologic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a number of ophthalmologic manifestations of SLE, all of which can be caused by other disorders. The manifestations include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Keratoconjunctivitis sicca (dry eye) (",
"      <a class=\"graphic graphic_table graphicRef77821 \" href=\"UTD.htm?37/39/38524\">",
"       table 26",
"      </a>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/22/18794?source=see_link\">",
"       \"Classification and diagnosis of Sj&ouml;gren's syndrome\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Retinal vasculitis (",
"      <a class=\"graphic graphic_table graphicRef56959 \" href=\"UTD.htm?2/38/2669\">",
"       table 27",
"      </a>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/17/13590?source=see_link\">",
"       \"Retinal vasculitis associated with primary ocular disorders\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/49/33561?source=see_link\">",
"       \"Retinal vasculitis associated with systemic disorders and infections\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Episcleritis and scleritis (",
"      <a class=\"graphic graphic_table graphicRef77619 \" href=\"UTD.htm?36/5/36955\">",
"       table 28",
"      </a>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/5/80?source=see_link\">",
"       \"Episcleritis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/32/22023?source=see_link\">",
"       \"Clinical manifestations and diagnosis of scleritis\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Hematologic abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of hematologic abnormalities can occur in SLE, each of which can be caused by other diseases. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/49/14106?source=see_link\">",
"     \"Hematologic manifestations of systemic lupus erythematosus in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The abnormalities include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Anemia, which can be associated with comorbid chronic disease, diet, or medication, as well as hemolytic anemia (",
"      <a class=\"graphic graphic_table graphicRef72394 \" href=\"UTD.htm?20/27/20924\">",
"       table 29",
"      </a>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/3/18489?source=see_link\">",
"       \"Approach to the diagnosis of hemolytic anemia in the adult\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Leukopenia, which most often reflects neutropenia but which can also be caused by lymphocytopenia (",
"      <a class=\"graphic graphic_table graphicRef69186 \" href=\"UTD.htm?5/19/5437\">",
"       table 30",
"      </a>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18170?source=see_link\">",
"       \"Overview of neutropenia\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Thrombocytopenia (",
"      <a class=\"graphic graphic_table graphicRef67855 \" href=\"UTD.htm?32/19/33084\">",
"       table 31",
"      </a>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/19/15674?source=see_link\">",
"       \"Approach to the adult patient with thrombocytopenia\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Microangiopathic hemolytic anemia, which can cause the combination of hemolytic anemia and thrombocytopenia and which can result from thrombotic thrombocytopenic",
"      <span class=\"nowrap\">",
"       purpura/hemolytic",
"      </span>",
"      uremic syndrome",
"      <span class=\"nowrap\">",
"       (TTP/HUS)",
"      </span>",
"      (",
"      <a class=\"graphic graphic_table graphicRef69868 \" href=\"UTD.htm?4/25/4508\">",
"       table 32",
"      </a>",
"      ) or from disseminated intravascular coagulation (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/61/36826?source=see_link\">",
"       \"Causes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/20/25929?source=see_link\">",
"       \"Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Hypercoagulable state (thrombophilia), which can lead to venous",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      arterial thromboemboli (",
"      <a class=\"graphic graphic_table graphicRef59759 \" href=\"UTD.htm?1/6/1132\">",
"       table 33",
"      </a>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43786?source=see_link\">",
"       \"Overview of the causes of venous thrombosis\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A predisposition to arterial thrombosis or thromboembolism is sometimes associated with the presence of antiphospholipid antibodies in patients with SLE. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/31/23034?source=see_link\">",
"     \"Clinical manifestations of the antiphospholipid syndrome\"",
"    </a>",
"    .) Other causes of arterial thromboembolism include those that cause nonbacterial (Libman-Sacks) endocarditis, as discussed earlier. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/43/35514?source=see_link\">",
"     \"Hypercoagulable disorders associated with malignancy\"",
"    </a>",
"    .) Atherosclerosis may be accelerated in patients with SLE. This may also occur in states with hyperhomocysteinemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/37/19034?source=see_link&amp;anchor=H8#H8\">",
"     \"Overview of homocysteine\", section on 'Hyperhomocysteinemia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Arterial thromboembolic disease during",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    therapy raises the possibility of heparin-induced thrombocytopenia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/59/40890?source=see_link\">",
"     \"Heparin-induced thrombocytopenia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h3\">",
"     Lymphadenopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disorders with prominent peripheral lymphadenopathy are presented separately (",
"    <a class=\"graphic graphic_table graphicRef77382 \" href=\"UTD.htm?24/2/24620\">",
"     table 34",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/10/39080?source=see_link\">",
"     \"Evaluation of peripheral lymphadenopathy in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?21/42/22178?source=see_link\">",
"       \"Patient information: Lupus (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?12/61/13265?source=see_link\">",
"       \"Patient information: Antinuclear antibodies (ANA) (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?28/35/29238?source=see_link\">",
"       \"Patient information: Systemic lupus erythematosus (SLE) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H500431\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnosis of systemic lupus erythematosus (SLE) is straightforward in a patient who presents with several compatible clinical features and who has supportive laboratory studies. SLE can also cause isolated cytopenias or single organ involvement (eg, nephritis or pericarditis) or may first be manifested by an incidental laboratory finding. Such patients may subsequently develop the characteristic multisystem features of SLE over a period of months or years. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      SLE usually begins with one or several of the following features (see",
"      <a class=\"local\" href=\"#H3\">",
"       'Presenting clinical manifestations'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Unexplained nonspecific symptoms such as fever, fatigue, or weight loss",
"     </li>",
"     <li>",
"      Photosensitive rash",
"     </li>",
"     <li>",
"      Arthralgia or arthritis",
"     </li>",
"     <li>",
"      Raynaud phenomenon",
"     </li>",
"     <li>",
"      Serositis (pleuritis, pericarditis, peritonitis)",
"     </li>",
"     <li>",
"      Nephritis or nephrotic syndrome",
"     </li>",
"     <li>",
"      Neurologic symptoms such as seizures, psychosis, cognitive dysfunction, stroke, headache, or peripheral neuropathy",
"     </li>",
"     <li>",
"      Alopecia",
"     </li>",
"     <li>",
"      Phlebitis, arterial",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      venous thromboembolic phenomena",
"     </li>",
"     <li>",
"      Recurrent miscarriage",
"     </li>",
"     <li>",
"      Anemia",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Testing that may provide diagnostically useful information when SLE is suspected includes (see",
"      <a class=\"local\" href=\"#H4\">",
"       'Laboratory testing'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Imaging'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Autoantibody testing, including antinuclear, antiphospholipid, anti-double-stranded DNA, and anti-Smith antibodies",
"     </li>",
"     <li>",
"      Complete blood count and differential",
"     </li>",
"     <li>",
"      Complement C3 and C4",
"     </li>",
"     <li>",
"      Urinalysis",
"     </li>",
"     <li>",
"      Erythrocyte sedimentation rate",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      C reactive protein",
"     </li>",
"     <li>",
"      Comprehensive metabolic profile",
"     </li>",
"     <li>",
"      Creatine kinase",
"     </li>",
"     <li>",
"      24-hour urine collection for calculation of creatinine clearance and for quantitation of proteinuria or",
"      <span class=\"nowrap\">",
"       protein/creatinine",
"      </span>",
"      ratios",
"     </li>",
"     <li>",
"      Diagnostic imaging, which is not routinely obtained unless indicated by the presence of symptoms, clinical findings, or laboratory abnormalities",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Other tests, including biopsy of an involved organ (eg, skin or kidney), is sometimes indicated depending upon the clinical presentation and upon associated differential diagnostic possibilities. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Biopsy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Other tests'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We classify patients with SLE as having classical or definite SLE or as having undifferentiated connective tissue disease (UCTD), depending upon the number of American College of Rheumatology classification criteria for SLE that are present (",
"      <a class=\"graphic graphic_table graphicRef86633 \" href=\"UTD.htm?1/31/1535\">",
"       table 4",
"      </a>",
"      ). Patients with UCTD need to be followed carefully and need to be encouraged to report new symptoms and to have periodic laboratory testing to assess for the emergence of new clinical features or laboratory findings. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Diagnostic criteria'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The antinuclear antibody (ANA) test is the best diagnostic test for SLE and should be performed whenever SLE is suspected. The ANA is positive in significant titer (usually 1:160 or higher) in virtually all patients with SLE but has only moderate specificity, especially at lower levels. The predictive value of a positive test depends upon the population being studied. ANAs are also present, usually in lower titer, in a variety of other disorders. There are two commonly obtained autoantibodies that are highly specific for SLE: anti-double-stranded DNA (dsDNA) antibodies and anti-Smith (Sm) antibodies. The sensitivity is much lower at about 75 and 25 percent, respectively. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Autoantibodies'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10\">",
"       'dsDNA and Sm antibodies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Some autoantibodies produced in patients with SLE or other rheumatic diseases tend to be associated with certain clinical settings with a variable degree of sensitivity and specificity (",
"      <a class=\"graphic graphic_table graphicRef58564 graphicRef71307 \" href=\"UTD.htm?38/63/39934\">",
"       table 5A-B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Association of specific antibodies with specific clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Given the protean manifestations of SLE, the differential diagnosis is correspondingly broad. However, in a particular patient in whom the diagnosis of SLE is being considered, it is likely that one or more clinical features will be salient, and the differential diagnosis should focus on the diagnostic approach to that symptom, physical finding, laboratory test, or imaging abnormality. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/1\">",
"      Von Feldt JM. Systemic lupus erythematosus. Recognizing its various presentations. Postgrad Med 1995; 97:79, 83, 86 passim.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/2\">",
"      Cervera R, Khamashta MA, Font J, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1993; 72:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/3\">",
"      Estes D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 1971; 50:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/4\">",
"      Fessler BJ, Boumpas DT. Severe major organ involvement in systemic lupus erythematosus. Diagnosis and management. Rheum Dis Clin North Am 1995; 21:81.",
"     </a>",
"    </li>",
"    <li>",
"     Rothfield N. Clinical features of systemic lupus erythematosus. In: Textbook of Rheumatology, Kelley WN, Harris ED, Ruddy S, Sledge CB (Eds), Saunders, Philadelphia 1981.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/6\">",
"      Nakamura RM, Bylund DJ. Contemporary concepts for the clinical and laboratory evaluation of systemic lupus erythematosus and \"lupus-like\" syndromes. J Clin Lab Anal 1994; 8:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/7\">",
"      Heinlen LD, McClain MT, Merrill J, et al. Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms. Arthritis Rheum 2007; 56:2344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/8\">",
"      Liang MH, Meenan RF, Cathcart ES, Schur PH. A screening strategy for population studies in systemic lupus erythematosus. Series design. Arthritis Rheum 1980; 23:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/9\">",
"      Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40:1725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/10\">",
"      Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/11\">",
"      Citera G, Wilson WA. Ethnic and geographic perspectives in SLE. Lupus 1993; 2:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/12\">",
"      Johnson AE, Gordon C, Palmer RG, Bacon PA. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum 1995; 38:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/13\">",
"      Meyer O. A critical appraisal of the classification criteria for systemic lupus erythematosus. Clin Exp Rheumatol 1994; 12 Suppl 11:S41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/14\">",
"      Symmons DP. Frequency of lupus in people of African origin. Lupus 1995; 4:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/15\">",
"      Bae SC, Fraser P, Liang MH. The epidemiology of systemic lupus erythematosus in populations of African ancestry: a critical review of the \"prevalence gradient hypothesis\". Arthritis Rheum 1998; 41:2091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/16\">",
"      Petri M, Magder L. Classification criteria for systemic lupus erythematosus: a review. Lupus 2004; 13:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/17\">",
"      Petri M, Orbai AM, Alarc&oacute;n GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64:2677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/18\">",
"      Greer JM, Panush RS. Incomplete lupus erythematosus. Arch Intern Med 1989; 149:2473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/19\">",
"      Lom-Orta H, Alarcon-Segovia D, Diaz-Jouanen E. Systemic lupus erythematosus. Differences between patients who do, and who do not, fulfill classification criteria at the time of diagnosis. J Rheumatol 1980; 7:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/20\">",
"      Bodolay E, Csiki Z, Szekanecz Z, et al. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol 2003; 21:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/21\">",
"      St&aring;hl Hallengren C, Nived O, Sturfelt G. Outcome of incomplete systemic lupus erythematosus after 10 years. Lupus 2004; 13:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/22\">",
"      Mosca M, Tani C, Bombardieri S. A case of undifferentiated connective tissue disease: is it a distinct clinical entity? Nat Clin Pract Rheumatol 2008; 4:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/23\">",
"      von M&uuml;hlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995; 24:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/24\">",
"      Tan EM, Feltkamp TE, Smolen JS, et al. Range of antinuclear antibodies in \"healthy\" individuals. Arthritis Rheum 1997; 40:1601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/25\">",
"      Shiel WC Jr, Jason M. The diagnostic associations of patients with antinuclear antibodies referred to a community rheumatologist. J Rheumatol 1989; 16:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/26\">",
"      Griner PF, Mayewski RJ, Mushlin AI, Greenland P. Selection and interpretation of diagnostic tests and procedures. Principles and applications. Ann Intern Med 1981; 94:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/27\">",
"      Calvo-Al&eacute;n J, Bastian HM, Straaton KV, et al. Identification of patient subsets among those presumptively diagnosed with, referred, and/or followed up for systemic lupus erythematosus at a large tertiary care center. Arthritis Rheum 1995; 38:1475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/28\">",
"      Smeenk R, Brinkman K, van den Brink H, et al. Antibodies to DNA in patients with systemic lupus erythematosus. Their role in the diagnosis, the follow-up and the pathogenesis of the disease. Clin Rheumatol 1990; 9:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/29\">",
"      Eaton RB, Schnneider G, Schur PH. Enzyme immunoassay for antibodies to native DNA. Specificity and quality of antibodies. Arthritis Rheum 1983; 26:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/30\">",
"      Munves EF, Schur PH. Antibodies to Sm and RNP. Prognosticators of disease involvement. Arthritis Rheum 1983; 26:848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/31\">",
"      Avi&ntilde;a-Zubieta JA, Galindo-Rodriguez G, Kwan-Yeung L, et al. Clinical evaluation of various selected ELISA kits for the detection of anti-DNA antibodies. Lupus 1995; 4:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/32\">",
"      Harley JB. Autoantibodies are central to the diagnosis and clinical manifestations of lupus. J Rheumatol 1994; 21:1183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/33\">",
"      Maddison PJ, Provost TT, Reichlin M. Serological findings in patients with \"ANA-negative\" systemic lupus erythematosus. Medicine (Baltimore) 1981; 60:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/34\">",
"      Cross LS, Aslam A, Misbah SA. Antinuclear antibody-negative lupus as a distinct diagnostic entity--does it no longer exist? QJM 2004; 97:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/35\">",
"      Blomberg S, Ronnblom L, Wallgren AC, et al. Anti-SSA/Ro antibody determination by enzyme-linked immunosorbent assay as a supplement to standard immunofluorescence in antinuclear antibody screening. Scand J Immunol 2000; 51:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/36\">",
"      Pistiner M, Wallace DJ, Nessim S, et al. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum 1991; 21:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/37\">",
"      Meyer O, Piette JC, Bourgeois P, et al. Antiphospholipid antibodies: a disease marker in 25 patients with antinuclear antibody negative systemic lupus erythematosus (SLE). Comparison with a group of 91 patients with antinuclear antibody positive SLE. J Rheumatol 1987; 14:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/16/3338/abstract/38\">",
"      Watson RM, Lane AT, Barnett NK, et al. Neonatal lupus erythematosus. A clinical, serological and immunogenetic study with review of the literature. Medicine (Baltimore) 1984; 63:362.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4668 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-F17749F6BC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_16_3338=[""].join("\n");
var outline_f3_16_3338=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H500431\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Presenting clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Laboratory testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Other tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Diagnostic criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Autoantibodies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - dsDNA and Sm antibodies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Association of specific antibodies with specific clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H49403701\">",
"      - ANA-negative lupus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Systemic symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Polyarthritis/polyarthralgia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Renal disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Cutaneous lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Mucosal lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Abdominal pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Liver disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Lung disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Pleural manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Pneumonitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Interstitial lung disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Pulmonary hypertension",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Alveolar hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Central nervous system disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Seizures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Stroke",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Ophthalmologic disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Hematologic abnormalities",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      - Lymphadenopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H500431\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/4668\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/4668|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?4/20/4416\" title=\"algorithm 1\">",
"      Evaluation of suspected PH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/4668|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/12/42191\" title=\"picture 1\">",
"      LE cell",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/4668|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/29/30173\" title=\"table 1\">",
"      Symptoms of SLE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?15/41/16027\" title=\"table 2\">",
"      Questionnaire for diagnosis SLE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/47/2813\" title=\"table 3\">",
"      ACR criteria for SLE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/31/1535\" title=\"table 4\">",
"      Classification criteria for SLE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/31/30205\" title=\"table 5A\">",
"      ANA disease associations I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?28/7/28797\" title=\"table 5B\">",
"      ANA disease associations II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/7/4221\" title=\"table 6\">",
"      Differential of chronic fatigue",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/61/9181\" title=\"table 7\">",
"      Major causes of weight loss",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/60/32716\" title=\"table 8\">",
"      Causes polyarticular joint pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?34/13/35036\" title=\"table 9\">",
"      Differential glomerular disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/22/2414\" title=\"table 10\">",
"      Drugs cutaneous vasculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/18/37164\" title=\"table 11\">",
"      Macules",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?34/3/34878\" title=\"table 12\">",
"      Drugs and photosensitivity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/50/31532\" title=\"table 13\">",
"      Factors associated with Raynauds",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/9/19613\" title=\"table 14\">",
"      Causes of abdominal pain by location",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/33/27164\" title=\"table 15\">",
"      Eval isolated transaminitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/44/8907\" title=\"table 16\">",
"      Causes of pleuritic chest pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/9/38045\" title=\"table 17\">",
"      Exudative pleural effusions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/21/38235\" title=\"table 18\">",
"      Noninfectious pneumonia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/50/27437\" title=\"table 19\">",
"      Drugs that induce ILD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/56/38795\" title=\"table 20\">",
"      Diseases associated with ILD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/22/17772\" title=\"table 21\">",
"      Classification of SPAH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?42/62/44013\" title=\"table 22\">",
"      Causes of DAH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/0/7181\" title=\"table 23\">",
"      Causes of pericardial disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/14/5355\" title=\"table 24\">",
"      Causes of acute symptomatic seizures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/51/27451\" title=\"table 25\">",
"      Acute stroke differential dx",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/39/38524\" title=\"table 26\">",
"      Differential dx Sjogrens synd",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/38/2669\" title=\"table 27\">",
"      Associations retinal vasculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/5/36955\" title=\"table 28\">",
"      Scleritis and systemic diseases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/27/20924\" title=\"table 29\">",
"      Causes intra- and extra-vascular hemolysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/19/5437\" title=\"table 30\">",
"      Classification of neutropenias",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/19/33084\" title=\"table 31\">",
"      Differential dx of ITP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/25/4508\" title=\"table 32\">",
"      Major causes of TTP-HUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/6/1132\" title=\"table 33\">",
"      Causes of venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/2/24620\" title=\"table 34\">",
"      Causes of lymphadenopathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/10/1192?source=related_link\">",
"      Antibodies to double-stranded (ds)DNA, Sm, and U1 RNP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27718?source=related_link\">",
"      Antiribosomal P protein antibodies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/36/23111?source=related_link\">",
"      Approach to the adult patient with fatigue",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/19/15674?source=related_link\">",
"      Approach to the adult patient with thrombocytopenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/20/22856?source=related_link\">",
"      Approach to the adult with interstitial lung disease: Clinical evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/3/18489?source=related_link\">",
"      Approach to the diagnosis of hemolytic anemia in the adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/18/34090?source=related_link\">",
"      Approach to the patient with abnormal liver biochemical and function tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/8/29831?source=related_link\">",
"      Approach to the patient with macular skin lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/35/2617?source=related_link\">",
"      Approach to the patient with weight loss",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/61/36826?source=related_link\">",
"      Causes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/22/18794?source=related_link\">",
"      Classification and diagnosis of Sj&ouml;gren's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/63/2041?source=related_link\">",
"      Clinical features and diagnosis of pulmonary hypertension in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/20/25929?source=related_link\">",
"      Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/32/22023?source=related_link\">",
"      Clinical manifestations and diagnosis of scleritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/48/6921?source=related_link\">",
"      Clinical manifestations and diagnosis of the Raynaud phenomenon",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/31/23034?source=related_link\">",
"      Clinical manifestations of the antiphospholipid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/3/27706?source=related_link\">",
"      Diagnosis and classification of renal disease in systemic lupus erythematosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/29/27096?source=related_link\">",
"      Diagnosis of the antiphospholipid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/24/41352?source=related_link\">",
"      Diagnostic approach to infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/43/5816?source=related_link\">",
"      Diagnostic approach to the neuropsychiatric manifestations of systemic lupus erythematosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/60/35785?source=related_link\">",
"      Diagnostic approach to the patient with acute kidney injury (acute renal failure) or chronic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/7/16505?source=related_link\">",
"      Diagnostic evaluation of a pleural effusion in adults: Initial testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/30/16874?source=related_link\">",
"      Differential diagnosis of abdominal pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/0/26634?source=related_link\">",
"      Differential diagnosis of chest pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/49/35608?source=related_link\">",
"      Differential diagnosis of fibromyalgia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/49/18200?source=related_link\">",
"      Epidemiology, natural history, and diagnosis of actinic keratosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/5/80?source=related_link\">",
"      Episcleritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/43/30392?source=related_link\">",
"      Etiology of pericardial disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/10/39080?source=related_link\">",
"      Evaluation of peripheral lymphadenopathy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/15/34039?source=related_link\">",
"      Evaluation of the adult with polyarticular pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/9/25753?source=related_link\">",
"      Evaluation of the first seizure in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/49/14106?source=related_link\">",
"      Hematologic manifestations of systemic lupus erythematosus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/59/40890?source=related_link\">",
"      Heparin-induced thrombocytopenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/43/35514?source=related_link\">",
"      Hypercoagulable disorders associated with malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/57/30614?source=related_link\">",
"      Hypersensitivity vasculitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/27/9656?source=related_link\">",
"      Lichen planus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28520?source=related_link\">",
"      Measurement and clinical significance of antinuclear antibodies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/57/24474?source=related_link\">",
"      Neonatal lupus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/24/23945?source=related_link\">",
"      Nonresolving pneumonia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/11/25786?source=related_link\">",
"      Oral lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/37/19034?source=related_link\">",
"      Overview of homocysteine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18170?source=related_link\">",
"      Overview of neutropenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43786?source=related_link\">",
"      Overview of the causes of venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/31/41464?source=related_link\">",
"      Overview of the clinical manifestations of systemic lupus erythematosus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/47/28410?source=related_link\">",
"      Overview of the evaluation of stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/38/41578?source=related_link\">",
"      Overview of the therapy and prognosis of systemic lupus erythematosus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?12/61/13265?source=related_link\">",
"      Patient information: Antinuclear antibodies (ANA) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/42/22178?source=related_link\">",
"      Patient information: Lupus (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/35/29238?source=related_link\">",
"      Patient information: Systemic lupus erythematosus (SLE) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/60/11210?source=related_link\">",
"      Pulmonary manifestations of systemic lupus erythematosus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/17/13590?source=related_link\">",
"      Retinal vasculitis associated with primary ocular disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/49/33561?source=related_link\">",
"      Retinal vasculitis associated with systemic disorders and infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/23/8568?source=related_link\">",
"      The anti-Ro/SSA and anti-La/SSB antigen-antibody systems",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/61/23512?source=related_link\">",
"      The diffuse alveolar hemorrhage syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/61/42968?source=related_link\">",
"      Undifferentiated systemic rheumatic (connective tissue) diseases and overlap syndromes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_16_3339="Associated disability of MR";
var content_f3_16_3339=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F64507&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F64507&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Associated disability and level of mental retardation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td>",
"       <strong>",
"        MILD (IQ 50-69):",
"       </strong>",
"       Capable of personal independence with a little guidance and assistance.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        MODERATE (IQ 35-49):",
"       </strong>",
"       Require assistance with more complex activities; communicate with simple sentences.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        SEVERE (IQ 20-34):",
"       </strong>",
"       Require assistance with most ADLs; communicate with words and gestures.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        PROFOUND (IQ &lt;20):",
"       </strong>",
"       Require comprehensive care and assistance; usually non-verbal; high incidence of secondary disabilities.",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_16_3339=[""].join("\n");
var outline_f3_16_3339=null;
var title_f3_16_3340="Fetal mean corpuscular vol by GA";
var content_f3_16_3340=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F69845&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F69845&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Fetal mean corpuscular volume by gestational age",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        GA",
"       </td>",
"       <td class=\"subtitle1\">",
"        5th percentile",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mean",
"       </td>",
"       <td class=\"subtitle1\">",
"        95th percentile",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        20",
"       </td>",
"       <td>",
"        119",
"       </td>",
"       <td>",
"        129",
"       </td>",
"       <td>",
"        140",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        22",
"       </td>",
"       <td>",
"        114",
"       </td>",
"       <td>",
"        124",
"       </td>",
"       <td>",
"        134",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        24",
"       </td>",
"       <td>",
"        110",
"       </td>",
"       <td>",
"        119",
"       </td>",
"       <td>",
"        130",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        26",
"       </td>",
"       <td>",
"        107",
"       </td>",
"       <td>",
"        116",
"       </td>",
"       <td>",
"        126",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        28",
"       </td>",
"       <td>",
"        104",
"       </td>",
"       <td>",
"        113",
"       </td>",
"       <td>",
"        123",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        103",
"       </td>",
"       <td>",
"        112",
"       </td>",
"       <td>",
"        122",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        32",
"       </td>",
"       <td>",
"        102",
"       </td>",
"       <td>",
"        111",
"       </td>",
"       <td>",
"        121",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        34",
"       </td>",
"       <td>",
"        102",
"       </td>",
"       <td>",
"        110",
"       </td>",
"       <td>",
"        120",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        36",
"       </td>",
"       <td>",
"        102",
"       </td>",
"       <td>",
"        110",
"       </td>",
"       <td>",
"        120",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        38",
"       </td>",
"       <td>",
"        102",
"       </td>",
"       <td>",
"        110",
"       </td>",
"       <td>",
"        120",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        40",
"       </td>",
"       <td>",
"        102",
"       </td>",
"       <td>",
"        110",
"       </td>",
"       <td>",
"        120",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     GA: gestational age.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_16_3340=[""].join("\n");
var outline_f3_16_3340=null;
var title_f3_16_3341="Ddx LPL path";
var content_f3_16_3341=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F69760&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F69760&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Histology, immunophenotype, and genetic features of differential diagnosis of lymphoplasmacytic lymphoma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Entity",
"       </td>",
"       <td class=\"subtitle1\">",
"        Histology",
"       </td>",
"       <td class=\"subtitle1\">",
"        Immunophenotype",
"       </td>",
"       <td class=\"subtitle1\">",
"        Genetic features/other",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lymphoplasmacytic lymphoma",
"       </td>",
"       <td>",
"        <p>",
"         &ge;10 percent infiltration by small lymphocytes, plasmacytoid lymphocytes, and plasma cells, with variable numbers of admixed immunoblasts.",
"        </p>",
"        <p>",
"         Characteristic (but not pathognomonic) hyperplasia of mast cells in marrow.",
"        </p>",
"        <p>",
"         Lymph nodes are usually diffusely effaced. Proliferation centers and marginal zone type differentiation are absent.",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Express pan B-cell antigens (CD19, CD20, CD22, CD79a). Most, but not all, cases fail to express CD5.",
"        </p>",
"        <p>",
"         Variable expression of CD11c, CD43, CD25. Most cases express IgM; fewer express IgG or IgA.",
"        </p>",
"        <p>",
"         CD10 and cyclin D1 are not expressed.",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Majority have a monoclonal IgM paraprotein.",
"        </p>",
"        <p>",
"         No specific chromosomal abnormalities.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic lymphocytic leukemia/small lymphocytic lymphoma",
"       </td>",
"       <td>",
"        \"Typical\" CLL/SLL cells are small mature appearing lymphocytes with a dense nucleus, partially aggregated chromatin, no discernible nucleoli, and a narrow border of clear to slightly basophilic cytoplasm.",
"       </td>",
"       <td>",
"        Always express CD5, usually CD23 positive. Dim expression of CD20 and surface Ig.",
"       </td>",
"       <td>",
"        Del13q, del 11q, del17p, trisomy 12",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        B-cell prolymphocytic leukemia",
"       </td>",
"       <td>",
"        Prolymphocytes &gt;55 percent of the neoplastic cells. Bone marrow has interstitial pattern of infiltration. Lymph nodes may show vague nodularity, but proliferation centers are absent.",
"       </td>",
"       <td>",
"        Express bright surface IgM +/- IgD and bright CD20 as well as other B-cell antigens (CD19, CD22, CD79a, FMC7).",
"       </td>",
"       <td>",
"        <p>",
"         t(11;14) must be excluded.",
"        </p>",
"        <p>",
"         No associated paraproteinemia.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Follicular lymphoma",
"       </td>",
"       <td>",
"        Nodular growth pattern of follicle center cells (centrocytes and centroblasts).",
"       </td>",
"       <td>",
"        Typically express CD10, HLA-DR, pan B-cell antigens (CD19, CD20, CD79a), CD21, and surface IgM, IgG, or IgA.",
"       </td>",
"       <td>",
"        t(14;18)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Multiple myeloma",
"       </td>",
"       <td>",
"        Infiltration of plasma cells in the bone marrow.",
"       </td>",
"       <td>",
"        Surface Ig is absent. Express CD138, CD38, CD79a, and VS38c. Infrequently express CD19. Approximately 70 percent of myeloma cells will express CD56.",
"       </td>",
"       <td>",
"        Cytogenetics usually abnormal, although there is no specific cytogenetic abnormality.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mantle cell lymphoma",
"       </td>",
"       <td>",
"        Monomorphous small to medium-sized B lymphocytes with irregular nuclei.",
"       </td>",
"       <td>",
"        CD5+ and CD23-; typically co-express surface IgM and IgD; the vast majority over-express cyclin D1.",
"       </td>",
"       <td>",
"        t(11;14)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Marginal zone lymphoma",
"       </td>",
"       <td>",
"        Polymorphous infiltrate of small cells with paler-appearing marginal zone-type differentiation in lymph nodes.",
"       </td>",
"       <td>",
"        Expresses B cell markers CD19, CD20, and CD22, and not CD5, CD10, and CD23.",
"       </td>",
"       <td>",
"        <p>",
"         Chromosomal abnormalities, usually trisomy 3 or t(11;18), are found in most cases.",
"        </p>",
"        <p>",
"         May demonstrate mixed cryoglobulinemia +/- hepatitis C infection.",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     Ig: immunoglobulin.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_16_3341=[""].join("\n");
var outline_f3_16_3341=null;
var title_f3_16_3342="Outcome CRI VE VCO2";
var content_f3_16_3342=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F66454&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F66454&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 477px\">",
"   <div class=\"ttl\">",
"    Outcome in patients with heart failure is related to VE/VCO2 and the chronotropic index",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 457px; height: 323px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In a study of 470 patients with heart failure, Kaplan-Meier plot shows that survival is reduced when VE/VCO2 is increased to &ge;44.7 (33 versus 10 percent for value &lt;44.7) and the chronotropic index (CRI), which correlates with the peak heart rate during exercise, is reduced to &le;0.51 (27 versus 11 percent for CRI &gt;0.51). The combination of VE/VCO2 and CRI was associated with the highest risk of death.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Robbins, M, Francis, G, Pashkow, FJ, et al, Circulation 1999; 100:2411.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_16_3342=[""].join("\n");
var outline_f3_16_3342=null;
var title_f3_16_3343="Early esoph ca endoscopy";
var content_f3_16_3343=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F55091&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F55091&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Early, superficial esophageal cancer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 236px; height: 287px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Early, superficial esophageal cancer seen on endoscopy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William Brugge, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_16_3343=[""].join("\n");
var outline_f3_16_3343=null;
